Sentence,class,file
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 0 0 –104 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/69/ad/main.PMC4552808.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 0 0 –104 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/69/ad/main.PMC4552808.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 0 0 –104 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/69/ad/main.PMC4552808.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,1 0 0 –104 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/69/ad/main.PMC4552808.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1016/j.nicl.2015.07.0112213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.nicl.2015.07.011 .",OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2011.06.00721813210 .,OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1016/ j.jalz.2011.03.00821514249 .,OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
"2 (1), 21 –24.http://dx.doi.org/10.1089/brain.",Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.3233/JAD-2010- 10017720847450 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5698-11.201222745490 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
"Neuron 58 (1), 42 –51.http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1023/A: 102383230570212887040 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
"3, 28. http://dx.doi.org/10.3389/ neuro.05.028.200919949482 .",Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
"J. Neurosci.Methods 222, 56 –61.http://dx.doi.org/10.1016/j.jneumeth.2013.10.01924200506 .",OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
"Rep.441 (1), 1 –46.http://dx.doi.org/10.1016/j.physrep.2006.12.004 .",OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
"34 (44), 14551– 14559. http://dx.doi.org/10.1523/ JNEUROSCI.0964-14.201425355209 .",Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1016/j.clinph.2012.03.,OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
"2011, 156869. http://dx.doi.org/10.1155/2011/15686921253357 .",Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1111/j.1365-2796.2004.01388.x15324362 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1126/science.107406912399581 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1093/brain/ awn26218952674 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1088/0031-9155/51/7/00816552102 .,Non-OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
http://dx.doi.org/10.1016/S1474- 4422(13)70044-923477989 .,OADS,/arxiv_data1/oa_pdf/6e/e4/main.PMC4552812.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/j.nicl.2015.07.0042213-1582/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/ S1053-8119(03)00435-X14568475 .,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1897- 04.200415496671 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/j.schres.2004.01.00415329307 .,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.08.06016246587 .,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1111/j.1601-5215.2010.00467.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4095-08.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1038/ nrn75511994752 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1037/0021-843X.94.4.4703865953 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1017/ S0140525X00058027 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1111/1469-8986.366066710554581 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"78 (1), 3 –13.http://dx.doi.org/10.1016/j.ijpsycho.2010.05.00520580752 .",OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"Psychiatry 35 (2), 96 –103  .http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1097/00001756-200112040-0004311726801 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/ 10.1176/appi.ajp.164.3.44217329469 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1111/j.1469-8986.1991.tb00417.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"6, 246. http://dx.doi.org/10.3389/fnhum.2012.0024622969714 .",Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"J. Psychiatry 168 (1), 73 –81.http://dx.doi.org/10.1176/appi.ajp.2010.0910152220952459 .",Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1111/ 1469-8986.381013311321614 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"35 (1),67–81.http://dx.doi.org/10.1093/schbul/sbn13319074498 .Kim, H., 2014.",Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"Psy- chopathology 41 (2), 77 –84.http://dx.doi.org/10.1159/00011155118033976 .",Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1152/jn.00674.,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1093/schbul/ sbn03818487225 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
1 –7http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1093/cercor/bhr19521840846 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"3, 70. http://dx.doi.org/10.3389/neuro.09.070.200920140266 .",Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/ 0013-4694(85)90083-53477444 .,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/ 10.1016/S0926-6410(02)00066-612063135 .,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/j.neuroimage.2003.10.,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1093/schbul/10.2.1606729409 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"37 (1),17–27.http://dx.doi.org/10.1503/jpn.10017621693094 .",Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1017/S003329171000220521144116 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/0168-5597(89)90061- 02471632 .,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.5587-06.200717329432 .,Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"17(1), 75 –82.http://dx.doi.org/10.1016/S0926-6410(03)00082-X12763194 .",OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
"Science 155 (3768), 1436– 1439. http://dx.doi.org/10.1126/ science.155.3768.14366018511 .",Non-OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.02.04218407525 .,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
http://dx.doi.org/10.1016/j.neuroimage.2003.12.02315050594 .102 J.K. Wynn et al.,OADS,/arxiv_data1/oa_pdf/37/77/main.PMC4552813.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.nicl.2015.07.014 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
Supplementary data related to this article can be found online at http://doi.dx.org/10.1016/j.nicl.2015.07.014 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1093/brain/awh13615033899 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.09.03615588603 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5101-09.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"Epilepsia 44, 7 –15.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"Epilepsia 46, 21 –33.http://dx.doi.org/10.1111/j.1528-1167.2005.00311.x16302873 .",Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1093/brain/awp02819339252 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1109/TBME.2010.205031920501341 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1162/jocn.1993.5.2.16223972151 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"NeuroImage 49 (1), 656– 667. http://dx.doi.org/10.1016/j.neuroimage.",OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1371/journal.pbio.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"Methods 134 (1), 9 –21.http://dx.doi.org/10.1016/j.jneumeth.2003.10.00915102499 .",OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1109/TBME.2009.203780820659822 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1093/brain/ 118.1.2797895011 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1097/ 00004691-199307000-000038408594 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1371/journal.pone.001571021187930 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1111/j.1528-1167.2010.02536.x20331461 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1371/journal.pbio.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.2307/1912791 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"Cortex 19 (1), 72 –78.http://dx.doi.org/10.1093/cercor/bhn05918403396 .",OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.02.,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.jneumeth.2010.11.01521130115 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1227/01.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.clinph.2004.11.,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1007/ BF001980911912013 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/ 10.1111/j.0013-9580.2005.31404.x15730537 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
157 –191http://dx.doi.org/10.1002/ cne.901710204 64477].,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1002/(SICI)1097-0193(1997)5:4 b238:: AID-HBM6 N3.0.CO;2-420408222 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/ 10.1002/1097-0193(200007)10:3 b120::AID-HBM30 N3.0.CO;2-810912591 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"114 (1), 63 –69.http://dx.doi.org/10.1016/S1388-2457(02)00337-112495765 .",OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"NeuroImage 50 (1), 15 –26.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1002/ hbm.2077219378280 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.10.04222036675 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1006/nimg.1997.03159558644 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.clinph.2012.04.02122608485 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.clinph.,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1002/hbm.2072319172633 .126 C.H.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"NeuroImage 42 (1), 87–98.http://dx.doi.org/10.1016/j.neuroimage.2008.04.25018539485 .",OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"21 (2), 71 –83.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1111/j.1528-1167.2010.02938.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"184 (1), 65 –70.http://dx.doi.org/10.1016/S0022-510X(00)00496- 211231034 .",OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.05.05322634857 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.06.06716150610 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1111/j.1528-1157.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"100 (23), 234101. http://dx.doi.org/10.1103/PhysRevLett.100.",Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1093/brain/aws29623250883 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1038/npp.2009.10419693001 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1002/hbm.2098920336686 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"http://dx.doi.org/10.1002/ cne.9032302041401255 .Ray, J.P., Price, J.L., 1993.",Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"337 (1), 1 –31.http://dx.doi.org/10.1002/cne.9033701027506270 .",Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1007/ BF011867697696088.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1002/cne.9025602023549796 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1523/ JNEUROSCI.5587-06.200717329432 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1111/j.1528-1167.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/ 10.1016/j.clinph.2014.05.03825088733 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.05.,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.clinph.2012.10.,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1109/TBME.2008.91988518990625 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1111/j.1528-1167.2009.02329.x19817817 .,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"Epilepsia 52 (1), 84 –93.http://dx.doi.org/10.1111/j.1528-1167.",Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.03.04321453776 .,OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
"126 (1), 27 –38.http://dx.doi.org/10.1016/j.clinph.2014.04.01124856460 .",OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/05/60/main.PMC4552814.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1016/j.nicl.2015.07.0132213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1007/s00415-012-6571- x22714135 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"Springerplus 4, 28. http://dx.doi.org/10.1186/s40064-015-0818-925646151 .",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1016/S0166- 4328(01)00297-211682119 .,OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1016/0028- 3908(91)90165-81663596 .,OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1111/j.1468-2982.2004.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1371/ journal.pone.002806222140507 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1097/NRL.0b013e3181906fc919590381 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"Cephalalgia 33 (9), 629 –808.http://dx.doi.org/10.1177/033310241348565823771276 .",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"19 (5), 696 –701.http://dx.doi.org/10.1016/j.jocn.2011.07.04422440862 .",OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1016/S0140-6736(98)03053-010459905 .,OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
Psychiatry http://dx.doi.org/10.1136/jnnp-2014-31005125722366 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1179/1743132812Y.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1097/01.phm.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"J. Headache Pain 11 (5), 417 –425.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1136/jnnp.2006.10827418202208 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"J. Headache Pain 14, 70. http://dx.doi.org/10.1186/1129-2377-14- 7023937696 .",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1007/s10072- 006-0582-216688611 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1056/ NEJMoa110064822150037 .,OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"10 (1), 53 –57.http://dx.doi.org/10.1046/ j.1468-1331.2003.00510.x12534993 .",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1016/j.pain.2013.07.05023911697 .,OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/ 10.1111/j.1468-2982.2008.01662.x18727645 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1007/s00415- 011-6226-321898138 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"16 (2), 262 –26 7.http://dx.doi.org/10.1111/ j.1468-1331.2008.02406.x19138330 .",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1016/j.ncl.2011.01.00821439453 .,OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"2), 2 –7.http://dx.doi.org/10.1111/j.1468-2982.2004.00892.x15595988 .",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1006/nimg.,OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"244 (1 –2), 137 –141.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"28 (3), 133– 135.http://dx.doi.org/10.1007/s10072-007-0805-117603764 .",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1007/ s10072-008-0908-318545918 .,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
"Psychiatry 32 (1), 35 –37.http://dx.doi.org/10.1136/jnnp.32.1.355774132 .",Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
http://dx.doi.org/10.1007/s10072-003-0147-614658040 .116 E. Graziano et al.,Non-OADS,/arxiv_data1/oa_pdf/48/24/main.PMC4552815.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2015.07.001,Non-OADS,/arxiv_data1/oa_pdf/26/d8/main.PMC4552816.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8 9–93 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/d8/main.PMC4552816.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8 9–93 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/d8/main.PMC4552816.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8 9–93 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/d8/main.PMC4552816.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Di seases, NMNI ,7,8 9–93 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )",Non-OADS,/arxiv_data1/oa_pdf/26/d8/main.PMC4552816.pdf
"11 The number, size, and type of coils were recorded for each case and this information was used to calcu-late the PD of the aneurysm using AngioCalc (http://www.angiocalc.com).",Non-OADS,/arxiv_data1/oa_pdf/ca/91/neurintsurg-2014-011289.PMC4552888.pdf
"Lacunarity was determined using the FracLac plugin(V.2013April.b6, http://rsbweb.nih.gov/ij/plugins/fraclac/) for ImageJ (V .1.44p, National Institutes of Health).",OADS,/arxiv_data1/oa_pdf/ca/91/neurintsurg-2014-011289.PMC4552888.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Molyneux A, Kerr R, Stratton I, et al.",Non-OADS,/arxiv_data1/oa_pdf/ca/91/neurintsurg-2014-011289.PMC4552888.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Khosla A, Brinjikji W, Cloft H, et al.",Non-OADS,/arxiv_data1/oa_pdf/ad/64/neurintsurg-2014-011305.PMC4552889.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Levy MM, Fink MP, Marshall JC, et al.",Non-OADS,/arxiv_data1/oa_pdf/c0/58/emermed-2014-203937.PMC4552895.pdf
Trial information https://www.icnarc.,Non-OADS,/arxiv_data1/oa_pdf/c0/58/emermed-2014-203937.PMC4552895.pdf
2005. http://www.acem.org.au/media/policies-and-guidelines/G24-Implementation-ATS.pdf (last accessed 5 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/c0/58/emermed-2014-203937.PMC4552895.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 National Institute for Health and Clinical Excellence.,Non-OADS,/arxiv_data1/oa_pdf/6d/06/bjophthalmol-2014-306055.PMC4552896.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2013-204733).,OADS,/arxiv_data1/oa_pdf/7b/9e/annrheumdis-2013-204733.PMC4552897.pdf
"57 Moreover, a speci ﬁc programme for patient self-assessment of joint count was explained via video (available at http://www.rhumatismes.net) and demonstration with volunteer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/annrheumdis-2013-204733.PMC4552897.pdf
Nurses were given a booklet to be used for the systematic identi ﬁcation and assessment of the comorbidities associated with RA (http://www.rhumatismes.net/ ﬁchiers/Brochure_SFR_ V7.pdf) (see online supplementary material).,Non-OADS,/arxiv_data1/oa_pdf/7b/9e/annrheumdis-2013-204733.PMC4552897.pdf
"Intervention in the self-assessment arm This nurse-led programme included: (1) a video presentation (available at http://www.rhumatismes.net) explaining thepurpose, calculation and interpretation of the DAS28-ESR tothe patient; (2) training on joint self-assessment by the partici-pating nurse using the video given to each participating patient;and (3) a booklet and DAS calculator asking the patient toreport the results of his/her ‘self-DAS28-ESR ’(using the last available ESR value) on a regular basis (at least monthly) anddiscuss the results with her/his treating rheumatologist.",Non-OADS,/arxiv_data1/oa_pdf/7b/9e/annrheumdis-2013-204733.PMC4552897.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Gabriel SE.,Non-OADS,/arxiv_data1/oa_pdf/7b/9e/annrheumdis-2013-204733.PMC4552897.pdf
August 2011. http://www.nice.org.uk/nicemedia/live/13561/56008/56008.pdf (accessed 6 Apr 2012).,Non-OADS,/arxiv_data1/oa_pdf/7b/9e/annrheumdis-2013-204733.PMC4552897.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Strand V, Gladman D, Isenberg D, et al.",OADS,/arxiv_data1/oa_pdf/2a/0a/annrheumdis-2013-205171.PMC4552899.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jmedgenet-2015-103071).,Non-OADS,/arxiv_data1/oa_pdf/8f/d0/jmedgenet-2015-103071.PMC4552900.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Gourraud PA, Harbo HF, Hauser SL, Baranzini SE.",Non-OADS,/arxiv_data1/oa_pdf/8f/d0/jmedgenet-2015-103071.PMC4552900.pdf
"2104. http://www.R-project.org 27 Benjamini Y, Hochberg Y.",Non-OADS,/arxiv_data1/oa_pdf/8f/d0/jmedgenet-2015-103071.PMC4552900.pdf
"These databases can either be public repositories such as the National Institutes of Health sequence database, Genbank (https://www.ncbi.nlm.nih.gov/ genbank/) or an aligned sequence such as Greengenes (http:// greengenes.lbl.gov/cgi-bin/nph-index.cgi), SIL V A (http://www.",Non-OADS,/arxiv_data1/oa_pdf/ad/a9/postgradmedj-2014-205826rep.PMC4552901.pdf
arb-silva.de/) or RDP-II (http://rdp.cme.msu.edu/).,Non-OADS,/arxiv_data1/oa_pdf/ad/a9/postgradmedj-2014-205826rep.PMC4552901.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Segal LN, Rom WN, Weiden MD.",Non-OADS,/arxiv_data1/oa_pdf/ad/a9/postgradmedj-2014-205826rep.PMC4552901.pdf
"32Table 2 The Public Health Intervenors in the USA ’s racketeering case against the tobacco industry The Intervenors are the following six public health groups that obtained party status through a legal procedure allowing them to join the case after the USA dramatically lowered the level of funding it was seeking for certain remedies, such as smoker cessation and counter-marketing American Cancer Society American Lung AssociationAmericans for Nonsmokers ’ RightsNational African American Tobacco Prevention Network American Heart Association Tobacco-Free Kids Action FundTable 1 Current information for accessing the tobacco company documents Minnesota Tobacco Document DepositoryPhone: (612) 378-5707 Address: 1045 Westgate Drive, Suite 40, Minneapolis, MN 55114, USA British American Tobacco document depositoryPhone: (44) 148-346-4300 Address: Unit 3A, Opus Business Park,Moorfield Road, Slyfield, Guildford GU11SZ, UK University of California, San Francisco —Legacy Tobacco Documents Libraryhttp://legacy.library.ucsf.edu Court-ordered tobacco company document websites Philip Morris USA, Inc http://www.pmdocs.com/R.J.",Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
"Reynolds Tobacco Company, American Tobacco and Brown &Williamsonhttp://www.rjrtdocs.com/rjrtdocs//index.",Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
wmt?tab=home Lorillard Tobacco Company http://www.lorillarddocs.com/public/index.,Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
"wmt?tab=home The Council for Tobacco Research USA, Inchttp://www.ctr-usa.org/ctr/index.wmt?",Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
"tab=home&tab=home The Tobacco Institute http://www.tobaccoinstitute.com/Special communication Muggli ME, et al.Tob Control 2015; 24:514–518.",Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 USCF Legal Tobacco Documents Library: Tobacco Industry Document Bibliography, Papers and Publications based on Document Research.",Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
23 November 1998. http://www.naag.org/backpages/naag/tobacco/msa/msa-pdf/MSA%20with%20Sig% 20Pages%20and%20Exhibits.pdf/ ﬁle_view (accessed 22 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
"24 March 2011. http://www.library.ucsf.edu/sites/all/ﬁles/ucsf_assets/DN5899-8_HirschhornDeclaration.pdf 26 United States v. Philip Morris USA, Inc.",Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3371306/ (accessed 22 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
"Increasing the minimum sale age for tobacco products to 21. http://www.tobaccofreekids.org/res earch/factsheets/pd f/0376.pdf (accessed 5 Apr 2014).Special communication 518 Muggli ME, et al.Tob Control 2015; 24:514–518.",Non-OADS,/arxiv_data1/oa_pdf/c7/15/tobaccocontrol-2014-051749.PMC4552902.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 World Health Organisation: WHO Framework Convention on Tobacco Control.,Non-OADS,/arxiv_data1/oa_pdf/67/64/tobaccocontrol-2014-052051.PMC4552903.pdf
"http://www.econ.uzh.ch/static/workingpapers.php?id=828 3 Kaul A, Wolf M. The (possible) effect of plain packaging on the smoking prevalence of minors in Australia: a trend analysis.",Non-OADS,/arxiv_data1/oa_pdf/67/64/tobaccocontrol-2014-052051.PMC4552903.pdf
"http://www.econ.uzh.ch/static/workingpapers.php?id=8444 Laverty AA, Watt HC, Arnott D, et al.",OADS,/arxiv_data1/oa_pdf/67/64/tobaccocontrol-2014-052051.PMC4552903.pdf
"http://www.aihw.gov.au/alcohol-and-other-drugs/ndshs/2013/tobacco/ 424 Laverty AA, et al.Tob Control 2015; 24:422–424.",Non-OADS,/arxiv_data1/oa_pdf/67/64/tobaccocontrol-2014-052051.PMC4552903.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ To cite Kopylev L, Christensen KY, Brown J W, et al.",Non-OADS,/arxiv_data1/oa_pdf/62/41/oemed-2015-103063.PMC4552904.pdf
Received 7 May 2015 Accepted 22 June 2015Published Online First 22 July 2015 ▸http://dx.doi.org/10.1136/oemed-2015-102894 Occup Environ Med 2015; 72:685 –686.,Non-OADS,/arxiv_data1/oa_pdf/62/41/oemed-2015-103063.PMC4552904.pdf
9 January 2015.http://ntp.niehs.nih.gov/ntp/ohat/pubs/handbookjan 2015_508.pdf (ac cessed 21 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/62/41/oemed-2015-103063.PMC4552904.pdf
"Currently in Canada, the most widely usedpatient education booklets are provided through the CanadianCancer Society (http://www.cancer.ca) and are available at nocharge to hospitals.",Non-OADS,/arxiv_data1/oa_pdf/59/90/tobaccocontrol-2013-051483.PMC4552906.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/59/90/tobaccocontrol-2013-051483.PMC4552906.pdf
2012. http://www.tobaccoreport.ca (accessed Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/59/90/tobaccocontrol-2013-051483.PMC4552906.pdf
2011. https://secure.cihi.ca/estore/productSeries.htm?pc=PCC526 (accessed Oct 2013).,OADS,/arxiv_data1/oa_pdf/59/90/tobaccocontrol-2013-051483.PMC4552906.pdf
Best Practice Guidelines 2007. http://www.rnao.org/bestpractices (accessed Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/59/90/tobaccocontrol-2013-051483.PMC4552906.pdf
Hospital-based Populations CAN-ADAPTT —Canadian Smoking Cessation Guideline 2011. http://www.nicotinedependenceclinic.com/English/CANADAPTT/ Guideline/Hospital%20Based%20Populations/Home.aspx (accessed Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/59/90/tobaccocontrol-2013-051483.PMC4552906.pdf
2011. http://www.occ.ca/Publications/Cost-Trends-in-Health-Bene ﬁts-Report.pdf (accessed Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/59/90/tobaccocontrol-2013-051483.PMC4552906.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ginsberg B.,Non-OADS,/arxiv_data1/oa_pdf/0e/69/acupmed-2014-010722.PMC4552907.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Simons DG, T ravell JG, Simons LS.",Non-OADS,/arxiv_data1/oa_pdf/8d/ff/acupmed-2014-010666.PMC4552908.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Olweus D. Bullying at school: What we know and what we can do .,Non-OADS,/arxiv_data1/oa_pdf/0e/9c/archdischild-2014-306667.PMC4552909.pdf
"24A modified online Delphi process, using an online survey tool (Survey Monkey: http://www.surveymonkey.com), was used tocollate suggestions for the required elements of the education package and was undertaken in three rounds.",Non-OADS,/arxiv_data1/oa_pdf/36/d9/bmjspcare-2013-000595.PMC4552910.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Fraser L, Miller M, Hain R, et al.",Non-OADS,/arxiv_data1/oa_pdf/36/d9/bmjspcare-2013-000595.PMC4552910.pdf
http://ctep.cancer.gov/ protocolDevelopment/electronic_applications/ctc.htm (accessed 28 May 2009).†Excluded from statistical analysis.,Non-OADS,/arxiv_data1/oa_pdf/62/a6/bmjspcare-2014-000699.PMC4552911.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Dy SM.,Non-OADS,/arxiv_data1/oa_pdf/62/a6/bmjspcare-2014-000699.PMC4552911.pdf
"http://wiki.cancer.org.au/australia/Guidelines:Cancer_pain_management 13 Currow DC, Rowett D, Doogue M, et al.",Non-OADS,/arxiv_data1/oa_pdf/62/a6/bmjspcare-2014-000699.PMC4552911.pdf
http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm (accessed 28 May 2009).,Non-OADS,/arxiv_data1/oa_pdf/62/a6/bmjspcare-2014-000699.PMC4552911.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Fraser LK, Miller M, Hain R, et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/d3/bmjspcare-2012-000355.PMC4552912.pdf
6 T ogether for Short Lives http://www.act.org.uk/page.asp?,Non-OADS,/arxiv_data1/oa_pdf/4f/d3/bmjspcare-2012-000355.PMC4552912.pdf
http://www.who.int/cancer/palliative/definition/en/ (accessed 23 Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/d3/bmjspcare-2012-000355.PMC4552912.pdf
8 T ogether for Short Lives http://www.act.org.uk/page.asp?,Non-OADS,/arxiv_data1/oa_pdf/4f/d3/bmjspcare-2012-000355.PMC4552912.pdf
2010. http://www.cabinetoffice.gov.uk/newsroom/news_releases/2010/101014-big-society-strategy .aspx (accessed 2 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/d3/bmjspcare-2012-000355.PMC4552912.pdf
http://www.pedro.org.au/wp-content/uploads/CIcalculator.xls (accessed 11 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/4f/d3/bmjspcare-2012-000355.PMC4552912.pdf
2011. http://www.mariecurie.org.uk/Documents/HEALTHCARE-PROFESSIONALS/Innovation/teenagers-transition/young-people-transition-psw-exec-summary.pdf (accessed 6 Jun 2012).,Non-OADS,/arxiv_data1/oa_pdf/4f/d3/bmjspcare-2012-000355.PMC4552912.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Smith R. A good death.,Non-OADS,/arxiv_data1/oa_pdf/5a/15/bmjspcare-2012-000338.PMC4552913.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/jech- 2014-205387).,OADS,/arxiv_data1/oa_pdf/71/4d/jech-2014-205387.PMC4552914.pdf
"Correspondence to Milagros Ruiz, Research Department of Epidemiology and Public Health, UniversityCollege London, 1 –19 Torrington Place, London WC1E 6BT, UK; milagros.ruiz.10@ucl.ac.uk Received 16 December 2014 Revised 2 February 2015 Accepted 10 February 2015 Published Online First24 April 2015 ▸http://dx.doi.org/10.1136/ jech-2015-205625 To cite: Ruiz M, Goldblatt P, Morrison J, et al.J Epidemiol Community Health2015; 69:826–833.ABSTRACT Background A healthy start to life is a major priority in efforts to reduce health inequalities across Europe,with important implications for the health of futuregenerations.",Non-OADS,/arxiv_data1/oa_pdf/71/4d/jech-2014-205387.PMC4552914.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 EURO-Peristat.,Non-OADS,/arxiv_data1/oa_pdf/71/4d/jech-2014-205387.PMC4552914.pdf
"http://health-gradient.eu/ 8 Commission on Social Determinants of Health, WHO.",Non-OADS,/arxiv_data1/oa_pdf/71/4d/jech-2014-205387.PMC4552914.pdf
http://www.oulu.,Non-OADS,/arxiv_data1/oa_pdf/71/4d/jech-2014-205387.PMC4552914.pdf
"https://eden.vjf.inserm.fr/15 Tzoumaka-Bakoula C. The Greek national perinatal survey: I: design, methodology, case ascertainment.",Non-OADS,/arxiv_data1/oa_pdf/71/4d/jech-2014-205387.PMC4552914.pdf
http://uic.edu/sph/glakes/research/ukraine_children.html (accessed 27 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/71/4d/jech-2014-205387.PMC4552914.pdf
http://www.euro.who.int/en/data-and-evidence/databases/ european-health-for-all-database-hfa-db (accessed 27 Jan 2015).,Non-OADS,/arxiv_data1/oa_pdf/71/4d/jech-2014-205387.PMC4552914.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/archdischild-2014-306764).,Non-OADS,/arxiv_data1/oa_pdf/52/c4/archdischild-2014-306764.PMC4552915.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 ter WolbeekM van DoornenLJP Kavelaars A, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/c4/archdischild-2014-306764.PMC4552915.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/archdischild-2014-307517).,Non-OADS,/arxiv_data1/oa_pdf/e5/0a/archdischild-2014-307517.PMC4552916.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Bedford Russell AR, Passant M, Kitt H. Engaging children and parents in service design and delivery.",Non-OADS,/arxiv_data1/oa_pdf/e5/0a/archdischild-2014-307517.PMC4552916.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Fonner VA, Denison J, Kennedy CE, et al.",Non-OADS,/arxiv_data1/oa_pdf/e5/6b/sextrans-2014-051658.PMC4552917.pdf
2009. https://www.unodc.org/documents/hiv-aids/Final_UNODC_WHO_UNAIDS_technical_ paper_2009_TC_prison_ebook.pdf (accessed 13 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/e5/6b/sextrans-2014-051658.PMC4552917.pdf
2013. http://www.chinadaily.,Non-OADS,/arxiv_data1/oa_pdf/e5/6b/sextrans-2014-051658.PMC4552917.pdf
2007. http://www.npc.gov.cn/ englishnpc/Law/2009-02/20/content_1471610.htm (accessed 25 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/e5/6b/sextrans-2014-051658.PMC4552917.pdf
"Sydney: Kirby Institute, University of New South Wales, 2013. http://www.kirby.unsw.edu.au/sites/default/ ﬁles/hiv/attachment/LabourCampDetaineesReport.pdf (accessed 13 Aug 2013).",Non-OADS,/arxiv_data1/oa_pdf/e5/6b/sextrans-2014-051658.PMC4552917.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better.",Non-OADS,/arxiv_data1/oa_pdf/68/dc/sextrans-2014-051759.PMC4552918.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/jech- 2014-204761).,OADS,/arxiv_data1/oa_pdf/b4/09/jech-2014-204761.PMC4552921.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Hemmingsson T, Melin B, Allebeck P, et al.",OADS,/arxiv_data1/oa_pdf/b4/09/jech-2014-204761.PMC4552921.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/jech- 2014-205345).,OADS,/arxiv_data1/oa_pdf/c3/a9/jech-2014-205345.PMC4552922.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 WHO.,Non-OADS,/arxiv_data1/oa_pdf/c3/a9/jech-2014-205345.PMC4552922.pdf
Secondary 10 fact on ageing and the life course 2012. http://www.who.int/features/fact ﬁles/ageing/en/ 2 International UaH.,Non-OADS,/arxiv_data1/oa_pdf/c3/a9/jech-2014-205345.PMC4552922.pdf
"Secondary Geocoding Tools & Utilities, 2014. http://newspat.csis.u-tokyo.ac.jp/geocode/ 32 Turner LW, Bass MA, Ting L, et al.I nﬂuence of yard work and weight training on bone mineral density among older U.S. women.",OADS,/arxiv_data1/oa_pdf/c3/a9/jech-2014-205345.PMC4552922.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/gutjnl-2015-309252).,Non-OADS,/arxiv_data1/oa_pdf/a6/23/gutjnl-2015-309252.PMC4552923.pdf
The ﬁve colleagues who could not attend the face-to-face meeting or missed the ﬁnal voting were invited later to giveBox 1 Current International Statistical Classi ﬁcation of Diseases and Related Health Problems (ICD-10)classi ﬁcation of gastritis (K29 code) http://apps.who.int/ classi ﬁcations/icd10/browse/2015/en#/K29 K29 Gastritis and duodenitis Excl: eosinophilic gastritis or gastroenteritis (K52.8) Zollinger –Ellison syndrome (E16.4) K29.0 Acute haemorrhagic gastritis Incl: Acute (erosive) gastritis with haemorrhageExcl: erosion (acute) of stomach (K25.,Non-OADS,/arxiv_data1/oa_pdf/a6/23/gutjnl-2015-309252.PMC4552923.pdf
"However, it remains a draft and can be changed from time to time before ﬁnalisation of ICD-11 (for more details, please visit http://www.who.int/classi ﬁcations/ icd/revision/betaexpectations/en/).",Non-OADS,/arxiv_data1/oa_pdf/a6/23/gutjnl-2015-309252.PMC4552923.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Strickland RG.,Non-OADS,/arxiv_data1/oa_pdf/a6/23/gutjnl-2015-309252.PMC4552923.pdf
6 http://apps.who.int/classi ﬁcations/icd10/browse/2015/en#/K29 (20 January 2015).,Non-OADS,/arxiv_data1/oa_pdf/a6/23/gutjnl-2015-309252.PMC4552923.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjsports-2015-094959).,Non-OADS,/arxiv_data1/oa_pdf/82/13/bjsports-2015-094959.PMC4552924.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Engebretsen L, Soligard T, Steffen K, et al.",Non-OADS,/arxiv_data1/oa_pdf/82/13/bjsports-2015-094959.PMC4552924.pdf
"Limitations Data from antenatal diagnosis through to postnatal outcome areunavailable nationally in the UK, and limited elsewhere to regis-ters belonging to the European Congenital AnomalySurveillance System (http://www.eurocat-network.eu).",Non-OADS,/arxiv_data1/oa_pdf/b7/e5/fetalneonatal-2014-306985.PMC4552926.pdf
Competing interests All authors have completed the Uni ﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from thecorresponding author) and declare: LKS had ﬁnancial support from UK Department of Health ’s National Institute of Health Research for the submitted work; no ﬁnancial relationships with any organisations that might have an interest in the submitted work in the previous 3 years and no other relationships or activities thatcould appear to have in ﬂuenced the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/b7/e5/fetalneonatal-2014-306985.PMC4552926.pdf
Aggregated EMSYCAR data may be requested from BINOCAR http://www.binocar.,OADS,/arxiv_data1/oa_pdf/b7/e5/fetalneonatal-2014-306985.PMC4552926.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1 Oakley L, Maconochie N, Doyle P, et al.",Non-OADS,/arxiv_data1/oa_pdf/b7/e5/fetalneonatal-2014-306985.PMC4552926.pdf
"of Public and Occupational Health,EMGO+ Institute, VU University Medical Center, Amsterdam, 3581BT, the Netherlands; r.baines@vumc.nl Received 21 October 2014 Revised 5 May 2015 Accepted 11 May 2015 ▸http://dx.doi.org/10.1136/ bmjqs-2015-004461▸http://dx.doi.org/10.1136/ bmjqs-2015-004403 To cite: Baines R, Langelaan M, de Bruijne M, et al.BMJ Qual Saf 2015; 24:561–571.ABSTRACT Objectives To assess whether, compared with previous years, hospital care became safer in 2011/2012, expressing itself in a fall in preventable adverse event (AE) rates alongsidepatient safety initiatives.",Non-OADS,/arxiv_data1/oa_pdf/80/d8/bmjqs-2014-003702.PMC4552927.pdf
See: http://creativecommons.org/licenses/by- nc/4.0/ REFERENCES 1 Institute of Medicine.,Non-OADS,/arxiv_data1/oa_pdf/80/d8/bmjqs-2014-003702.PMC4552927.pdf
Secondary VMS Safety Programme 2014. http://www.vmszorg.nl.,Non-OADS,/arxiv_data1/oa_pdf/80/d8/bmjqs-2014-003702.PMC4552927.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/jech- 2014-204657).,OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 UN Inter-agency Group for Child Mortality Estimation.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.who.int/maternal_child_adolescent/documents/levels_trends_ child_mortality_2013.pdf?ua=1 2 Victora CG, Fenn B, Bryce J, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.populationmedia.org/ wp-content/uploads/2009/03/rwanda-hiv-mch-spa-2007.pdf 8 National Institute of Statistics of Rwanda, Ministry of Health, ICF International.",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://statistics.gov.rw/publications/demographic-and-health-survey-2010- ﬁnal-report 9 Bucagu M, Kagubare JM, Basinga P, et al.",OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://www.who.int/healthsystems/strategy/everybodys_business.pdf 12 Republic of Rwanda Ministry of Health.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
https://www.google.rw/url?,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://www.ilo.org/gimi/gess/ShowRessource.action?ressource.ressourceId=23208 14 ICF Macro.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://www.measuredhs.com/What-We-Do/survey-search.cfm?pgtype=main&SrvyTp=country.%20Accessed%202013-20-09 15 National Institute of Statistics of Rwanda.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.statistics.gov.rw/publications/gdp- national-accounts-2012 17 Gwatkin DR, Rustein S, Johnson K, et al.Socio-economic differences in health, nutrition, and population in Bangladesh .",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://siteresources.worldbank.org/INTPAH/Resources/Publications/ Country-Reports/bangladesh.pdf 18 Bates D, Maechler M, Bolker B, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://CRAN.R-project.org/package=lme4 19 Therneau T. Coxme: Mixed effects Cox models.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://CRAN.R-project.org/package=coxme 20 Curtis SL.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.measuredhs.com/pubs/pdf/ OP3/OP3.pdf 21 Pose Rodriguez R, Samuels F. Rwanda ’s progress in health: leadership, performance, and insurance .",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.developmentprogress.org/sites/developmentprogress.org/ ﬁles/ rwanda_report_-_master_0.pdf 22 James C, Morris SS, Keith R, et al.",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://www.statistics.gov.rw/publications/ statistical-yearbook-201227 Republic of Rwanda Ministry of Health.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://www.moh.gov.rw/ ﬁleadmin/ templates/HMIS_Docs/MOH_Annual_booklet-2011.pdf 28 Republic of Rwanda Ministry of Health.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://www.moh.gov.rw/ ﬁleadmin/templates/MOH-Reports/ Final-MoH-annual-report-2008.pdf 29 Republic of Rwanda Ministry of Health.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
ftp://iff-immunisation.org/MannionDaniels/HSFP%20review%20May% 202012/Rwanda_Resubmission/Attachment%201/Annex%201c%20Rwanda% 20Vaccine%20Preventable%20Disease%20Strategic%20plan%20(cMYP).doc 30 Republic of Rwanda Ministry of Health.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://www.moh.gov.rw/ ﬁleadmin/templates/MOH-Reports/ MoH-Annual-Report-July-2011-June-2012.pdf 31 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
http://apps.who.int/iris/bitstream/10665/92814/1/WHO_RHR_13.15_eng.pdf 32 Republic of Rwanda Ministry of Health.,Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.moh.gov.rw/index.php?id=3 33 Rusa L, Ngirabega Jde D, Janssen W, et al.",OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.transparency.org/cpi2012/results 36 Peña R, Wall S, Persson LA.",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.mineduc.gov.rw/IMG/pdf/Foward_looking_report_EDPRS1.pdf 41 Houweling TA, Kunst AE.",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
"http://www.statistics.gov.rw/publications/economic- development-poverty-reduction-strategy-2008 –2012 840 Musa ﬁli A, et al.J Epidemiol Community Health 2015; 69:834 –840.",Non-OADS,/arxiv_data1/oa_pdf/43/6a/jech-2014-204657.PMC4552928.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jech-2014-205436).,Non-OADS,/arxiv_data1/oa_pdf/84/a7/jech-2014-205436.PMC4552929.pdf
"The tool is availableat: https://www.webdepot.umontreal.ca/Usagers/johrim/MonDepotPublic/HealthLiteracyT ool/HealthLiteracyT ool.pdf.Potential confounders and effect modi ﬁers Sociodemographic characteristics Maternal and paternal education, maternal age, religion and birth order of child are associated with immunisation in India20 and worldwide.21Attitudes towards child sex may be correlated with education.",Non-OADS,/arxiv_data1/oa_pdf/84/a7/jech-2014-205436.PMC4552929.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Cleland J.,Non-OADS,/arxiv_data1/oa_pdf/84/a7/jech-2014-205436.PMC4552929.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Len TK, Neary JP.",Non-OADS,/arxiv_data1/oa_pdf/fc/07/jnnp-2014-308571.PMC4552930.pdf
"Questions about which parts of The V eterinary Times (http://www.vetsonline.com/publications/veterinary-times/about.html) and the V eterinary Record (http://veterinaryrecord.bmj.com/site/about/index.xhtml) were read were asked; these publications are commonly accessed by UK veterinarians, andare often found in veterinary practices across the UK.",Non-OADS,/arxiv_data1/oa_pdf/65/01/vetrec-2014-103068.PMC4552931.pdf
Comparison of proportions between clinicians and non-clinicians were done using z-tests (http://epitools.ausvet.com.au/content.php?page=z-test-2).,OADS,/arxiv_data1/oa_pdf/65/01/vetrec-2014-103068.PMC4552931.pdf
"The V eterinary Times and UKV et are free resources, and the V eterinary Record and In Practicecome free as part of membership of the BV A (http://www.bva.TABLE 3: The five most accessed electronic sources nominated by different subgroups of the UK veterinary profession based on 4340* responses to a national survey Source rank All respondents (n=4340*) Non-clinicians (n=597*)Clinicians (n=3736*) Small animal †(n=3043) Production animal †(n=955) Equine (n=1054) 1 Google (3076, 71%) Google (437, 73%) Google (2632, 70%) Google (2140, 70%) Google (693, 73%) 2 RCVS (2324, 54%) DEFRA (376, 63%) RCVS (1986, 53%) RCVS (1665, 55%) DEFRA (569, 60%) 3 DEFRA (1709, 39%) RCVS (336, 56%) BSAVA (1453, 39%) BSAVA (1422, 47%) NOAH (499, 52%)4 BVA (1612, 37%) PubMed (261, 44%) BVA (1416, 38%) BVA (1193, 39%) RCVS (475, 50%)5 BSAVA (1539, 35%) BVA (196, 33%) DEFRA (1333, 36%) NOAH (1030, 34%) BVA (464, 49%) *Number of respondents to this question (3736 clinicians, 597 non-clinicians, 7 not stated).",Non-OADS,/arxiv_data1/oa_pdf/65/01/vetrec-2014-103068.PMC4552931.pdf
Initiatives such as BestBET s for V ets (www.bestbetsforvets.org) and Ban ﬁeld CATs (http://www.ban ﬁeld.com/veterinary-professionals/resources/ research/cats) are examples of such resources in the veterinaryﬁeld.,Non-OADS,/arxiv_data1/oa_pdf/65/01/vetrec-2014-103068.PMC4552931.pdf
"To view, please visit the journal online (http://dx.doi.org/10.1136/vr.103068).Funding The Centre for Evidence-based Veterinary Medicine is supported by an unrestricted grant from The University of Nottingham and Elanco Animal Health.",Non-OADS,/arxiv_data1/oa_pdf/65/01/vetrec-2014-103068.PMC4552931.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ References BUCHANAN, R. A.",Non-OADS,/arxiv_data1/oa_pdf/65/01/vetrec-2014-103068.PMC4552931.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ References ARGO, C. M., DuGDALE, H. A.",Non-OADS,/arxiv_data1/oa_pdf/13/08/vetrec-2015-103226.PMC4552932.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Headache Classi ﬁcation Subcommittee of the International Headache Society.,Non-OADS,/arxiv_data1/oa_pdf/ce/bf/jnnp-2013-307149.PMC4552933.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 McLeod JG, Pollard JD, Macaskill P, et al.",Non-OADS,/arxiv_data1/oa_pdf/00/f1/jnnp-2014-309697.PMC4552934.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ To cite Zhang C, Xie B, Shi F-D, et al.J Neurol Neurosurg Psychiatry 2015; 86:1044 –1045.",Non-OADS,/arxiv_data1/oa_pdf/30/b8/jnnp-2014-308048.PMC4552935.pdf
To view this ﬁle please visit the journal online (http://dx.doi.org/10.1136/vr.102975) Funding Funding for the study in Zenzele was provided by the International Fund for Animal Welfare (IFAW) and World Animal Protection (WAP).,Non-OADS,/arxiv_data1/oa_pdf/f9/75/vetrec-2014-102975.PMC4552936.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ References AAHA [American Animal Hospital Association (AAHA) Canine Vaccination T ask Force] (2011) Canine vaccination guidelines.,Non-OADS,/arxiv_data1/oa_pdf/f9/75/vetrec-2014-102975.PMC4552936.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2014-307020).,OADS,/arxiv_data1/oa_pdf/ab/d6/gutjnl-2014-307020.PMC4552937.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Suerbaum S, Michetti P. Helicobacter pylori infection.",Non-OADS,/arxiv_data1/oa_pdf/ab/d6/gutjnl-2014-307020.PMC4552937.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/sextrans-2014-051925).,Non-OADS,/arxiv_data1/oa_pdf/ab/92/sextrans-2014-051925.PMC4552955.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Holmes KK.,Non-OADS,/arxiv_data1/oa_pdf/ab/92/sextrans-2014-051925.PMC4552955.pdf
"http://www.measuredhs.com/data/available- datasets.cfm 10 Chemaitelly H, Awad SF, Shelton JD, et al.",OADS,/arxiv_data1/oa_pdf/ab/92/sextrans-2014-051925.PMC4552955.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1e/b3/ircmj-17-06-23731.PMC4552958.pdf
Available from:  http://www3.weforum.org/docs/WEF_GenderGap_Report_2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1e/b3/ircmj-17-06-23731.PMC4552958.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/96/ce/ircmj-17-06-22525.PMC4552959.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fe/92/ircmj-17-06-22479.PMC4552963.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5e/be/ircmj-17-06-28265.PMC4552964.pdf
Supportin ginformat ionforthisarticle isavailab leontheWWW under http://dx.doi.or g/10.10 02/cbic.20150 0269.,Non-OADS,/arxiv_data1/oa_pdf/7d/98/cbic0016-1730.PMC4552966.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/13/0b/ircmj-17-06-20374.PMC4552976.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/cf/80/ircmj-17-06-23067.PMC4553020.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/79/f0/ircmj-17-06-23571.PMC4553169.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/57/fc/ircmj-17-06-23038.PMC4553170.pdf
"4: 167-176, August, 2015http://dx.doi.org/10.4110/in.2015.15.4.167 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 167Received on May 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5c/e4/in-15-167.PMC4553254.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/e4/in-15-167.PMC4553254.pdf
"4: 177-185, August, 2015http://dx.doi.org/10.4110/in.2015.15.4.177 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 177Received on June 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/de/4e/in-15-177.PMC4553255.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/4e/in-15-177.PMC4553255.pdf
"4: 186-190, August, 2015http://dx.doi.org/10.4110/in.2015.15.4.186 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 186Received on July 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/82/20/in-15-186.PMC4553256.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/20/in-15-186.PMC4553256.pdf
"4: 191-198, August, 2015http://dx.doi.org/10.4110/in.2015.15.4.191 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 191Received on June 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/48/11/in-15-191.PMC4553257.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/11/in-15-191.PMC4553257.pdf
"4: 199-205, August, 2015http://dx.doi.org/10.4110/in.2015.15.4.199 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 199Received on June 7, 2015.",Non-OADS,/arxiv_data1/oa_pdf/08/9a/in-15-199.PMC4553258.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/9a/in-15-199.PMC4553258.pdf
"4: 206-211, August, 2015http://dx.doi.org/10.4110/in.2015.15.4.206 pISSN 1598-2629    eISSN 2092-6685 206Received on June 23, 2015.",OADS,/arxiv_data1/oa_pdf/6c/83/in-15-206.PMC4553259.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any me- dium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/83/in-15-206.PMC4553259.pdf
More papers from this issue can be found at http://www.journalofextracellularvesicles.net Received: 13 February 2015; Revised: 15 July 2015; Accepted: 24 July 2015; Published: 28 August 2015 The NIH Extracellular RNA Communication Pro- gram has 5 key initiatives: 1) General reference cata-logue of extracellular RNAs (exRNA) in bodily fluids of normal individuals.,Non-OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575",OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"These studies indicate that MSC-EV have thecapacity to reverse radiation damage to bone marrow stem cells and may represent an important new strategy in radiation mitigation (45).Potential functional applications of EVs Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575",OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"Most sporadic CRCs have mutations that activatePotential functional applications of EVs Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575",OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"Our own recent work demonstratesPotential functional applications of EVs Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"2013;2:20389, doi: http://dx.doi.org/10.3402/jev.v2i0.20389 3.",Non-OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575",OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"2009;27:2293/C1300.Potential functional applications of EVs Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575",OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"2012;1:18704, doi: http://dx.doi.org/10.3402/ jev.v1i0.18704 84.",Non-OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"2012;53:848 /C185.Potential functional applications of EVs Citation: Journal of Extracellular Vesicles 2015, 4: 27575 - http://dx.doi.org/10.3402/jev.v4.27575 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/75/9f/JEV-4-27575.PMC4553260.pdf
"More papers from this issue can be found at http://www.journalofextracellularvesicles.net Received: 4 February 2015; Revised: 26 June 2015; Accepted: 24 July 2015; Published: 28 August 2015 To catalyze the understanding of extracellular RNA (exRNA) in human health and disease, the Extra- cellular RNA Communication Consortium (ERC Consortium) aims to generate a large volume of highly diverse exRNA expression profiles, assimilate them into a publicly accessible exRNA Atlas and enable their integra- tive analysis using online accessible exRNA analysis tools.The exRNA Atlas profiles will originate from biofluid samples provided by multiple Consortium participants, will be generated using diverse experimental methods and will be made publicly accessible according to a public data release policy developed by the ERC Consortium and made accessible at www.exrna.org.",OADS,/arxiv_data1/oa_pdf/22/e2/JEV-4-27497.PMC4553261.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27497 - http://dx.doi.org/10.3402/jev.v4.27497 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/22/e2/JEV-4-27497.PMC4553261.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27497 - http://dx.doi.org/10.3402/jev.v4.27497",OADS,/arxiv_data1/oa_pdf/22/e2/JEV-4-27497.PMC4553261.pdf
"The metastatic brain tumour pathway (www.wikipathways.org/index.php/Pathway:WP2 249) in panel e shows enrichment for the exRNA genes overexpressed in this hypothetical case.Integration of extracellular RNA profiling data Citation: Journal of Extracellular Vesicles 2015, 4: 27497 - http://dx.doi.org/10.3402/jev.v4.27497 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/22/e2/JEV-4-27497.PMC4553261.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27497 - http://dx.doi.org/10.3402/jev.v4.27497",OADS,/arxiv_data1/oa_pdf/22/e2/JEV-4-27497.PMC4553261.pdf
"1 was retrieved fromWikiPathways (21).Integration of extracellular RNA profiling data Citation: Journal of Extracellular Vesicles 2015, 4: 27497 - http://dx.doi.org/10.3402/jev.v4.27497 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/22/e2/JEV-4-27497.PMC4553261.pdf
Available from: https://www.encodeproject.,Non-OADS,/arxiv_data1/oa_pdf/22/e2/JEV-4-27497.PMC4553261.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27497 - http://dx.doi.org/10.3402/jev.v4.27497",OADS,/arxiv_data1/oa_pdf/22/e2/JEV-4-27497.PMC4553261.pdf
More papers from this issue can be found at http://www.journalofextracellularvesicles.net Received: 4 February 2015; Revised: 8 May 2015; Accepted: 8 July 2015; Published: 28 August 2015 Clinical research across the spectrum of human dis- ease is challenged by the immense cost of testingexperimental therapeutics in human subjects.,Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495",OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"Table I. ERCC biomarker projects PI(s)/site Grant title Organ system/biofluid Clinical cohort Patel/Mayo Clinic Jacksonville Extracellular Non-Coding RNA Biomarkers of Hepatocellular CancerHepatobiliary/serum and plasmaMayo Hepatobiliary Neoplasia Biorepository Wong/UCLA Clinical Utility of Salivary ExRNA Biomarkers of Gastric Cancer DetectionGastrointestinal/saliva UCLA PRoBE Das/Beth Israel Deaconess Plasma miRNA Predictors of Adverse Mechanical and Electrical Modeling after MICardiac/plasma PROSPECT-CMR Cohort; Thrombolysis in Myocardial Infarction (TIMI) Freedman/University of Massachusetts Extracellular RNAs /C1Biomarkers for Cardiovascular Risk and DiseaseCardiac/plasma Framingham Heart Study Laurent/University of California San Diego ExRNAs for Early Identification of Pregnancies at Risk for Placental DysfunctionPlacenta/serum UCSD Placental Dysfunction Study; PAPR Cohort from Sera Prognostics Saugstad, Quinn/Oregon Health & Science UniversityClinical Utility of MicroRNAs As Diagnostic Biomarkers of Alzheimer’s DiseaseCentral nervous system/ CSFOregon ADC Biorepository; Alzheimer’s Disease Neuroimaging Initiative Carter, Hochberg/University of California San DiegoExRNA Biomarkers for Human Glioma Central nervous system/ CSF and plasmaUCSD Biorepository Van Keuren-Jensen, Huentelman, Adelson, Kalani/Translational Genomics ResearchInstituteExRNA Signatures Predict Outcomes after Brain InjuryCentral nervous system/ CSF and plasmaBarrow Neurological Institute Biorepository; Biologic Materials Availability Program at Phoenix Children’sHospital Weiner, Gandhi/Brigham and Women’s Hospital Circulating MicroRNAs As Disease Biomarkers in Multiple SclerosisCentral nervous system/ plasmaCLIMB MS Cohort Tuschl, Suthanthiran/Rockefeller Clinical Utility of Extracellular RNA As Marker of Kidney Disease ProgressionRenal/urine Multiple Longitudinal CohortsDevelopment of exRNA as biomarkers Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495",OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"Furthermore,Development of exRNA as biomarkers Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495",OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"After RNA sequencing ofDevelopment of exRNA as biomarkers Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495",OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"Biopsies do notimprove morbidity or survival, inadequately predict histopathologic diagnosis and seldom take into accountDevelopment of exRNA as biomarkers Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495",OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"Whole transcriptome sequencing with the additionDevelopment of exRNA as biomarkers Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495",OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"Usefulness of preimplantation B-typeDevelopment of exRNA as biomarkers Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495",OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"2014;3:24247,doi: http://dx.doi.org/10.3402/jev.v3.24247 63.",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"2013;2:20677, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"Pediatric Academic Societies Meeting, San Diego, CA; 2015 Apr 25 /C128.Development of exRNA as biomarkers Citation: Journal of Extracellular Vesicles 2015, 4: 27495 - http://dx.doi.org/10.3402/jev.v4.27495 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/32/JEV-4-27495.PMC4553262.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"More papers from this issue can be found at http://www.journalofextracellularvesicles.net Received: 3 November 2014; Revised: 17 April 2015; Accepted: 3 May 2015; Published: 28 August 2015 Investigators in the Extracellular RNA Communication Consortium are probing avariety of scientific questions, such as elucidating mechanisms responsible for the biogenesis of RNA-containing extracellular particles, theiruptake and potential function in recipient cells; discovering extracellular RNA (exRNA) biomarkers for various diseases and developing exRNA-based therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"Likewise, specimensDiscussions and findings on exRNA measurement methods Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"None of the Extracellular RNA Commu-nication Consortium groups used gel filtration chromato-graphy (also referred to as ‘‘size exclusion chromatography’’) as their primary modality for EV or non-vesicular particleDiscussions and findings on exRNA measurement methods Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"The Exiqon miRCURY biofluids kit was determined to have the best performanceDiscussions and findings on exRNA measurement methods Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"if qRT-PCR is the analytical method that will be used,a qRT-PCR based evaluation of RNA yield/reproducibil- ity should be used rather than Bioanalyzer (Agilent), QubitDiscussions and findings on exRNA measurement methods Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"However, when the libraries madefrom phosphorylated and non-phosphorylated RNA sam- ples were sequenced, researchers found that the phosphory- lated samples showed a shift in the distribution of reads.They noted a markedly increased percentage of readsmapping to rRNA sequences and concomitant decreasesDiscussions and findings on exRNA measurement methods Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"The3 cDNA synthesis and amplification kits were (a) the Ovation RNA-Seq System V2 (NuGEN, San Carlos, CA, USA), (b) the Ovation RNA-Seq FFPE System (Nu-GEN; the researchers reasoned that this kit mightDiscussions and findings on exRNA measurement methods Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 13 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2014;3:26913, doi: http://dx.doi.org/10.3402/jev.v3.26913 3.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2013;2:22859, doi: http://dx.doi.org/10.3402/jev.v2i0.22859 4.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2010;16:991 /C11006, doi: 10.1261/rna.1947110.Discussions and findings on exRNA measurement methods Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 15 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2013;2:20360, doi: http://dx.doi.org/10.3402/jev.v2i0.20360 17.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2014;3:24783, doi: http://dx.doi.org/10.3402/jev.v3.24783 24.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2014;3:24858, doi: http://dx.doi.org/10.3402/jev.v3.24858 32.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2014;3:23430, doi: http://dx.doi.org/10.3402/jev.v3.23430 38.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2014;3:23262, doi: http://dx.doi.org/10.3402/jev.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"16 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2014;3:23111, doi: http://dx.doi.org/10.3402/jev.v3.23111 46.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"Burgos KL, Van Keuren-Jensen K. RNA isolation for small RNA next-generation sequencing from acellular bioﬂuids.Discussions and findings on exRNA measurement methods Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533 17 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2014;3:23743, doi: http://dx.doi.org/10.3402/jev.v3.23743 77.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"2013, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
"18 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26533 - http://dx.doi.org/10.3402/jev.v4.26533",OADS,/arxiv_data1/oa_pdf/fb/ce/JEV-4-26533.PMC4553263.pdf
More papers from this issue can be found at http://www.journalofextracellularvesicles.net Received: 4 February 2015; Revised: 15 April 2015; Accepted: 3 May 2015; Published: 28 August 2015 /C230 Journal of Extracellular Vesicles 2015.,Non-OADS,/arxiv_data1/oa_pdf/1e/77/JEV-4-27493.PMC4553264.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27493 - http://dx.doi.org/10.3402/jev.v4.27493 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1e/77/JEV-4-27493.PMC4553264.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27493 - http://dx.doi.org/10.3402/jev.v4.27493",OADS,/arxiv_data1/oa_pdf/1e/77/JEV-4-27493.PMC4553264.pdf
"Structure of the Extracellular RNA Communication Consortium.NIH Extracellular RNA Communication Citation: Journal of Extracellular Vesicles 2015, 4: 27493 - http://dx.doi.org/10.3402/jev.v4.27493 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/1e/77/JEV-4-27493.PMC4553264.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27493 - http://dx.doi.org/10.3402/jev.v4.27493",OADS,/arxiv_data1/oa_pdf/1e/77/JEV-4-27493.PMC4553264.pdf
"The second UH3 phase will support latter stage pre-clinical studies to further findingsNIH Extracellular RNA Communication Citation: Journal of Extracellular Vesicles 2015, 4: 27493 - http://dx.doi.org/10.3402/jev.v4.27493 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1e/77/JEV-4-27493.PMC4553264.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27493 - http://dx.doi.org/10.3402/jev.v4.27493",OADS,/arxiv_data1/oa_pdf/1e/77/JEV-4-27493.PMC4553264.pdf
"More papers from this issue can be found at http://www.journalofextracellularvesicles.net Received: 4 February 2015; Revised: 8 April 2015; Accepted: 3 May 2015; Published: 28 August 2015 The RNA world and analysis of modern roles for RNA have produced a number of surprises,notably catalytic RNA, the discovery of introns, the prevalence of alternative splicing to generate protein diversity, RNA interference, and riboswitches that link metabolism with gene expression (1).",Non-OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27494 - http://dx.doi.org/10.3402/jev.v4.27494 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27494 - http://dx.doi.org/10.3402/jev.v4.27494",OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"GBMsrepresent one of the most common and aggressive brain tumours in humans, with time from diagnosis to deathBiogenesis, delivery, and function of exRNA Citation: Journal of Extracellular Vesicles 2015, 4: 27494 - http://dx.doi.org/10.3402/jev.v4.27494 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27494 - http://dx.doi.org/10.3402/jev.v4.27494",OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"Identify the RNA targetsBiogenesis, delivery, and function of exRNA Citation: Journal of Extracellular Vesicles 2015, 4: 27494 - http://dx.doi.org/10.3402/jev.v4.27494 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27494 - http://dx.doi.org/10.3402/jev.v4.27494",OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"2013;121:984 /C195.Biogenesis, delivery, and function of exRNA Citation: Journal of Extracellular Vesicles 2015, 4: 27494 - http://dx.doi.org/10.3402/jev.v4.27494 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 27494 - http://dx.doi.org/10.3402/jev.v4.27494",OADS,/arxiv_data1/oa_pdf/cc/c4/JEV-4-27494.PMC4553266.pdf
"Keywords:  Tendon, Surgical repair, Anesthesia, Rehabilitation Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/23/cios-7-275.PMC4553273.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received May 6, 2015; Accepted June 17, 2015 Correspondence to: Jin Bo Tang, MD Department of Hand Surgery, The Hand Surgery Research Center,  Affiliated Hospital of Nantong University, 20 West Temple Road, Nantong  226001, Jiangsu, China Tel: +86-513-85052524, Fax: +86-513-85110966 E-mail: jinbotang@yahoo.comReview Article    Clinics in Orthopedic Surgery 2015;7:275-281   •  http://dx.doi.org/10.4055/cios.2015.7.3.275",Non-OADS,/arxiv_data1/oa_pdf/2b/23/cios-7-275.PMC4553273.pdf
"Keywords:  Forearm, Diaphyses, Fracture, Internal fixation Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/cios-7-282.PMC4553274.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received November 24, 2014; Accepted May 21, 2015 Correspondence to: Youn Moo Heo, MD  Department of Orthopedic Surgery, Konyang University Hospital, Konyang  University College of Medicine, 158 Gwanjeodong-ro, Seo-gu, Daejeon  302-718, Korea Tel: +82-42-600-6937, Fax: +82-42-545-2373 E-mail: hurym1973@hanmail.netOriginal Article    Clinics in Orthopedic Surgery 2015;7:282-290   •  http://dx.doi.org/10.4055/cios.2015.7.3.282",Non-OADS,/arxiv_data1/oa_pdf/e5/e9/cios-7-282.PMC4553274.pdf
"Keywords:  Hip fractures, Femur head, Postoperative complication, Orthopedic fixation devices  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/0a/cios-7-291.PMC4553275.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received May 1, 2014; Accepted April 26, 2015 Correspondence to: Takafumi Hiranaka, MD  Department of Orthopedic Surgery, Takatsuki General Hospital, 1-3-13  Kosobe-cho, Takatsuki 569-1192, Japan Tel: +81-72-681-3801, Fax: +81-72-682-3834 E-mail: takafumi.hiranaka@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:291-297   •  http://dx.doi.org/10.4055/cios.2015.7.3.291",Non-OADS,/arxiv_data1/oa_pdf/ee/0a/cios-7-291.PMC4553275.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/0a/cios-7-291.PMC4553275.pdf
"Keywords:  Hip fracture, Preoperative, Deep vein thrombosis, Delayed admission, Delayed operation Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/09/cios-7-298.PMC4553276.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received March 13, 2015; Accepted June 3, 2015 Correspondence to: Young-Ho Cho, MD  Department of Orthopaedic Surgery, Daegu Fatima Hospital, 99 Ayang-ro,  Dong-gu, Daegu 701-724, Korea  Tel: +82-53-940-7320, Fax: +82-53-954-7417 E-mail: femur1973@hanmail.netOriginal Article    Clinics in Orthopedic Surgery 2015;7:298-302   •  http://dx.doi.org/10.4055/cios.2015.7.3.298",Non-OADS,/arxiv_data1/oa_pdf/93/09/cios-7-298.PMC4553276.pdf
Available from: http://www.nice.org.uk/guidance/cg92.,Non-OADS,/arxiv_data1/oa_pdf/93/09/cios-7-298.PMC4553276.pdf
"Keywords:  Gait, Kinematics, Kinetics Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/99/cios-7-303.PMC4553277.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received December 4, 2014; Accepted March 13, 2015 Correspondence to: Kap Jung Kim, MD  Department of Orthopedic Surgery, Eulji University College of Medicine,  95 Dunsanseo-ro, Seo-gu, Daejeon 302-799, Korea Tel: +82-42-611-3271, Fax: +82-42-259-1289 E-mail: oskkj@eulji.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:303-309   •  http://dx.doi.org/10.4055/cios.2015.7.3.303",Non-OADS,/arxiv_data1/oa_pdf/94/99/cios-7-303.PMC4553277.pdf
"Keywords:  Articulating spacer, Metal-on-cement, Infection, Total knee arthroplasty, Two-stage revision Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/06/cios-7-310.PMC4553278.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received September 11, 2014; Accepted May 27, 2015 Correspondence to: Hee-Soo Kyung, MD  Department of Orthopaedic Surgery, Kyungpook National University  Hospital, 130 Dongduk-ro, Jung-gu, Daegu 700-721, Korea Tel: +82-53-420-5636, Fax: +82-53-422-6605  E-mail: hskyung@knu.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:310-317   •  http://dx.doi.org/10.4055/cios.2015.7.3.310",Non-OADS,/arxiv_data1/oa_pdf/b8/06/cios-7-310.PMC4553278.pdf
"Keywords:  Septic, Arthritis, Hyaluronic acid, Knee Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/f5/cios-7-318.PMC4553279.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received November 11, 2014; Accepted January 9, 2015 Correspondence to: Ki-Choul Kim, MD  Department of Orthopedic Surgery, Dankook University School of Medicine,  359 Manghyang-ro, Dongnam-gu, Cheonan 330-715, Korea  Tel: +82-41-550-6290, Fax: +82-41-550-6319  E-mail: puhoo73@hanmail.net Original Article    Clinics in Orthopedic Surgery 2015;7:318-322   •  http://dx.doi.org/10.4055/cios.2015.7.3.318",Non-OADS,/arxiv_data1/oa_pdf/be/f5/cios-7-318.PMC4553279.pdf
"The number  of men and women above 50 years of age was obtained  from the Statistics Korea web site (http://www.kosis.kr),  the official web site of the Central Government Organiza - tion for Statistics.22) The changes in incidence of septic  knee from 2008 to 2012 were calculated using annual per - centage change for trends (Joinpoint Regression Program  ver.",OADS,/arxiv_data1/oa_pdf/be/f5/cios-7-318.PMC4553279.pdf
Available from:  http://kosis.kr/.,Non-OADS,/arxiv_data1/oa_pdf/be/f5/cios-7-318.PMC4553279.pdf
"Keywords:  Spine, Spinal stenosis, Therapeutics, Review Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/ec/cios-7-323.PMC4553280.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received March 22, 2015; Accepted March 28, 2015 Correspondence to: Dong-Jun Kim, MD  Department of Orthopedic Surgery, Ewha Womans University Hospital,  1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea Tel: +82-2-2650-5300, Fax: +82-2-2646-6804 E-mail: djkim@ewha.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:323-329   •  http://dx.doi.org/10.4055/cios.2015.7.3.323",Non-OADS,/arxiv_data1/oa_pdf/dc/ec/cios-7-323.PMC4553280.pdf
"Keywords:  Ankylosing spondylitis, Osteotomy, Sagittal alignment Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/33/cios-7-330.PMC4553281.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received February 9, 2015; Accepted May 4, 2015 Correspondence to: Dae-Hyun Park, MD  Department of Orthopedic Surgery, Inje University Busan Paik Hospital,  Inje University College of Medicine, 75 Bokji-ro, Busanjin-gu, Busan 614- 735, Korea Tel: +82-51-890-6257, Fax: +82-51-892-6619 E-mail: 97111033@hanmail.netOriginal Article    Clinics in Orthopedic Surgery 2015;7:330-336   •  http://dx.doi.org/10.4055/cios.2015.7.3.330",Non-OADS,/arxiv_data1/oa_pdf/3d/33/cios-7-330.PMC4553281.pdf
"Keywords:  Surgical site infection, Posterior lumbar interbody fusion, Organ/space infection, Delayed diagnosis Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/b6/cios-7-337.PMC4553282.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received April 17, 2015; Accepted May 26, 2015 Correspondence to: Dong Ki Ahn, MD  Department of Orthopedic Surgery, Seoul Sacred Heart General Hospital,  259 Wangsan-ro, Dongdaemun-gu, Seoul 130-867, Korea Tel: +82-2-966-1616, Fax: +82-2-968-2394 E-mail: adkajs@hanmail.netOriginal Article    Clinics in Orthopedic Surgery 2015;7:337-343   •  http://dx.doi.org/10.4055/cios.2015.7.3.337",Non-OADS,/arxiv_data1/oa_pdf/21/b6/cios-7-337.PMC4553282.pdf
"Keywords:  Neoplasm metastasis, Spine, Prognosis Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/ed/cios-7-344.PMC4553283.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received April 5, 2015; Accepted June 21, 2015 Correspondence to: Young Hoon Kim, MD Department of Orthopedic Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul  137-701, Korea Tel: +82-2-2258-6118, Fax: +82-2-535-9834, E-mail: boscoa@catholic.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:344-350   •  http://dx.doi.org/10.4055/cios.2015.7.3.344",Non-OADS,/arxiv_data1/oa_pdf/80/ed/cios-7-344.PMC4553283.pdf
"Keywords:  Tendons, Shoulder joint, Synovial fluid, Synovitis, Ultrasonography Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/65/cios-7-351.PMC4553284.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 3, 2014; Accepted May 11, 2015 Correspondence to: Yang-Soo Kim, MD  Department of Orthopedic Surgery, Seoul St. Mary’s Hospital, College of  Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu,  Seoul 137-701, Korea Tel: +82-2-2258-6117, Fax: +82-2-535-9834 E-mail: kysoos@catholic.ac.krOriginal Article    Clinics in Orthopedic Surgery 2015;7:351-358   •  http://dx.doi.org/10.4055/cios.2015.7.3.351",Non-OADS,/arxiv_data1/oa_pdf/31/65/cios-7-351.PMC4553284.pdf
"Keywords:  Shoulder, Replacement, Reverse, Polarity, Delta Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/c4/cios-7-359.PMC4553285.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received April 17, 2015; Accepted May 26, 2015 Correspondence to: Shah Jehan, MRCS  Department of Trauma and Orthopaedic Surgery, Diana Princess of Wales  Hospital, Scartho Road, Grimsby, Lincolnshire DN33 2BA, UK Tel: +44-1482-212457, Fax: +44-1472-875444 E-mail: shahjehan200@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:359-364   •  http://dx.doi.org/10.4055/cios.2015.7.3.359",Non-OADS,/arxiv_data1/oa_pdf/9a/c4/cios-7-359.PMC4553285.pdf
"Keywords:  Rotator cuff, Arthroscopy, Subscapularis tendon Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/cios-7-365.PMC4553286.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received March 13, 2015; Accepted June 18, 2015 Correspondence to: Seok Jun Kim, MD  Department of Orthopaedic Surgery, Daegu Catholic University Medical  Center, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-4276, Fax: +82-53-626-4272 E-mail: pearlnet85@naver.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:365-371   •  http://dx.doi.org/10.4055/cios.2015.7.3.365",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/cios-7-365.PMC4553286.pdf
"Keywords:  Thumb, Carpometacarpal joint, Osteoarthritis, Tendon, Suspension ligamentoplasty Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/62/cios-7-372.PMC4553287.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received April 17, 2015; Accepted May 26, 2015 Correspondence to: In-Ho Jeon, MD  Department of Orthopaedic Surgery, Asan Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138- 736, Korea  Tel: +82-2-3010-3536, Fax: +82-2-488-7877 E-mail: jeonchoi@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:372-376   •  http://dx.doi.org/10.4055/cios.2015.7.3.372",Non-OADS,/arxiv_data1/oa_pdf/40/62/cios-7-372.PMC4553287.pdf
"Keywords:  Radius fractures, Fractures comminuted, Splints Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/1d/cios-7-377.PMC4553288.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received May 4, 2015; Accepted June 30, 2015 Correspondence to: In-Ho Jeon, MD  Department of Orthopaedic Surgery, Asan Medical Center, University of  Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138- 736, Korea  Tel: +82-2-3010-3896, Fax: +82-2-488-7877 E-mail: jeonchoi@gmail.comOriginal Article    Clinics in Orthopedic Surgery 2015;7:377-382   •  http://dx.doi.org/10.4055/cios.2015.7.3.377",Non-OADS,/arxiv_data1/oa_pdf/0a/1d/cios-7-377.PMC4553288.pdf
"Keywords:  Bone substitute, Osteogenesis, Distraction, Bone development Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/e4/cios-7-383.PMC4553289.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received November 11, 2014; Accepted March 23, 2015 Correspondence to: Dong Yeon Lee, MD   Department of Orthopedic Surgery, Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel: +82-2-2072-1863, Fax: +82-2-745-3367 E-mail: leedy@snu.ac.kr Original Article    Clinics in Orthopedic Surgery 2015;7:383-391   •  http://dx.doi.org/10.4055/cios.2015.7.3.383",Non-OADS,/arxiv_data1/oa_pdf/5c/e4/cios-7-383.PMC4553289.pdf
"Keywords:  Hip, Arthroscopy, Medial portal Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/b9/cios-7-392.PMC4553290.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received December 15, 2013; Accepted September 11, 2014 Correspondence to: Deuk-Soo Hwang, MD  Department of Orthopedic Surgery, Chungnam National University Hospital,  282 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea Tel: +82-42-338-2475, Fax: +82-42-338-2482 E-mail: dshwang@cnu.ac.krTechnical Note    Clinics in Orthopedic Surgery 2015;7:392-395   •  http://dx.doi.org/10.4055/cios.2015.7.3.392",Non-OADS,/arxiv_data1/oa_pdf/35/b9/cios-7-392.PMC4553290.pdf
"Keywords:  Pelvis, Fractures, Malunited, Ununited Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/39/cios-7-396.PMC4553291.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received October 9, 2013; Accepted March 7, 2014 Correspondence to: Byung-Woo Min, MD  Department of Orthopaedic Surgery, Keimyung University Dongsan  Medical Center, Keimyung University School of Medicine, 56 Dalseong- ro, Jung-gu, Daegu 700-712, Korea  Tel: +82-53-250-7267, Fax: +82-53-250-7205 E-mail: min@dsmc.or.krCase Report    Clinics in Orthopedic Surgery 2015;7:396-401   •  http://dx.doi.org/10.4055/cios.2015.7.3.396",Non-OADS,/arxiv_data1/oa_pdf/d5/39/cios-7-396.PMC4553291.pdf
"Keywords:  Birmingham Mid-Head Resection, Fracture, Birmingham Hip Resurfacing Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/c9/cios-7-402.PMC4553292.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received January 11, 2014; Accepted May 26, 2014 Correspondence to: Adeel Aqil, MRCS  Department of Orthopaedics, Charing Cross Hospital, Imperial College  London, St. Dunstan's Road, Hammersmith, London W68RP , UK Tel: +44-78-4327-2006, Fax: +44-20-3313-0970  E-mail: a.aqil@imperial.ac.ukCase Report    Clinics in Orthopedic Surgery 2015;7:402-405   •  http://dx.doi.org/10.4055/cios.2015.7.3.402",Non-OADS,/arxiv_data1/oa_pdf/fa/c9/cios-7-402.PMC4553292.pdf
"Ad - ditional hematologic evaluation that included total leuko - cyte count, erythrocyte sedimentation rate, serum calcium,  serum alkaline phosphatase, and serum protein electro - phoresis was performed, in order to rule out a pathologic  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/32/cios-7-406.PMC4553293.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Case Report    Clinics in Orthopedic Surgery 2015;7:406-409   •  http://dx.doi.org/10.4055/cios.2015.7.3.406,Non-OADS,/arxiv_data1/oa_pdf/44/32/cios-7-406.PMC4553293.pdf
"Keywords:  Spondylolysis, Dura pathology, Spina bifida Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/86/cios-7-410.PMC4553294.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received January 13, 2014; Accepted April 23, 2014 Correspondence to: Young Dong Song, MD  Department of Orthopaedic Surgery, National Medical Center, 245 Eulji- ro, Jung-gu, Seoul 100-799, Korea Tel: +82-2-2269-7199, Fax: +82-2-2267-8685 E-mail: osdryd@gmail.comCase Report    Clinics in Orthopedic Surgery 2015;7:410-413   •  http://dx.doi.org/10.4055/cios.2015.7.3.410",Non-OADS,/arxiv_data1/oa_pdf/4f/86/cios-7-410.PMC4553294.pdf
"Keywords:  Pisotriquetral joint, Wrist, Synovial chondromatosis, Calcification Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/cios-7-414.PMC4553295.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received August 2, 2012; Accepted April 30, 2013 Correspondence to: Sung-Han Ha, MD Department Orthopedic Surgery, MS Jaegeon Hospital, 227 Jungang- daero, Nam-gu, Daegu 705-817, Korea Tel: +82-53-653-0119, Fax: +82-53-653-0770  E-mail: hash-7@hanmail.netCase Report    Clinics in Orthopedic Surgery 2015;7:414-417   •  http://dx.doi.org/10.4055/cios.2015.7.3.414",Non-OADS,/arxiv_data1/oa_pdf/73/ba/cios-7-414.PMC4553295.pdf
"Keywords:  Fibromatosis, Glomus tumor, Toe Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/65/cios-7-418.PMC4553296.pdf
"Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Received January 28, 2013; Accepted May 9, 2013 Correspondence to: Soo Uk Chae, MD  Department of Orthopedic Surgery, Gunsan Medical Center of Wonkwang  University Hospital, 27 Uiryowon-ro, Gunsan 573-713, Korea Tel: +82-63-472-5100, Fax: +82-63-472-5688 E-mail: oschae68@hanmail.netCase Report    Clinics in Orthopedic Surgery 2015;7:418-421   •  http://dx.doi.org/10.4055/cios.2015.7.3.418",Non-OADS,/arxiv_data1/oa_pdf/5a/65/cios-7-418.PMC4553296.pdf
"Berger, PhD, Xin He, BS * National Cancer Institute and University of Maryland Baltimore County, Biometry Research Group, National Cancer Institute, Rockville, MD, *Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA  Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/80/cios-7-422.PMC4553297.pdf
"2003;22(19):3017-28.  http://dx.doi.org/10.4055/cios.2015.7.3.422 Jeehyoung Kim and Wonshik Shin, Reply: Thank you for your valuable and insightful comments.",Non-OADS,/arxiv_data1/oa_pdf/38/80/cios-7-422.PMC4553297.pdf
"Still, block randomization is the most  popular and most widely accepted method recommended  by CONSORT (http://www.consort-statement.org/check - lists/view/32-consort/87-randomisation-type).",Non-OADS,/arxiv_data1/oa_pdf/38/80/cios-7-422.PMC4553297.pdf
"2002;359(9310):  966-70. http://dx.doi.org/10.4055/cios.2015.7.3.423Received March 13, 2015; Accepted March 20, 2015 Correspondence to: Vance W. Berger, PhD   National Cancer Institute and University of Maryland Baltimore County,  Biometry Research Group, National Cancer Institute, 9609 Medical Center  Drive, Rockville, MD 20850, USA Tel: +1-240-276-7142, Fax: +1-240-276-7845 E-mail: vb78c@nih.gov Correspondence to: Jeehyoung Kim, MD   Department of Orthopedic Surgery, Seoul Sacred Heart General Hospital,  259 Wangsan-ro, Dongdaemoon-gu, Seoul 130-011, Korea Tel: +82-2-966-1616, Fax: +82-2-968-2394 E-mail: kjhnav@naver.com",Non-OADS,/arxiv_data1/oa_pdf/38/80/cios-7-422.PMC4553297.pdf
"Clinics in Orthopedic Surgery 2015;7:225-233  http://dx.doi.org/10.4055/cios.2015.7.2.225 In the article “Evaluation of the Accuracy and Precision of a Next Generation Computer-Assisted Surgical System, ”  the Conflict of Interest statement was incorrect.",Non-OADS,/arxiv_data1/oa_pdf/9c/90/cios-7-424.PMC4553298.pdf
"Gulbransen, Xeve S. Silver, BS Engineering and Development, Knee, Exactech Inc., Gainesville, FL,   *North Carolina Specialty Hospital, Durham, NC, USA Copyright © 2015 by The Korean Orthopaedic Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/90/cios-7-424.PMC4553298.pdf
Clinics in Orthopedic Surgery  • pISSN 2005-291X    eISSN 2005-4408 Corrigendum    Clinics in Orthopedic Surgery 2015;7:424   •  http://dx.doi.org/10.4055/cios.2015.7.3.424,Non-OADS,/arxiv_data1/oa_pdf/9c/90/cios-7-424.PMC4553298.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/58/15/ceo-8-183.PMC4553344.pdf
"3: 183- 188, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.183 Original Article INTRODUCTION Psoriatic arthritis (PsA) is an inflammatory arthritis interrelated  with psoriasis (Ps) and 50% of PsA patients are seronegative for  rheumatoid factor [1].",Non-OADS,/arxiv_data1/oa_pdf/58/15/ceo-8-183.PMC4553344.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/30/c6/ceo-8-189.PMC4553345.pdf
"3: 189- 193, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.189 Original Article INTRODUCTION Patients with sensorineural hearing loss (SNHL) tend to suffer  deterioration of speech intelligibility with progressive elevation  of their hearing threshold [1,2].",Non-OADS,/arxiv_data1/oa_pdf/30/c6/ceo-8-189.PMC4553345.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/f7/fd/ceo-8-194.PMC4553346.pdf
"3: 194- 197, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.194 Original Article INTRODUCTION  The prevalence of obesity worldwide has more than doubled  since the 1980s.",Non-OADS,/arxiv_data1/oa_pdf/f7/fd/ceo-8-194.PMC4553346.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/4c/92/ceo-8-198.PMC4553347.pdf
"3: 198- 201, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.198 Original Article INTRODUCTION Tinnitus is defined as auditory perception in the absence of ex - ternal sound [1].",Non-OADS,/arxiv_data1/oa_pdf/4c/92/ceo-8-198.PMC4553347.pdf
SUPPLEMENTARY MATERIAL Supplementary material can be found via http://www.e-ceo.org/ src/sm/ceo-8-p. 198-s001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4c/92/ceo-8-198.PMC4553347.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/9b/ed/ceo-8-202.PMC4553348.pdf
"3: 202- 205, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.202 Original Article INTRODUCTION The sense of hearing is essential for speech and language devel - opment in children.",Non-OADS,/arxiv_data1/oa_pdf/9b/ed/ceo-8-202.PMC4553348.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/da/be/ceo-8-206.PMC4553349.pdf
"3: 206- 210, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.206 Original Article INTRODUCTION  Idiopathic sudden sensorineural hearing loss (SSNHL) has been  long known since its first documentation in 1944 [1].",Non-OADS,/arxiv_data1/oa_pdf/da/be/ceo-8-206.PMC4553349.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/f7/ad/ceo-8-211.PMC4553350.pdf
"3: 211- 217, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.211 Original Article INTRODUCTION Hearing loss is one of the most common disorders of sensorineu - ral function and it affects at least 30% of the population at some time in their lives.",Non-OADS,/arxiv_data1/oa_pdf/f7/ad/ceo-8-211.PMC4553350.pdf
Those babies with two times of “REFER” need to further audio - logical examination and identification of permanent hearing loss  (http://www.cdc.gov/ncbddd/ehdi/ehdi.htm).,Non-OADS,/arxiv_data1/oa_pdf/f7/ad/ceo-8-211.PMC4553350.pdf
"The m.1494C >T and m.1555A >  G mutational sites in mtDNA 12Sr RNA were screened by using  direct sequencing screening, with the primers designed by the  online software Primer 3 (http://biotools.umassmed.edu/bioapps/ primer3_www.cgi).",OADS,/arxiv_data1/oa_pdf/f7/ad/ceo-8-211.PMC4553350.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/71/ba/ceo-8-218.PMC4553351.pdf
"3: 218- 223, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.218 Original Article INTRODUCTION Complications from chronic ear infections are decreasing be - cause of earlier diagnosis and initiation of appropriate treat - ments.",Non-OADS,/arxiv_data1/oa_pdf/71/ba/ceo-8-218.PMC4553351.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/17/9d/ceo-8-224.PMC4553352.pdf
"3: 224- 229, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.224 Original Article INTRODUCTION Microscopic myringoplasty is one of the most frequently per - formed traditional procedures.",Non-OADS,/arxiv_data1/oa_pdf/17/9d/ceo-8-224.PMC4553352.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/9a/70/ceo-8-230.PMC4553353.pdf
"3: 230- 236, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.230 Original Article INTRODUCTION A common potential problem with traditional canal wall down  (CWD) mastoidectomy procedures in treating cholesteatoma is  the long-term morbidity associated with discharging cavities [1].",Non-OADS,/arxiv_data1/oa_pdf/9a/70/ceo-8-230.PMC4553353.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/2b/05/ceo-8-237.PMC4553354.pdf
"3: 237- 242, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.237 Original Article INTRODUCTION Hearing-impaired individuals, especially with sensorineural  hearing loss (HL), are known to have substantial difficulty in  understanding speech in noisy environments based on the hear -ing threshold level and configuration.",Non-OADS,/arxiv_data1/oa_pdf/2b/05/ceo-8-237.PMC4553354.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/81/4f/ceo-8-243.PMC4553355.pdf
"3: 243- 249, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.243 Original Article INTRODUCTION Allergic rhinitis is a common inflammatory disease of the nasal  mucosa that is characterized by pruritus, sneezing, rhinorrhea,  and nasal obstruction.",Non-OADS,/arxiv_data1/oa_pdf/81/4f/ceo-8-243.PMC4553355.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/12/ff/ceo-8-250.PMC4553356.pdf
"3: 250- 255, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.250 Original Article INTRODUCTION Orbital floor fracture is one of the most common facial skeleton  fractures after mid facial trauma, accounting for up to 40% of  craniofacial injuries [1,2].",Non-OADS,/arxiv_data1/oa_pdf/12/ff/ceo-8-250.PMC4553356.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/10/35/ceo-8-256.PMC4553357.pdf
"3: 256- 260, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.256 Original Article INTRODUCTION Obstructive sleep apnea syndrome (OSAS) is a common disease  in childhood, with a prevalence of 1% to 3% [1-4].",Non-OADS,/arxiv_data1/oa_pdf/10/35/ceo-8-256.PMC4553357.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/89/38/ceo-8-261.PMC4553358.pdf
"3: 261- 267, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.261 Original Article INTRODUCTION  A foreign body in the upper gastrointestinal tract occurs sporad - ically as food is ingested, and in many cases, it can cause irrita - tion and pain.",Non-OADS,/arxiv_data1/oa_pdf/89/38/ceo-8-261.PMC4553358.pdf
http://dx.doi.org/10.1002/lary.25340.,Non-OADS,/arxiv_data1/oa_pdf/89/38/ceo-8-261.PMC4553358.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/53/0e/ceo-8-268.PMC4553359.pdf
"3: 268- 274, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.268 Original Article INTRODUCTION Angiogenin (ANG) is a member of the ribonuclease superfamily  comprising 123 amino acids.",Non-OADS,/arxiv_data1/oa_pdf/53/0e/ceo-8-268.PMC4553359.pdf
Available from: http://seer.cancer.gov/csr/1975_2010/.,Non-OADS,/arxiv_data1/oa_pdf/53/0e/ceo-8-268.PMC4553359.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/5c/11/ceo-8-275.PMC4553360.pdf
"3: 275- 280, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.275 Original Article INTRODUCTION In 2008, with an estimated 263,000 new cases, oral (including  lip) squamous cell carcinoma (SCC) ranked as the 15th most  common cancer worldwide when the global incidence and relat - ed mortality of 27 malignancies was estimated for 182 countries  by the International Agency for Research on Cancer as part of the GLOBOCAN scheme [1].",Non-OADS,/arxiv_data1/oa_pdf/5c/11/ceo-8-275.PMC4553360.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/f8/4b/ceo-8-281.PMC4553361.pdf
"3: 281- 288, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.281 Original Article INTRODUCTION Pharyngocutaneous fistula (PCF) is one of the most troublesome  complications in early postoperative period after total laryngec - tomy.",Non-OADS,/arxiv_data1/oa_pdf/f8/4b/ceo-8-281.PMC4553361.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/78/ceo-8-289.PMC4553362.pdf
"3: 289- 294, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.289 Original Article INTRODUCTION Papillary thyroid carcinoma (PTC) is the most common malig - nancy of the thyroid.",Non-OADS,/arxiv_data1/oa_pdf/40/78/ceo-8-289.PMC4553362.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/ca/8f/ceo-8-295.PMC4553363.pdf
"3: 295- 297, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.295 Case  Report INTRODUCTION Verruca vulgaris is caused by a human papillomavirus (HPV) in - fection of the epidermis.",Non-OADS,/arxiv_data1/oa_pdf/ca/8f/ceo-8-295.PMC4553363.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/27/e8/ceo-8-298.PMC4553364.pdf
"3: 298- 301, September 2015 http://dx.doi.org/10.3342/ceo.2015.8.3.298 Case  Report INTRODUCTION Intramuscular hemangioma (IMH) is a rare, benign vascular le - sion that frequently develops within skeletal muscles [1].",Non-OADS,/arxiv_data1/oa_pdf/27/e8/ceo-8-298.PMC4553364.pdf
"389Korean J Physiol Pharmacol Vol 19: 389 －399, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.389pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: MT, metallothionein; Zip, zinc importer; Zn, zinc;  Zn2+, free zinc or labile zinc; ZnT, zinc exporter.",Non-OADS,/arxiv_data1/oa_pdf/03/ab/kjpp-19-389.PMC4553398.pdf
"401Korean J Physiol Pharmacol Vol 19: 401 －411, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.401pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: EPS, Epalrestat; PF, Pulmonary fibrosis; ECM,  extracellular matrix; α-SMA, α-smooth muscle actin; COPD, chronic  obstructive pulmonary diseases; SMC, smooth muscle cells; TGF- β1,  transforming growth factor- β1; DMEM, Dulbecco’s modified Eagle’s medium; BLM, bleomycin.",Non-OADS,/arxiv_data1/oa_pdf/51/9a/kjpp-19-401.PMC4553399.pdf
"413Korean J Physiol Pharmacol Vol 19: 413 －420, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.413pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: Dex, dexmedetomidine; IL, interluekin; HSG,  human salivary glands; STIM1, stromal interaction molecule 1;  CRAC, Ca2+ release-activated Ca2+.",Non-OADS,/arxiv_data1/oa_pdf/46/07/kjpp-19-413.PMC4553400.pdf
"421Korean J Physiol Pharmacol Vol 19: 421 －426, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.421pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: CDK, cyclin-dependent kinase; ERK1/2, extracell- ular signal-regulated kinase 1/2; MAPK, mitogen-activated protein kinase; PCNA, proliferating cell nuclear antigen; PDGF, plate- let-derived growth factor; PI3K, phosphatidylinositol-3-kinase; Akt/  PKB, protein kinase B; PLC γ1, phospholipase C γ1; Rb, retinobla- stoma; STAT3, signal transducer and activator of transcription 3;  VSMC, vascular smooth muscle cell.",Non-OADS,/arxiv_data1/oa_pdf/7b/7d/kjpp-19-421.PMC4553401.pdf
"427Korean J Physiol Pharmacol Vol 19: 427 －434, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.427pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: AMPA, 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)  propanoic acid; MVN, medial vestibular nucleus; NMDA, N-methyl  D-asparate; RVLM, rostral ventrolateral medullary nucleus; SAD, sinoaortic denervation; SNP, sodium nitroprusside; VSA, vestibulo-  spino-adrenal.",Non-OADS,/arxiv_data1/oa_pdf/eb/4b/kjpp-19-427.PMC4553402.pdf
"435Korean J Physiol Pharmacol Vol 19: 435 －440, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.435pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: PACAP, pituitary adenylate cyclase-activating  peptide; ICC, interstitial cells of Cajal; cAMP, cyclic AMP; L-NAME,  NG-nitro-L-arginine methyl ester; ODQ, 1 H-[1,2,4]oxadiazolo[4,3- a]  quinoxalin-1-one; GI, gastrointestinal; VIP, vasoactive intestinal poly-peptide; TEA, tetraethylammonium chloride; NO, nitric oxide; PGE 2,  prostaglandin E 2.",Non-OADS,/arxiv_data1/oa_pdf/1a/89/kjpp-19-435.PMC4553403.pdf
"441Korean J Physiol Pharmacol Vol 19: 441 －449, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.441pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: SCT, scutellarein; NO, nitric oxide; TNF- α, tumor  necrosis factor- α; LPS, lipopolysaccharide; NF- κB, nuclear factor- κ B; TRIF, TIR-domain-containing adapter-inducing interferon- β; TLR,  Toll-like receptor; MyD88, Myeloid differentiation primary response gene 88; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; PEI,  polyethylenimine; IKK, I κB kinase; COX-2, cyclooxygenase-2.",Non-OADS,/arxiv_data1/oa_pdf/64/49/kjpp-19-441.PMC4553404.pdf
"451Korean J Physiol Pharmacol Vol 19: 451 －460, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.451 ABBREVIATIONS: SIRT1, sirtuin 1; NAD, nicotinamide adenine  dinucleotide; NF- κB, nuclear factor kappa B; TNF- α, tumor necrosis  factor-α; IL-6, interleukin-6; IRS-1, insulin receptor substrate-1;  NAFLD, non-alcoholic fatty liver disease; GTT, glucose tolerance test; ITT, insulin tolerance test; AST, aspartate aminotransferase; ALT,  alanine aminotransferase; FFA, free fatty acids; TG, triglyceride;  HMGB1, high mobility group protein B1; RAGE, receptor for advanced glycation end-products; TNFR1, TNF receptor 1; SREBP1,  sterol regulatory element-binding protein 1; ACC, acetyl CoA  carboxylase; CTGF, connective tissue growth factor; α-SMA,  alpha-smooth muscle actin; 4-HNE, 4-hydroxynonenal; HSC, hepatic  stellate cells; hCLS, hepatic crown-like structures; JNK, c-Jun  N-terminal kinase; KN, normal-diet fed knockout mice; KH, high-fat diet-fed knockout mice; WN, normal-diet fed wild type mice; WH,  high-fat diet-fed wild type mice.",Non-OADS,/arxiv_data1/oa_pdf/94/99/kjpp-19-451.PMC4553405.pdf
"461Korean J Physiol Pharmacol Vol 19: 461 －465, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.461pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: TLR2, toll-like receptor 2; CNS, central nervous  system; KO, knock out; IL, interleukin; TNF, tumor necrosis factor;  NO, nitric oxide.",Non-OADS,/arxiv_data1/oa_pdf/67/8e/kjpp-19-461.PMC4553406.pdf
TLR2 in Early Microglia Reaction to Injury 465 SUPPLEMENTARY MATERIALS   Supplementary data includ ing one video can be found  with this article online at http://dx.doi.org/10.4196/kjpp.,Non-OADS,/arxiv_data1/oa_pdf/67/8e/kjpp-19-461.PMC4553406.pdf
"467Korean J Physiol Pharmacol Vol 19: 467 －472, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.467pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: HDAC, histone deacetylases; TSA, trichostatin A;  ROS, reactive oxygen species;  VSMC, vascular smooth muscle cells;  Ang II, Angiotensin II; AT1R, angiotensin II receptor type 1; AT2R, angiotensin II receptor type 2; IACUC, Institutional animal care and  use committee; PE-50, Polyethylene tubing; SBP, systolic blood  pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP, pulse pressure; NADPH, nicotinamide adenine  dinucleotide phosphate; PCAF, p300/CBP-associated factor.",Non-OADS,/arxiv_data1/oa_pdf/43/69/kjpp-19-467.PMC4553407.pdf
"473Korean J Physiol Pharmacol Vol 19: 473 －478, September, 2015 http://dx.doi.org/10.4196/kjpp.2015.19.5.473pISSN 1226-4512 eISSN 2093-3827 ABBREVIATIONS: 5-HT, 5-hydroxytryptamine; EFS, electrical field  stimulation; GABA, γ-aminobutyric acid; NANC, Non-noradrenergic,  non-cholinergic transmitter; PKC, protein kinase C; PLC, phospholipase  C; ROCK, Rho-associated protein kinase.",Non-OADS,/arxiv_data1/oa_pdf/3b/20/kjpp-19-473.PMC4553408.pdf
"S375 Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Kahn University; Karachi,  Sindh, PakistanAbstract Background: Cavernomas are benign lesions that most commonly occur  intra‑parenchymally, but occasionally they have been described as arising from  the dura mater.",Non-OADS,/arxiv_data1/oa_pdf/fe/b3/SNI-6-375.PMC4553634.pdf
"http://surgicalneurologyint.com/Cavernous-hemangioma-of-the-dura-mater-mimicking-meningioma/ Copyright: © 2015 Di Vitantonio  H.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/fe/b3/SNI-6-375.PMC4553634.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam,  MD  Aga Kahn University; Karachi,  Sindh, PakistanS367A case of intravascular lymphoma presenting as myelopathy  diagnosed with a skin biopsy Masatoshi Yunoki, Kenta Suzuki, Atsuhito Uneda, Kimihiro Y oshino Department of Neurosurgery, Kagawa Rosai Hospital, Kagawa, Japan E‑mail: *Masatoshi Yunoki ‑ yunomasato@yahoo.co.jp; Kenta Suzuki ‑ flying1369@yahoo.co.jp; Atsuhito Uneda ‑ atsuhitouneda@yahoo.co.jp;   Kimihiro Yoshino ‑ yoshino@kagawah.rofuku.go.jp   *Corresponding author Received: 04 March 15   Accepted: 15 June 15   Published: 20 August 15 Abstract Background:  Intravascular lymphoma (IVL) is a rare subtype of non‑Hodgkin  lymphoma with exclusively or predominantly intravascular proliferation.",Non-OADS,/arxiv_data1/oa_pdf/bb/dd/SNI-6-367.PMC4553635.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,   University of Washington Medical  Center, Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS355Abstract Background: Surgical resection and stereotactic radiosurgery (SRS) are  well‑established treatment methods for patients with brain metastases, yet their  respective roles in the management of brain metastases remain incompletely defined.",Non-OADS,/arxiv_data1/oa_pdf/87/bd/SNI-6-355.PMC4553636.pdf
http://surgicalneurologyint.com/Stereotactic‑radiosurgery‑for ‑brain‑metastases‑from‑malignant‑melanoma/ Access this article online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.163315  Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/87/bd/SNI-6-355.PMC4553636.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: S. A. Enam , MD  Aga Kahn University; Karachi,  Sindh, PakistanS371Abstract Background:  Giant cysts of the midline, not associated to a tumor, are exceptional  finding in the brain of adults.",Non-OADS,/arxiv_data1/oa_pdf/1d/d0/SNI-6-371.PMC4553637.pdf
"http://surgicalneurologyint.com/Treatment-of-giant-congenital-cysts-of-the-midline-in-adults:-Report-of-two-cases-and-review-of-the-literature/ Copyright: © 2015 Lauretti  L.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/1d/d0/SNI-6-371.PMC4553637.pdf
Available from:  http://www.cdc.gov/nchs/data/series/sr_10/sr10_242.pdf.,OADS,/arxiv_data1/oa_pdf/49/e6/yjbm_88_3_205.PMC4553639.pdf
Available from: http://www.niaaa.nih.gov/news-events/news-  releases/college-drinking-hazardous-campus-communities-  task-force-calls-research.,Non-OADS,/arxiv_data1/oa_pdf/49/e6/yjbm_88_3_205.PMC4553639.pdf
Available  from: http://www.cdc.gov/alcohol/fact-sheets/alcohol-  use.htm.,Non-OADS,/arxiv_data1/oa_pdf/49/e6/yjbm_88_3_205.PMC4553639.pdf
Available from: http://www.nitrc.org/.,Non-OADS,/arxiv_data1/oa_pdf/03/6d/yjbm_88_3_211.PMC4553640.pdf
http://www.uptodate.com/contents/motivational-interview - ing-for-substance-use-disorder.,Non-OADS,/arxiv_data1/oa_pdf/17/fe/yjbm_88_3_227.PMC4553642.pdf
Available from:  http://www.cdc.gov/media/releases/2013/p0220_drug_over - dose_deaths.html.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available  from: http://www.drugabuse.gov/about-nida/legislative-ac - tivities/testimony-to-congress/2014/prescription-opioid-  heroin-abuse.,OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from:  http://www.wsj.com/articles/SB124225891527617397.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://www.cdc.gov/mmwr/pre - view/mmwrhtml/mm6423a2.htm.,OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available  from: http://www.whitehouse.gov/blog/2014/12/17/updated-  infographic-overdose-prevention-state-state.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from:  http://www.hhs.gov/news/press/2015pres/03/20150326a.html.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from:  http://www.ncsl.org/research/civil-and-criminal-  justice/drug-overdose-immunity-good-samaritan-laws.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://www.cdc.gov/mmwr/pre - view/mmwrhtml/mm6340a1.htm.,OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://www.supportprop.org/educa - tional/PROP_OpioidPrescribing.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from:  http://www.drugabuse.gov/publications/teaching-  packets/neurobiology-drug-addiction.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Avail - able from: http://www.dea.gov/divisions/hq/2014/hq110514.shtml.,OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://store.samhsa.gov/prod - uct/Opioid-Overdose-Prevention-Toolkit-Updated-  2014/SMA14-4742.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://www.bu.edu/bniart/sbirt-in-health-  care/sbirt-brief-negotiated-interview-bni/.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://harmreduction.org/.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://archive.samhsa.gov/data/2k12/DA wN096/SR096eD - Highlights2010.htm.,OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://www.drugpolicy.org/re - source/expanding-access-naloxone-reducing-fatal-overdose-  saving-lives.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://projectlazarus.org/.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://www.ag.ny.gov/feature/community-  overdose-prevention-program-cop-program.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from:  http://www.whitehouse.gov/blog/2013/08/28/announcing-  opioid-overdose-toolkit.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://www.casacolumbia.org/addiction-re - search/reports/addiction-medicine.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from:  http://www.noperi.org/cpa.html.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Avail - able from: http://adai.uw.edu/pubs/infobriefs/ADAi-iB-  2011-05.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available from: http://www.white - house.gov/blog/2013/03/29/good-samaritan-overdose-respo  nse-laws-lessons-learned-washington-state.,Non-OADS,/arxiv_data1/oa_pdf/b4/81/yjbm_88_3_235.PMC4553643.pdf
Available  from: https://www.tga.gov.au/auspar/auspar-nabiximols.,Non-OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available from: http://www.gwpharm.com/Sativex.aspx.,Non-OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available from: http://www.brookings.edu/research/papers/2013/05/29-pol- itics-marijuana-legalization-galston-dionne.,Non-OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available from: http://medicalmarijuana.procon.org/view.resource.php?re - sourceID=00881.,Non-OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available from: http://www.newyorkerest.com/2008/dr- kush-how-medical-marijuana-is-transforming-the-pot-in - dustry/.,Non-OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available from: https://www.colorado.gov/pacific/cdphe/retail-marijuana.,OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available from: http://www.liq.wa.gov/marijuana/I-502.,OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available  from: http://marijuana.heraldtribune.com/2015/01/04/colorado- medical-marijuana-rules-vulnerable-change/.,Non-OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available  from: http://www.desmoinesregister.com/story/opinion/colum - nists/rekha-basu/2014/08/17/colorados-marijuana-law-brought- tourists-tax-revenues/14178219/.,Non-OADS,/arxiv_data1/oa_pdf/97/40/yjbm_88_3_257.PMC4553645.pdf
Available from:  http://www.ct.gov/dcp/cwp/view.asp?a=4287&q=503670&dcp - Nav=|.,OADS,/arxiv_data1/oa_pdf/e8/4b/yjbm_88_3_265.PMC4553646.pdf
Available from:  http://www.dsm5.org/.,Non-OADS,/arxiv_data1/oa_pdf/e8/4b/yjbm_88_3_265.PMC4553646.pdf
Available from: http://www.dru - gabuse.gov/publications/drugfacts/marijuana.,Non-OADS,/arxiv_data1/oa_pdf/e8/4b/yjbm_88_3_265.PMC4553646.pdf
Available from:  http://www.integration.samhsa.gov/health-wellness/wellness-  strategies/tobacco-cessation-2.,Non-OADS,/arxiv_data1/oa_pdf/28/c2/yjbm_88_3_271.PMC4553647.pdf
Available from: http://www.ahrq.gov/profes - sionals/clinicians-providers/guidelines-recommendations/to - bacco/clinicians/update/treating_tobacco_use08.pdf.,Non-OADS,/arxiv_data1/oa_pdf/28/c2/yjbm_88_3_271.PMC4553647.pdf
Available from:  http://www.fda.gov/Drugs/DrugSafety/ucm436494.htm.,Non-OADS,/arxiv_data1/oa_pdf/28/c2/yjbm_88_3_271.PMC4553647.pdf
Available from: http://www.fda.gov/NewsEv - ents/PublicHealthFocus/ucm172906.htm.,Non-OADS,/arxiv_data1/oa_pdf/28/c2/yjbm_88_3_271.PMC4553647.pdf
Available from: http://www.theesa.com/wp- content/uploads/2014/10/ESA_EF_2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b9/1f/yjbm_88_3_309.PMC4553652.pdf
Available from: http://nikopartners.com/chinese-pc-on - line-games-market-expected-double-2013-2018/.,Non-OADS,/arxiv_data1/oa_pdf/b9/1f/yjbm_88_3_309.PMC4553652.pdf
Available from: http://www.cbc.ca/news/canada/montreal/ubisoft-has-new- video-game-designed-to-treat-lazy-eye-1.2979850.,Non-OADS,/arxiv_data1/oa_pdf/b9/1f/yjbm_88_3_309.PMC4553652.pdf
Available from: http://www.dsm5.org/.,Non-OADS,/arxiv_data1/oa_pdf/b9/1f/yjbm_88_3_309.PMC4553652.pdf
Available from: http://www.amazon.com/gp/bestsellers/2014/videogames/ref=  zg_bsar_cal_ye#1.,Non-OADS,/arxiv_data1/oa_pdf/b9/1f/yjbm_88_3_309.PMC4553652.pdf
Available from: http://www.npd.com/wps/por - tal/npd/us/news/press-releases/research-shows-15.39-billion-  dollars-spent-on-video-game-content-in-the-us-in-2013-a-1-per  cent-increase-over-2012/.,Non-OADS,/arxiv_data1/oa_pdf/58/f4/yjbm_88_3_319.PMC4553653.pdf
Available  from: http://www.dsm5.org/Documents/Internet Gaming  Disorder Fact Sheet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/f4/yjbm_88_3_319.PMC4553653.pdf
Available from: http://kff.org/other/event/generation-m2-  media-in-the-lives-of/.,Non-OADS,/arxiv_data1/oa_pdf/58/f4/yjbm_88_3_319.PMC4553653.pdf
Available from: http://www.addictionsandrecov - ery.org/relapse-prevention.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/1d/yjbm_88_3_325.PMC4553654.pdf
Available from: http://www.univer - sityaffairs.ca/news/news-article/heavy-drinking-a-problem-  at-most-canadian-campuses-report/.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from: http://www.cacuss.ca/_Li - brary/documents/NCHA-II_WeB_SPRING_2013_CANA - DIAN_ReFeReNCe_GROUP_eXeCUtIve_SUMMAR  Y .pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from:  http://www.sccollege.edu/StudentServices/SLOs/Docu - ments/2012-2013%20SLO%20Reports/L tUt%20SCC%20Fall - ReportMar9%20FINAL%20(2).pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available  from: http://www.cbc.ca/news/canada/nova-scotia/acadia-  student-dies-after-heavy-drinking-1.1001713.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available  from: http://www.macleans.ca/education/uniandcollege/coroner-  says-queens-should-address-culture-of-drinking/.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from:  http://www.medicaldaily.com/rutgers-student-caitlyn-ko - vacs-death-raises-concerns-over-how-college-students-so - cialize-304358.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from:  http://abcnews.go.com/US/wvu-student-died-fraternity-  pledging-blood-alcohol-time/story?id=28536569.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from:  http://usurj.journalhosting.ucalgary.ca/usurj/index.php/usurj/  article/view/115/53.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from:  http://www.theotherhangover.umn.edu/about.html.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from: http://www.macleans.ca/edu - cation/uniandcollege/battling-the-binge/.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from: http://www.whatsurcap.ca/about-us/.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from: http://www.sbir-diba.ca/docs/de - fault-document-library/2012-screening-brief-intervention-  and-referral-clinical-guide-enB0e406423349865474B15064  .pdf?sfvrsn=4.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from:  http://pubs.niaaa.nih.gov/publications/Practitioner/Clini - ciansGuide2005/guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from:  http://www2.gov.bc.ca/gov/content/health/practitioner-pro - fessional-resources/bc-guidelines/problem-drinking.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available  from: http://medicine.yale.edu/sbirt/curriculum/index.aspx.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from: http://www.sbir-  diba.ca/.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
2008 [cited 2015 Jul 7] Available  from: http://www.integration.samhsa.gov/clinical-prac - tice/sbirt/NHtSA_SBIRt_for_Colleges_and_Universi - ties.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from: http://www.nrepp.samhsa.gov/viewIn - tervention.aspx?id=124.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available  from: http://www.researchgate.net/profile/Richard_Saitz/publi - cation/5771873_Screening_and_brief_intervention_enter_their_  5th_decade/links/0deec52e281443b870000000.pdf#page=24.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Avail - able from: http://www.macleans.ca/education/uniandcol - lege/the-perils-of-drinking-on-canadian-campuses/.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Avail - able from: http://www.ccsa.ca/Resource%20Library/2011-  Summary-of-evidence-and-Guidelines-for-Low-Risk%20Dr  inking-en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from: http://cssc.uscannenberg.org/wp-content/up - loads/2014/01/v2art5.pdf.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from:  http://www.echeckuptogo.com/can/.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
Available from: http://www.uvic.ca/research/centres/carbc/pub - lications/screening-tools/index.php.,Non-OADS,/arxiv_data1/oa_pdf/40/51/yjbm_88_3_339.PMC4553656.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comBook Review A critique of Dr. Miguel Faria’s Book, Vandals at the Gates of  Medicine  Russell L. Blaylock Theoretical Neuroscience Research, LLC, Ridgeland, MS 39157, USA E‑mail: *Russell L. Blaylock ‑ blay6307@comcast.net   *Corresponding author Received: 24 June 15  Accepted: 24 June 15  Published: 19 August 15 It is not often one comes across a book that contains  so much useful and enlightening information and  wisdom.",Non-OADS,/arxiv_data1/oa_pdf/85/01/SNI-6-140.PMC4553659.pdf
"Surg Neurol Int 2015;6:140. http://surgicalneurologyint.com/A-critique-of-Dr.-Miguel-Faria’s-Book,-Vandals-at-the-Gates-of-Medicine/ Copyright: © 2015 Blaylock RL.",Non-OADS,/arxiv_data1/oa_pdf/85/01/SNI-6-140.PMC4553659.pdf
"Surgical Neurology International 2015, 6:140  http://www.surgicalneurologyint.com/content/6/1/140demonstrates the virtues that built the foundation of a  free republic — the rule of law, family structure, justice,  courage, and temperance.",Non-OADS,/arxiv_data1/oa_pdf/85/01/SNI-6-140.PMC4553659.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comAbstract Background:  Neurosurgeons are frequently involved in the management of  patients with traumatic frontal sinus injury; however, management options and  operative techniques can vary significantly.",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
Surg  Neurol Int 2015;6:141. http://surgicalneurologyint.com/Surgical-management-of-traumatic-frontal-sinus-fractures:-Case-series-from-a-single-institution-and-literature-review/ Copyright: © 2015 Ravindra VM.,Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology International 2015, 6:141  http://www.surgicalneurologyint.com/content/6/1/141INTRODUCTION In trauma patients, frontal sinus fractures are common  and account for 5–15% of all facial fractures.",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology International 2015, 6:141  http://www.surgicalneurologyint.com/content/6/1/141Of the patients in this series, 31/33 (94%) were male, and  the mean age was 33.9 ± 11 years (range 15–62 years).",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology International 2015, 6:141  http://www.surgicalneurologyint.com/content/6/1/141fracture with near‑complete opacification of the frontal  sinus [Figure 3a].",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology International 2015, 6:141  http://www.surgicalneurologyint.com/content/6/1/141We found that 67% of the patients in our series had  concomitant intracranial injuries, a common finding  in patients with frontal sinus fractures with associated  NFOT injury.",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology International 2015, 6:141  http://www.surgicalneurologyint.com/content/6/1/141the frontonasal opening, which is usually located in the  posteromedial aspect of the floor, and the NFOT course is  posterior and caudal [Figure 4].",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology International 2015, 6:141  http://www.surgicalneurologyint.com/content/6/1/141injuries and critical illness in blunt trauma patients,  which can lead to delay in the surgical treatment of  these patients.",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology International 2015, 6:141  http://www.surgicalneurologyint.com/content/6/1/141on initial presentation), none of whom were started on  CNS‑penetrating doses of antibiotics prophylactically.",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology International 2015, 6:141  http://www.surgicalneurologyint.com/content/6/1/141REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
Centers for Disease Control and Prevention;  Available from: http://www.cdc.gov/vaccines/vpd -vac/pneumo/vacc-in-short.,Non-OADS,/arxiv_data1/oa_pdf/42/83/SNI-6-141.PMC4553660.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comNeurosurgery Concepts Neurosurgery concepts: Key perspectives on deferoxamine  and chronic hydrocephalus from intraventricular hemorrhage,  laboratory dissection training in neurosurgical residency,  tetanus toxoid and dendritic cell vaccines for glioblastoma, and  intracranial hypertension after surgery for craniosynostosis Winward Choy, Angela M. Bohnen, Panayiotis Pelargos1, Sandi Lam2, Isaac Yang1, Zachary A. Smith Department of Neurosurgery, Feinberg School of Medicine, Northwestern University, Chicago, IL, 1Department of Neurosurgery, David Geffen School of Medicine,  University of California, Los Angeles, CA, 2Department of Neurosurgery, Baylor College of Medicine, T exas Children’s Hospital, Houston, TX, USA  E‑mail: Winward Choy ‑ winward.choy@northwestern.edu; Angela M. Bohnen ‑ angela‑bohnen@northwestern.edu; Panayiotis Pelargos ‑ ppelargo@uci.edu;   Sandi Lam ‑ sandilam@gmail.com; Isaac Yang ‑ iyang@mednet.ucla.edu; *Zachary A. Smith ‑ zsmith@nmff.org   *Corresponding author Received: 26 May 15  Accepted: 09 June 15  Published: 19 August 15 DEFEROXAMINE ALLEVIATES  CHRONIC HYDROCEPHALUS AFTER  INTRAVENTRICULAR HEMORRHAGE  THROUGH IRON CHELATION AND  WNT1/WNT3A INHIBITION[4] Study Question : Does deferoxamine (DFX) alleviate  posthemorrhagic chronic hydrocephalus (PHCH) by  chelation of iron and suppression of the Wnt1/Wnt3a  cellular pathway?",Non-OADS,/arxiv_data1/oa_pdf/ea/dd/SNI-6-139.PMC4553661.pdf
"Surg Neurol Int 2015;6:139. http://surgicalneurologyint.com/Neurosurgery-concepts:-Key-perspectives-on-deferoxamine-and-chronic-hydrocephalus-from-intraventricular-hemorrhage,-laboratory- dissection-training-in-neurosurgical-residency,-tetanus-toxoid-and-dendritic-cell-vaccines-for-glioblastoma,-and-intracranial-hypertension-after-surgery-for-craniosynostosis/ Copyright: © 2015 Choy W.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ea/dd/SNI-6-139.PMC4553661.pdf
"Surgical Neurology International 2015, 6:139  http://www.surgicalneurologyint.com/content/6/1/139DFX following IVH significantly improved performance  on the Water Morris navigation test, a measure of rat  behavior.",Non-OADS,/arxiv_data1/oa_pdf/ea/dd/SNI-6-139.PMC4553661.pdf
"Surgical Neurology International 2015, 6:139  http://www.surgicalneurologyint.com/content/6/1/139through years of training only to feel inept at the end.",Non-OADS,/arxiv_data1/oa_pdf/ea/dd/SNI-6-139.PMC4553661.pdf
"Surgical Neurology International 2015, 6:139  http://www.surgicalneurologyint.com/content/6/1/139Craniosynostosis is typically diagnosed and surgically  treated in childhood.",Non-OADS,/arxiv_data1/oa_pdf/ea/dd/SNI-6-139.PMC4553661.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowReview Article Methylprednisolone in the management of spinal cord injuries:  Lessons from randomized, controlled trials Vincent Cheung, Reid Hoshide, Vishal Bansal1, Ekkehard Kasper2, Clark C. Chen Division of Neurosurgery, University of California, 1Department of Surgery, University of California, San Diego, CA, 2Division of Neurosurgery,   Beth Israel Deaconess Medical Center, Boston, MA, USA E‑mail:  Vincent Cheung ‑ vjcheung@ucsd.edu; Reid Hoshide ‑ rhoshide@ucsd.edu; Vishal Bansal ‑ v3bansal@ucsd.edu;   Ekkehard Kasper ‑ ekasper@BIDMC.harvard.edu; *Clark C. Chen ‑ clarkchen@ucsd.edu   *Corresponding author Received: 17 June 15  Accepted: 02 July 15  Published: 24 August 15 Abstract The efficacy of glucocorticoid for treatment of acute spinal cord injuries remains  a controversial topic.",Non-OADS,/arxiv_data1/oa_pdf/b3/38/SNI-6-142.PMC4553662.pdf
"Surg Neurol Int 2015;6:142. http://surgicalneurologyint.com/Methylprednisolone-in-the-management-of-spinal- cord-injuries:-Lessons-from-randomized,-controlled-trials/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/b3/38/SNI-6-142.PMC4553662.pdf
"Surgical Neurology International 2015, 6:142  http://www.surgicalneurologyint.com/content/6/1/142The study design did not involve a placebo group  because the prevailing belief at the time was that  glucocorticoid treatment was likely beneficial and  could not be withheld based on ethical considerations.",Non-OADS,/arxiv_data1/oa_pdf/b3/38/SNI-6-142.PMC4553662.pdf
"Surgical Neurology International 2015, 6:142  http://www.surgicalneurologyint.com/content/6/1/142EXPERT OPINIONS “There is convincing and undeniable data justifying the  clinical use of glucocorticoid, particularly in those who  suffered from incomplete SCI” by Ekkehard Kasper,  M.D., Ph.D., Beth Israel Deaconess Medical Center,  Boston, MA, USA.",Non-OADS,/arxiv_data1/oa_pdf/b3/38/SNI-6-142.PMC4553662.pdf
"Surgical Neurology International 2015, 6:142  http://www.surgicalneurologyint.com/content/6/1/142REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/b3/38/SNI-6-142.PMC4553662.pdf
Available	 from:	https://www.nscisc.uab.edu/PublicDocuments/fact_figures_ docs/Facts%202014.pdf [Last accessed on 2015 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/b3/38/SNI-6-142.PMC4553662.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowCase Report Successful sinus restoration for transverse‑sigmoid sinus  dural arteriovenous fistula complicated by multiple venous  sinus occlusions: The usefulness of preoperative computed  tomography venography Koichiro Takemoto, Toshio Higashi1, Seisaburo Sakamoto, Tooru Inoue1 Department of Neurosurgery, Sasebo Chuo Hospital, Nagasaki, 1Department of Neurosurgery, Fukuoka University Hospital and Faculty of Medicine,   Fukuoka University, Fukuoka, Japan E‑mail:  Koichiro Takemoto ‑ take9016@gmail.com; *T oshio Higashi ‑ toshi‑higashi@pop13.odn.ne.jp; Seisaburo Sakamoto ‑ ns.sanchan@hakujyujikai.or.jp;   T ooru Inoue ‑ toinoue@fukuoka‑u.ac.jp   *Corresponding author Received: 12 March 15  Accepted: 25 June 15  Published: 18 August 15 Abstract Background:  Although sinus restoration for transverse‑sigmoid sinus (TSS) dural  arteriovenous fistula (DAVF) has rarely been reported over the past decade, its  advantage and indication still remain unclear.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/SNI-6-137.PMC4553663.pdf
"Surg Neurol Int 2015;6:137. http://surgicalneurologyint.com/Successful-sinus-restoration-for-transverse-sigmoid- sinus-dural-arteriovenous-fistula-complicated-by-multiple-venous-sinus-occlusions:- The-usefulness-of-preoperative-computed-tomography-venography/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/SNI-6-137.PMC4553663.pdf
"Surgical Neurology International 2015, 6:137  http://www.surgicalneurologyint.com/content/6/1/137preferable compared with TAE or TVE.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/SNI-6-137.PMC4553663.pdf
"Surgical Neurology International 2015, 6:137  http://www.surgicalneurologyint.com/content/6/1/137portion.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/SNI-6-137.PMC4553663.pdf
"Surgical Neurology International 2015, 6:137  http://www.surgicalneurologyint.com/content/6/1/137configuration of the occluded region and predicting the  feasibility of stenting than conventional angiography.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/SNI-6-137.PMC4553663.pdf
"Surgical Neurology International 2015, 6:137  http://www.surgicalneurologyint.com/content/6/1/137of a self-expanding stent with balloon angioplasty in the treatment of  dural arteriovenous fistulas involving the transverse and/or sigmoid sinus:  Functional and neuroimaging-based outcome in 10 patients.",Non-OADS,/arxiv_data1/oa_pdf/45/d7/SNI-6-137.PMC4553663.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article Cerebral intraventricular echinococcosis in an adult Sharad Pandey, Deepa Pandey1, Neeraj Shende, Anurag Sahu, Vivek Sharma Departments of Neurosurgery, Sir Sunderlal Hospital, IMS, BHU, 1Clinical Microbiology, DLW ,  Varanasi, Uttar Pradesh, India E‑mail: *Sharad Pandey ‑ drsharad23@yahoo.com; Deepa Pandey ‑ deepalohani02lhmc@gmail.com; Neeraj Shende ‑ neerajshende11@gmail.com;   Anurag Sahu ‑ anuragsahu25@rediffmail.com;  Vivek Sharma ‑ neurosurgeryimsbhu@gmail.com   *Corresponding author Received: 20 March 15  Accepted: 31 May 15  Published: 18 August 15 Abstract Background:  Echinococcosis in humans occurs as a result of infection by the  larval stages of taeniid cestodes of the genus echinococcus.",Non-OADS,/arxiv_data1/oa_pdf/d6/82/SNI-6-138.PMC4553664.pdf
"Surg Neurol Int 2015;6:138. http://surgicalneurologyint.com/Cerebral-intraventricular-echinococcosis-in-an-adult/ Copyright: © 2015 Pandey S.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d6/82/SNI-6-138.PMC4553664.pdf
"Surgical Neurology International 2015, 6:138  http://www.surgicalneurologyint.com/content/6/1/138resonance imaging (MRI) of the brain showed evidence  of altered signal intensity complex cystic lesion measuring,  approximately 4 cm × 3 cm × 3 cm, noted in left lateral  ventricle near foramen of Munro leading to widening of  left lateral ventricle with mild midline shift toward right  side.",Non-OADS,/arxiv_data1/oa_pdf/d6/82/SNI-6-138.PMC4553664.pdf
"Surgical Neurology International 2015, 6:138  http://www.surgicalneurologyint.com/content/6/1/138Geramizadeh reported that the most common locations  of the hydatid cyst, after the lung and liver, to be the  central nervous system (CNS), orbit, musculoskeletal  system, cardiovascular system, kidney, and urinary tract.",Non-OADS,/arxiv_data1/oa_pdf/d6/82/SNI-6-138.PMC4553664.pdf
"Surgical Neurology International 2015, 6:138  http://www.surgicalneurologyint.com/content/6/1/138major role in patient management as symptoms are  quite often nonspecific.",Non-OADS,/arxiv_data1/oa_pdf/d6/82/SNI-6-138.PMC4553664.pdf
"Surgical Neurology International 2015, 6:138  http://www.surgicalneurologyint.com/content/6/1/138epidermoid cyst, pyogenic abscess, parasitic diseases  involving CNS such as neurocysticercosis, cerebral  toxoplasma abscesses.",Non-OADS,/arxiv_data1/oa_pdf/d6/82/SNI-6-138.PMC4553664.pdf
"Surgical Neurology International 2015, 6:138  http://www.surgicalneurologyint.com/content/6/1/138of the disease adds to the morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/d6/82/SNI-6-138.PMC4553664.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Editing, Publishing and Aggregating Video Articles: Do We Need  a Scholarly Approach?",Non-OADS,/arxiv_data1/oa_pdf/88/8f/jkms-30-1211.PMC4553665.pdf
"Keywords:  Video Recording; Publishing; Quality; Peer Review; PubTube; Science  CommunicationReza Assadi1,2 and   Armen Yuri Gasparyan3 1Medical Toxicology Research Center, School of  Medicine, Mashhad University of Medical Sciences,  Mashhad, Iran; 2Zamen Salamati Scientific  Publishing Agency, Mashhad, Iran; 3Departments of  Rheumatology and Research and Development,  Dudley Group NHS Foundation Trust (Teaching Trust  of the University of Birmingham, UK), Russells Hall  Hospital, Dudley, West Midlands, UK Received: 2 April 2015 Accepted: 13 May 2015 Address for Correspondence: Reza Assadi, MD Emam Reza Hospital, Mashhad University of Medical Sciences,  Ibn-Sina St, Mashhad PO box 9137913316, Iran Tel/Fax: +98.513-841-4499 E-mail: assadi.reza@gmail.comhttp://dx.doi.org/10.3346/jkms.2015.30.9.1211  • J Korean Med Sci 2015; 30: 1211-1212 The current generation of scientific authors and readers has  wide access to digital media, which contains much greater vol ­ ume of scholarly information than traditional hubs of print sour­ ces.",Non-OADS,/arxiv_data1/oa_pdf/88/8f/jkms-30-1211.PMC4553665.pdf
"• Editing, Publishing and Aggregating Video Articles 1212  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1211available YouTube files, however, remains questionable as not  all files are authoritative and based on solid evidence (10, 11).",Non-OADS,/arxiv_data1/oa_pdf/88/8f/jkms-30-1211.PMC4553665.pdf
ORCID Reza Assadi http://orcid.org/0000-0002-5016-2994 Armen Yuri Gasparyan http://orcid.org/0000-0001-8749-6018 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/88/8f/jkms-30-1211.PMC4553665.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Endothelial Dysfunction: Clinical Implications in Cardiovascular  Disease and Therapeutic Approaches Atherosclerosis is a chronic progressive vascular disease.",Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
"Keywords:  Endothelium; Atherosclerosis; Cardiovascular DiseaseKyoung-Ha Park and Woo Jung Park Cardiovascular Division, Department of Internal  Medicine, Hallym University Medical Center,  Anyang, Korea Received: 9 January 2015 Accepted: 29 May 2015 Address for Correspondence: Woo Jung Park, MD Cardiovascular Division, Department of Internal Medicine,  Hallym University Medical Center, 22 Gwanpyeong-ro   170beon-gil, Dongan-gu, Anyang 431-796, Korea Tel: +82.31-380-3877, Fax: +82.31-386-2269 E-mail: cathpark@hallym.or.krhttp://dx.doi.org/10.3346/jkms.2015.30.9.1213  • J Korean Med Sci 2015; 30: 1213-1225 The functional integrity of the endothelium is a fundamental  element of vascular health.",Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
"• : Endothelial Dysfunction and Cardiovascular Disease 1214  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1213thelium’s integrity, smooth muscle cell proliferation and migra - tion, and leukocyte adhesion and migration (12).",Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
"• : Endothelial Dysfunction and Cardiovascular Disease http://jkms.org   1215 http://dx.doi.org/10.3346/jkms.2015.30.9.1213ED, and there seems to be a causal relationship between oxida - tive stress and inflammation (16).",Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
• : Endothelial Dysfunction and Cardiovascular Disease 1216  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1213date.,Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
• : Endothelial Dysfunction and Cardiovascular Disease http://jkms.org   1217 http://dx.doi.org/10.3346/jkms.2015.30.9.1213of developing hypertension and ED associated with atheroscle - rotic disease (46).,Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
"• : Endothelial Dysfunction and Cardiovascular Disease 1218  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1213often make use of indirect NO measurements to confirm ED,  such as levels of nitrogen oxide or nitrite and nitrate, which are  stable degradation products of NO (65).",Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
"• : Endothelial Dysfunction and Cardiovascular Disease http://jkms.org   1219 http://dx.doi.org/10.3346/jkms.2015.30.9.1213diovascular disease (treatment of atherosclerosis, heart failure,  and renal failure), which are clearly supported by clinical evi - dence (Fig.",Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
"• : Endothelial Dysfunction and Cardiovascular Disease 1220  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1213vegetables, fruits, and olive oil, has been found to reduce sec - ondary cardiovascular events (87).",Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
• : Endothelial Dysfunction and Cardiovascular Disease http://jkms.org   1221 http://dx.doi.org/10.3346/jkms.2015.30.9.1213function in patients with ED caused by various conditions and  are superior to calcium channel blockers and β-blockers.,Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
ORCID Woo Jung Park http://orcid.org/0000-0003-3896-5169 Kyoung-Ha Park http://orcid.org/0000-0002-5935-8715 REFERENCES      1.,Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
• : Endothelial Dysfunction and Cardiovascular Disease 1222  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1213     5.,Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
• : Endothelial Dysfunction and Cardiovascular Disease http://jkms.org   1223 http://dx.doi.org/10.3346/jkms.2015.30.9.1213lium.,Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
• : Endothelial Dysfunction and Cardiovascular Disease 1224  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1213  77.,Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
• : Endothelial Dysfunction and Cardiovascular Disease http://jkms.org   1225 http://dx.doi.org/10.3346/jkms.2015.30.9.1213108.,Non-OADS,/arxiv_data1/oa_pdf/38/38/jkms-30-1213.PMC4553666.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Influenza Vaccination Coverage and Its Associated Factors  among North Korean Defectors Living in the Republic of Korea This study aimed to examine influenza vaccination coverage of North Korean defectors  (NKD) in the Republic of Korea (Korea) and explore the factors affected the vaccination  coverage.",Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
"Keywords:  Refugees; Influenza, Human; Vaccination; Korea; Healthcare DisparitiesIn Gyu Song,1,2 Haewon Lee,2 Jinseon Yi,2  Min Sun Kim,3 and Sang Min Park4,5 1Department of Pediatrics, Hana Medical Center,  Settlement Support Center for North Korean  Refugees, Anseong; 2Center for Medicine and  Korean Reunification, Seoul National University  College of Medicine, Seoul; 3Public Health Medical  Service, Seoul National University Hospital, Seoul  National University College of Medicine, Seoul;  4Department of Family Medicine, Seoul National  University Hospital, Seoul National University  College of Medicine, Seoul; 5Department of  Biomedical Sciences, Seoul National University  College of Medicine, Seoul, Korea Received: 19 March 2015 Accepted: 13 May 2015 Address for Correspondence: Haewon Lee, MD Center for Medicine and Korean Reunification, Seoul National  University College of Medicine, 103 Daehak-ro, Jongno-gu,  Seoul 110-799, Korea Tel: +82.2-740-8873, Fax: +82.2-745-8874 E-mail: fm.hwlee@gmail.com Funding:  This work was funded by North Korean Refugees  Foundation (NKRF-2012-12).http://dx.doi.org/10.3346/jkms.2015.30.9.1226  • J Korean Med Sci 2015; 30: 1226-1231 INTRODUCTION After the fall of communism in Eastern Europe in the late 1980s  and dissolution of the Soviet Union in 1991, North Korea had  economic difficulties.",Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
• Influenza Vaccination Coverage of North Korean Defectors http://jkms.org   1227 http://dx.doi.org/10.3346/jkms.2015.30.9.1226health care since its influence on communities have greater  impacts compared to non-communicable diseases.,Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
• Influenza Vaccination Coverage of North Korean Defectors 1228  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1226were significantly associated with influenza vaccination cover - age.,Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
"• Influenza Vaccination Coverage of North Korean Defectors http://jkms.org   1229 http://dx.doi.org/10.3346/jkms.2015.30.9.1226defectors was related only to gender (adjusted OR, 2.57; 95% CI;  1.22-5.44) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
"• Influenza Vaccination Coverage of North Korean Defectors 1230  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1226(8, 10, 14, 19).",Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
• Influenza Vaccination Coverage of North Korean Defectors http://jkms.org   1231 http://dx.doi.org/10.3346/jkms.2015.30.9.1226ORCID In Gyu Song http://orcid.org/0000-0002-3205-9942 Haewon Lee http://orcid.org/0000-0001-9401-8671 Jinseon Yi http://orcid.org/0000-0002-9533-8295 Min Sun Kim http://orcid.org/0000-0001-5323-9857 Sang Min Park http://orcid.org/0000-0002-7498-4829 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
Available at http://www.unikorea.go.kr/content.,Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
Available at  http://cdc.go.kr/CDC/notice/CdcKrTogether0302.jsp?menuIds=HOME001-  MNU1154-MNU0004-MNU0088&cid=19605 [accessed on 4 July 2015].,OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
Available at http://www.promovax.eu/pdfs/ HOSTING_COUNTRIES.pdf [accessed on 4 July 2015].,Non-OADS,/arxiv_data1/oa_pdf/0c/fe/jkms-30-1226.PMC4553667.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Preserved Hippocampal Glucose Metabolism on 18F-FDG PET  after Transplantation of Human Umbilical Cord Blood-derived  Mesenchymal Stem Cells in Chronic Epileptic Rats  Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) may be a  promising modality for treating medial temporal lobe epilepsy.",Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
http://dx.doi.org/10.3346/jkms.2015.30.9.1232  • J Korean Med Sci 2015; 30: 1232-1240 INTRODUCTION Epilepsy is a chronic disorder characterized by spontaneous re - current seizures (SRS).,Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
"• PET Findings after Stem Cell Therapy http://jkms.org   1233 http://dx.doi.org/10.3346/jkms.2015.30.9.1232can help understand serial changes in disease pathogenesis  and assess treatment efficacy in neurologic conditions, includ - ing epilepsy (4-8).",Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
"• PET Findings after Stem Cell Therapy 1234  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1232Extract preparation and hUCB-MSCs transplantation hUCB samples were obtained from the Seoul City Borame Hos - pital Cord Blood Bank (Seoul, Korea) and cultured, as previous - ly described (10), with the approval of the Borame Hospital In - stitutional Board and Seoul National University (Seoul, Korea)  (IRB No.",Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
"Volume analysis was performed using Im - ageJ software (freeware version 1.44, developed by Wayne Ras - band, NIH; http://rsb.info.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
"• PET Findings after Stem Cell Therapy http://jkms.org   1235 http://dx.doi.org/10.3346/jkms.2015.30.9.123218-week post-SE), the surviving rats were monitored with a vid - eo recorder (6 hr/day, 3 days/week) to assess SRS.",Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
• PET Findings after Stem Cell Therapy 1236  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1232RESULTS Glucose metabolism Hippocampal glucose metabolism was normalized to the pons.,Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
• PET Findings after Stem Cell Therapy http://jkms.org   1237 http://dx.doi.org/10.3346/jkms.2015.30.9.1232Behavioral changes and seizure frequency  Sixty-four rats were treated with pilocarpine and developed SE.,Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
• PET Findings after Stem Cell Therapy 1238  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1232lateral hippocampi but did not differentiate.,Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
"• PET Findings after Stem Cell Therapy http://jkms.org   1239 http://dx.doi.org/10.3346/jkms.2015.30.9.1232esthesia, and used the pons as the standard for normalization  in each rat because the metabolic rate of the pons is unaffected  by pilocarpine-induced seizures (13-16).",Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
ORCID Ga Young Park http://orcid.org/0000-0002-0560-9638 Eun Mi Lee http://orcid.org/0000-0001-6423-0081 Min-Soo Seo http://orcid.org/0000-0002-2840-9831 Yoo-Jin Seo http://orcid.org/0000-0001-8159-7918 Jungsu S. Oh http://orcid.org/0000-0002-1925-8103 Woo-Chan Son http://orcid.org/0000-0002-4052-8745 Ki Soo Kim http://orcid.org/0000-0003-1547-5220 Jae Seung Kim http://orcid.org/0000-0003-1710-1185 Joong Koo Kang http://orcid.org/0000-0003-0941-3824 Kyung-Sun Kang http://orcid.org/0000-0002-9322-741X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
• PET Findings after Stem Cell Therapy 1240  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.123211.,Non-OADS,/arxiv_data1/oa_pdf/59/fe/jkms-30-1232.PMC4553668.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357S1000A12, Chitotriosidase, and Resolvin D1 as Potential  Biomarkers of Familial Mediterranean Fever Familial Mediterranean fever (FMF) is an auto-inflammatory disease characterised by  periodic inflammatory attacks.",Non-OADS,/arxiv_data1/oa_pdf/7d/a9/jkms-30-1241.PMC4553669.pdf
"Keywords:  Familial Mediterranean Fever; S100A12; Chitotriosidase; Resolvin D1; Serum  Amiloid AAli Taylan,1 Oguz Gurler,2 Burak Toprak,3  Ali Riza Sisman,4 Hulya Yalcin,3   Ayfer Colak,3 and Ismail Sari5 1Izmir Tepecik Training and Research Hospital,  Department of Rheumatology, Izmir; 2Medical Park  Hospital, Department of Internal Medicine, Division  of Rheumatology, Samsun; 3Izmir Tepecik Training  and Research Hospital, Department of Biochemistry,  Izmir; 4Dokuz Eylul University School of Medicine,  Department of Biochemistry, Izmir; 5Dokuz Eylul  University School of Medicine, Department of  Internal Medicine, Division of Rheumatology, Izmir,  Turkey Received: 6 March 2015 Accepted: 14 May 2015 Address for Correspondence: Ali Taylan, MD Izmir Tepecik Teaching and Research Hospital, Department of  Rheumatology, Yenisehir, Izmir, Turkey Tel: +00902324696969/2401, Fax: +00902324330756 E-mail: taylanally@yahoo.comhttp://dx.doi.org/10.3346/jkms.2015.30.9.1241  • J Korean Med Sci 2015; 30: 1241-1245 INTRODUCTION Familial Mediterranean fever (FMF) is the most common auto- inflammatory disease prevalent in the Middle East but cases in  other ethnic groups in other parts of the world are increasingly  presented (1, 2, 3).",Non-OADS,/arxiv_data1/oa_pdf/7d/a9/jkms-30-1241.PMC4553669.pdf
"• S1000A12, Chitotriosidase and Resolvin D1 as New Biomarkers in FMF 1242  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1241vent related complications in those patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/a9/jkms-30-1241.PMC4553669.pdf
"• S1000A12, Chitotriosidase and Resolvin D1 as New Biomarkers in FMF http://jkms.org   1243 http://dx.doi.org/10.3346/jkms.2015.30.9.1241the attack free period of the same patients (44 [9.4-100] vs. 4.2  [0.6-15.8] mg/L, P< 0.001 and 716 [411-1,198] vs. 408 [316-554]  mg/L, P< 0.001 and 30,336 [17,731-47,507] mg/L vs. 25,816  [14,237-41,403] pg/mL, P= 0.026; respectively).",Non-OADS,/arxiv_data1/oa_pdf/7d/a9/jkms-30-1241.PMC4553669.pdf
"• S1000A12, Chitotriosidase and Resolvin D1 as New Biomarkers in FMF 1244  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1241showed correlation with hs-CRP and SAA ( P< 0.05; r= 0.4 and  0.5, respectively).",OADS,/arxiv_data1/oa_pdf/7d/a9/jkms-30-1241.PMC4553669.pdf
"• S1000A12, Chitotriosidase and Resolvin D1 as New Biomarkers in FMF http://jkms.org   1245 http://dx.doi.org/10.3346/jkms.2015.30.9.1241of results and drafting the manuscript: Taylan A, Toprak B. Anal - ysis and interpretation of data: Toprak B, Gurler O, Sari I. Acqui - sition of data: Sisman AR, Colak A, Yalcin H. Critical revision of  manuscript: Taylan A, Toprak B. Manuscript approval: all au - thors.",Non-OADS,/arxiv_data1/oa_pdf/7d/a9/jkms-30-1241.PMC4553669.pdf
ORCID Ali Taylan http://orcid.org/0000-0002-5758-1825 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/a9/jkms-30-1241.PMC4553669.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Age-related NADPH Oxidase (arNOX) Activity Correlated with Cartilage Degradation and Bony Changes in Age-related  Osteoarthritis The purpose of this study was to investigate the age-related NADPH oxidase (arNOX)  activity in patients with age-related knee osteoarthritis (OA).",Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
"Received: 28 January 2015 Accepted: 6 May 2015 Address for Correspondence: Young-Hoon Hong, MD Departments of Internal Medicine, College of Medicine,  Yeungnam University, 170 Hyeonchung-ro, Nam-gu,   Daegu 705-703, Korea Tel: +82.53-620-3820, Fax: +82.53-654-8386  E-mail: yhhong@med.yu.ac.kr Funding:  This research was supported by a grant of Yeungnam  University Medical Center (2013).http://dx.doi.org/10.3346/jkms.2015.30.9.1246  • J Korean Med Sci 2015; 30: 1246-1252 INTRODUCTION Osteoarthritis (OA) is a degenerative joint disease characterized  by articular cartilage degradation, subchondral bony sclerosis,  and osteophyte formation leading to chronic joint disability.",Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
"• arNOX Activity and Cartilage Degradation in Osteoarthritis http://jkms.org   1247 http://dx.doi.org/10.3346/jkms.2015.30.9.1246age, increase in correlation with the advance of age, which indi - cates that as energy source shifts to glycolysis, aging results in a  hyperactive plasma membrane oxido-reductase system (6).",Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
• arNOX Activity and Cartilage Degradation in Osteoarthritis 1248  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1246at room temperature.,Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
• arNOX Activity and Cartilage Degradation in Osteoarthritis http://jkms.org   1249 http://dx.doi.org/10.3346/jkms.2015.30.9.1246Statistical analysis Statistical analysis was performed using SPSS program version  12.,Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
"• arNOX Activity and Cartilage Degradation in Osteoarthritis 1250  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1246ty in OA ( r= 0.577, P= 0.03) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
• arNOX Activity and Cartilage Degradation in Osteoarthritis http://jkms.org   1251 http://dx.doi.org/10.3346/jkms.2015.30.9.1246cartilage and bony changes.,Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
ORCID Min-Jung Kim http://orcid.org/0000-0002-2637-7979 Hyun-Je Kim http://orcid.org/0000-0003-1075-5645 Young-Hoon Hong http://orcid.org/0000-0003-3988-6884 Choong-Ki Lee http://orcid.org/0000-0001-6820-8877 Yong-Woon Kim http://orcid.org/0000-0003-2868-9690 Oog-Jin Shon http://orcid.org/0000-0002-9123-5694 In-Hwan Song http://orcid.org/0000-0002-0573-1836 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
• arNOX Activity and Cartilage Degradation in Osteoarthritis 1252  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.12464.,Non-OADS,/arxiv_data1/oa_pdf/87/b8/jkms-30-1246.PMC4553670.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma Despite a low risk of liver failure and preserved liver function, non-cirrhotic hepatocellular  carcinoma (HCC) has a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
"Keywords:  Carcinoma, Hepatocellular; Prognosis; Biological MarkersJung-Hee Kwon,1 Keun Soo Ahn,2   Young Ho Moon,1 Jin Young Park,1   Hee Jung Wang,3 Kwan Yong Choi,4  Gundo Kim,5 Jae Won Joh,6   Kyeong Geun Lee,7 and Koo Jeong Kang2 1Cbs Bioscience Inc., Daejeon; 2Department of  Surgery, Keimyung University School of Medicine,  Dongsan Medical Center, Daegu; 3Department of  Surgery, Ajou University School of Medicine, Suwon;  4Department of Life Science, Pohang University of  Science and Technology, Pohang; 5Department of  Microbiology, Pukyong National University, Busan;  6Department of Surgery, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul; 7Department of Surgery, Hanyang University  School of Medicine, Seoul, Korea Received: 24 December 2014 Accepted: 27 May 2015 Address for Correspondence: Koo Jeong Kang, MD Department of Surgery, Keimyung University School of  Medicine, Dongsan Medical Center, 56 Dalseong-ro, Jung-gu,  Daegu 700-712, Korea Tel: +82.53-250-7655, Fax: +82.53-250-7322  E-mail: kjkang@dsmc.or.kr Funding:  This research was supported by the annex research  institute (Medical Genetics Institute) Research Grant of Keimyung  University in 2011, the National Research Foundation of Korea  (NRF) grant funded by the Korea government (MEST) (Grant  number: NRF-2013R1A1A4A01009053) and the National R &D  Program for Cancer Control, Ministry of Health & Welfare  (1320240).http://dx.doi.org/10.3346/jkms.2015.30.9.1253  • J Korean Med Sci 2015; 30: 1253-1259 INTRODUCTION Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer  and one of the most fatal solid tumors in the world (1).",Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
"• Biomarker for Non-cirrhotic Hepatocellular Carcinoma 1254  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253roles of SIRT1, its interacting partner AROS may have diverse  functions in cancer through a SIRT1-dependent pathway.",Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org   1255 http://dx.doi.org/10.3346/jkms.2015.30.9.1253Student’s t-test.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
• Biomarker for Non-cirrhotic Hepatocellular Carcinoma 1256  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253increased along with the stages (stage I: 0.2331 vs. 0.3089; stage  II: 0.2198 vs. 0.4021; stage III_IV: 0.2110 vs. 0.4187).,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
"• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org   1257 http://dx.doi.org/10.3346/jkms.2015.30.9.1253HCCs analyzed by RT-PCR, a high AROS mRNA level was iden - tified as one of the important risk factors for 2-yr DFS.",Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
"• Biomarker for Non-cirrhotic Hepatocellular Carcinoma 1258  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253strated for the first time that AROS is overexpressed in non-cir - rhotic HCC, suggesting the potential of AROS as a prognostic  biomarker.",Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
ORCID  Jung-Hee Kwon http://orcid.org/0000-0003-4099-4006 Keun Soo Ahn http://orcid.org/0000-0001-8738-8009 Young Ho Moon http://orcid.org/0000-0003-0206-2806  Jin Young Park http://orcid.org/0000-0003-4179-9165 Hee Jung Wang http://orcid.org/0000-0002-0687-007X  Kwan Yong Choi http://orcid.org/0000-0002-9628-8939 Gundo Kim http://orcid.org/0000-0001-5965-0495 Jae Won Joh http://orcid.org/0000-0003-1732-6210  Kyeong Geun Lee http://orcid.org/0000-0002-8317-8124 Koo-Jeong Kang http://orcid.org/0000-0003-1385-8308 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org   1259 http://dx.doi.org/10.3346/jkms.2015.30.9.12538.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253Table S1.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253Table S2.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253Table S3.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253 Expression level of   AROS/reference genes (Log scale)  Non-recurrence Recurrence1.000 0.500 0.100 0.050 0.010 0.005 0.001P = 0.014 Fig.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
"• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253 Sensitivity  1-Specificity 0 0.2 0.4 0.6 0.8 1.01.0 0.8 0.6 0.4 0.2 0AROS (DFS vs. Non-DFS) AUC = 0.575 (95% CI, 0.517-0.632) DFS = 159 Non-DFS = 124 P value = 0.015 A Disease-free survival Day0 500 1,000 1,5001.0 0.8 0.6 0.4 0.2 0P = 0.005 High (n = 71) Low (n = 212) B Fig.",Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
• Biomarker for Non-cirrhotic Hepatocellular Carcinoma http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1253Fig.,Non-OADS,/arxiv_data1/oa_pdf/fd/30/jkms-30-1253.PMC4553671.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Analysis of Protrusio Acetabuli Using a CT-based Diagnostic  Method in Korean Patients with Marfan Syndrome: Prevalence  and Association with Other Manifestations A new CT-based diagnostic method of protrusio acetabuli (PA) was introduced.",Non-OADS,/arxiv_data1/oa_pdf/53/6e/jkms-30-1260.PMC4553672.pdf
"Keywords:  Protrusio Acetabuli; Marfan Syndrome; FBN1 Mutation; Computed  TomographyKwang Jin Chun,1 Jeong Hoon Yang,1,2  Shin Yi Jang,1 Seung Hwa Lee,1   Hye Bin Gwag,1 Tae-Young Chung,3   June Huh,4 Chang-Seok Ki,5 Kiick Sung,6  Seung-Hyuk Choi,1 Sung Mok Kim,7   Yeon Hyeon Choe,7 and Duk-Kyung Kim1 1Division of Cardiology, Department of Medicine,  Heart Vascular Stroke Institute, 2Department of  Critical Care Medicine, 3Department of  Ophthalmology, 4Department of Pediatrics,  5Department of Laboratory Medicine and Genetics,  6Department of Thoracic and Cardiovascular  Surgery, 7Department of Radiology, Cardiovascular  and Stroke Imaging Center, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, Seoul, Korea Received: 14 November 2014 Accepted: 13 May 2015 Address for Correspondence: Duk-Kyung Kim, MD Division of Cardiology, Department of Medicine, Heart Vascular  Stroke Institute, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu,   Seoul 135-710, Korea Tel: +82.2-3410-3419, Fax: +82.2-3410-3849 E-mail: dukkyung.kim@gmail.com  Funding:  This work was supported by the Samsung Biomedical  Research Institute (grant C-A9-204-3).http://dx.doi.org/10.3346/jkms.2015.30.9.1260  • J Korean Med Sci 2015; 30: 1260-1265 INTRODUCTION Marfan syndrome (MFS) is an autosomal dominant connective  tissue disorder with cardiovascular, skeletal and ocular mani - festations (1).",Non-OADS,/arxiv_data1/oa_pdf/53/6e/jkms-30-1260.PMC4553672.pdf
• Analysis of Protrusio Acetabuli in Patients with Marfan Syndrome http://jkms.org   1261 http://dx.doi.org/10.3346/jkms.2015.30.9.1260using this method (13).,Non-OADS,/arxiv_data1/oa_pdf/53/6e/jkms-30-1260.PMC4553672.pdf
"• Analysis of Protrusio Acetabuli in Patients with Marfan Syndrome 1262  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1260Revised Ghent nosology In the revised Ghent nosology, cardiovascular manifestations  are more heavily weighted and aortic root aneurysm and ecto - pia lentis are the cardinal clinical features.",Non-OADS,/arxiv_data1/oa_pdf/53/6e/jkms-30-1260.PMC4553672.pdf
• Analysis of Protrusio Acetabuli in Patients with Marfan Syndrome http://jkms.org   1263 http://dx.doi.org/10.3346/jkms.2015.30.9.1260Ethics statement This study received institutional review board approval (IRB  File No.,Non-OADS,/arxiv_data1/oa_pdf/53/6e/jkms-30-1260.PMC4553672.pdf
• Analysis of Protrusio Acetabuli in Patients with Marfan Syndrome 1264  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1260Table 5.,Non-OADS,/arxiv_data1/oa_pdf/53/6e/jkms-30-1260.PMC4553672.pdf
• Analysis of Protrusio Acetabuli in Patients with Marfan Syndrome http://jkms.org   1265 http://dx.doi.org/10.3346/jkms.2015.30.9.1260well as the presence of PA. Sohn et al.,Non-OADS,/arxiv_data1/oa_pdf/53/6e/jkms-30-1260.PMC4553672.pdf
ORCID Kwang Jin Chun http://orcid.org/0000-0001-7683-1343 Shin Yi Jang http://orcid.org/0000-0003-4319-7029 Seung-Hyuk Choi http://orcid.org/0000-0002-0304-6317 Duk-Kyung Kim http://orcid.org/0000-0001-9227-4196 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/53/6e/jkms-30-1260.PMC4553672.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Treatment Gap in the National Health-screening Program in  Korea: Claim-based Follow-up of Statin Use for Sustained  Hypercholesterolemia  Participation in a screening program by itself may not improve clinical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
"2012E3302800).http://dx.doi.org/10.3346/jkms.2015.30.9.1266  • J Korean Med Sci 2015; 30: 1266-1272 INTRODUCTION Hypercholesterolemia is a well-established risk factor for car - diovascular disease (CVD), and accounts for 4.5% of all-cause  mortality worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
"• Treatment Gap in the National Health-Screening Program for Dyslipidemia http://jkms.org   1267 http://dx.doi.org/10.3346/jkms.2015.30.9.1266surrogate marker of effective clinical intervention for hypercho - lesterolemia, because statins are the most frequently prescribed  (87%) lipid-lowering agents (10).",Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
• Treatment Gap in the National Health-Screening Program for Dyslipidemia 1268  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1266Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
• Treatment Gap in the National Health-Screening Program for Dyslipidemia http://jkms.org   1269 http://dx.doi.org/10.3346/jkms.2015.30.9.1266scribed statins more frequently if they were diagnosed as hy - pertension and aged from 20 to 59 yr old.,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
• Treatment Gap in the National Health-Screening Program for Dyslipidemia 1270  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1266 Compliance with lipid-lowering therapy is usually poor (9).,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
• Treatment Gap in the National Health-Screening Program for Dyslipidemia http://jkms.org   1271 http://dx.doi.org/10.3346/jkms.2015.30.9.1266information on statin prescription within the first 6 months (data  not shown).,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
ORCID Eunmi Ahn http://orcid.org/0000-0002-9826-0788 Dong Wook Shin http://orcid.org/0000-0001-8128-8920 Hyung-kook Yang http://orcid.org/0000-0003-0727-0874 So Hyun Chun http://orcid.org/0000-0002-2183-2119 Hyejin Lee http://orcid.org/0000-0001-5279-340X  Beomseok Suh http://orcid.org/0000-0003-0644-5855 Ki Young Son http://orcid.org/0000-0003-1262-100X BeLong Cho http://orcid.org/0000-0001-9558-689X   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
• Treatment Gap in the National Health-Screening Program for Dyslipidemia 1272  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.126614.,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
Available at  http://www.nhs.uk/Planners/NHSHealthCheck/Pages/NHSHealthCheck - what.aspx [accessed on 30 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/c7/a7/jkms-30-1266.PMC4553673.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Prognostic Value of Renal Function for Cardiac Events in Patients  Without Significant Stenosis on Coronary Computed  Tomography Angiography This study was conducted to determine clinical parameters predicting future major adverse  cardiovascular events (MACEs) in patients without significant stenosis on coronary  computed tomographic angiography (CCTA).",Non-OADS,/arxiv_data1/oa_pdf/45/22/jkms-30-1273.PMC4553674.pdf
"Keywords:  Creatinine Clearance; Coronary Artery Disease; Multidetector Computed  Tomography; PrognosisHack-Lyoung Kim,1,4 Yong-Jin Kim,2,4  Yeonyee E. Yoon,3,4 Seung-Pyo Lee,2,4  Hyung-Kwan Kim,2,4 Goo-Yeong Cho,3,4  Joo-Hee Zo,1,4 Dong-Ju Choi,3,4   and Dae-Won Sohn2,4 1Division of Cardiology, Boramae Medical Center,  Seoul; 2Division of Cardiology, Seoul National  University Hospital, Seoul; 3Division of Cardiology,  Seoul National University Bundang Hospital,  Seongnam; 4Department of Internal Medicine, Seoul  National University College of Medicine, Seoul,  Korea Received: 26 February 2015 Accepted: 21 May 2015 Address for Correspondence: Yong-Jin Kim, MD Division of Cardiology, Department of Internal Medicine, Seoul  National University College of Medicine, Seoul National  University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744,  Korea Tel: +82.2-2072-1963, Fax: +82.2-2072-2577 E-mail: kimdamas@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.9.1273  • J Korean Med Sci 2015; 30: 1273-1278 INTRODUCTION Coronary computed tomography angiography (CCTA) is an  emerging technique that allows high diagnostic accuracy for  the detection of coronary artery disease (CAD) and high nega - tive predictive value for the exclusion of CAD (1-3).",Non-OADS,/arxiv_data1/oa_pdf/45/22/jkms-30-1273.PMC4553674.pdf
"• Prognostic Value of Renal Function in Insignificant CCTA  1274  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1273line clinical characteristics, including cardiovascular risk factors  and type of symptoms, was obtained by reviewing patients’ medi- cal records.",OADS,/arxiv_data1/oa_pdf/45/22/jkms-30-1273.PMC4553674.pdf
• Prognostic Value of Renal Function in Insignificant CCTA  http://jkms.org   1275 http://dx.doi.org/10.3346/jkms.2015.30.9.1273RESULTS Baseline characteristics of study subjects Baseline clinical characteristics of study subjects are shown in  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/45/22/jkms-30-1273.PMC4553674.pdf
"• Prognostic Value of Renal Function in Insignificant CCTA  1276  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1273DISCUSSION The present study demonstrated that rate of cardiovascular events  including cardiac death, non-fatal MI, unstable angina and late  revascularization was 4.5%, and cardiac death and non-fatal MI  was 1.1% during follow-up period of 819 ± 529 days (median  837 days) in patients without significant CAD on CCTA.",Non-OADS,/arxiv_data1/oa_pdf/45/22/jkms-30-1273.PMC4553674.pdf
• Prognostic Value of Renal Function in Insignificant CCTA  http://jkms.org   1277 http://dx.doi.org/10.3346/jkms.2015.30.9.1273did not evaluate the prognostic impact of renal function in that  study.,Non-OADS,/arxiv_data1/oa_pdf/45/22/jkms-30-1273.PMC4553674.pdf
ORCID Hack-Lyoung Kim http://orcid.org/0000-0002-6703-1472 Yong-Jin Kim http://orcid.org/0000-0002-1366-432X Yeonyee E. Yoon http://orcid.org/0000-0002-8479-9889 Seung-Pyo Lee http://orcid.org/0000-0002-5502-3977 Hyung-Kwan Kim http://orcid.org/0000-0001-7950-2131 Goo-Yeong Cho http://orcid.org/0000-0002-7067-5535 Joo-Hee Zo http://orcid.org/0000-0003-1417-1049 Dong-Ju Choi http://orcid.org/0000-0003-0146-2189 Dae-Won Sohn http://orcid.org/0000-0002-1092-3285 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/45/22/jkms-30-1273.PMC4553674.pdf
• Prognostic Value of Renal Function in Insignificant CCTA  1278  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1273guidelines for the management of patients with chronic stable angina:  executive summary and recommendations.,Non-OADS,/arxiv_data1/oa_pdf/45/22/jkms-30-1273.PMC4553674.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Self-rated Subjective Health Status Is Strongly Associated with  Sociodemographic Factors, Lifestyle, Nutrient Intakes, and  Biochemical Indices, but Not Smoking Status: KNHANES 2007- 2012 Despite advertised health warnings regarding the deadly hazards of smoking, many people  have not heeded recommendations to quit smoking.",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
http://dx.doi.org/10.3346/jkms.2015.30.9.1279  • J Korean Med Sci 2015; 30: 1279-1287 INTRODUCTION Smoking remains one of the most preventable causes of mor - bidity and mortality worldwide (1).,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
"• Self-rated Subjective Health Status and Smoking  1280  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1279related behaviors and social well-being (16, 17).",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
• Self-rated Subjective Health Status and Smoking  http://jkms.org   1281 http://dx.doi.org/10.3346/jkms.2015.30.9.1279HANES.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
"• Self-rated Subjective Health Status and Smoking  1282  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1279getable, fruit and milk intake groups (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
• Self-rated Subjective Health Status and Smoking  http://jkms.org   1283 http://dx.doi.org/10.3346/jkms.2015.30.9.1279Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
"• Self-rated Subjective Health Status and Smoking  1284  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1279DISCUSSION Public health warnings about the adverse effects of smoking  have been advocated intensively, but these warnings have been  ineffective (6, 12).",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
• Self-rated Subjective Health Status and Smoking  http://jkms.org   1285 http://dx.doi.org/10.3346/jkms.2015.30.9.1279Table 6.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
• Self-rated Subjective Health Status and Smoking  1286  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1279other BMI groups.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
"Writing manuscript: Ahn J, Park S. Final acceptance  of manuscript: all authors.ORCID Sunmin Park http://orcid.org/0000-0002-6092-8340 Jaeouk Ahn http://orcid.org/0000-0002-8870-1527 Byung-Kook Lee http://orcid.org/0000-0001-9162-3390 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
• Self-rated Subjective Health Status and Smoking  http://jkms.org   1287 http://dx.doi.org/10.3346/jkms.2015.30.9.1279and self-rated health and mental health in Canadian adolescents.,Non-OADS,/arxiv_data1/oa_pdf/ea/b7/jkms-30-1279.PMC4553675.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Risk of Colorectal Neoplasia in Patients with Gallbladder  Diseases  Cholecystectomy is associated with an increased risk of colorectal cancer, but little is  known about the relationship between gallbladder disease and colorectal adenoma.",Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
"Keywords:  Gallbladder; Colorectal Neoplasms; Risk Factors; KoreaSung Noh Hong,1 Tae Yoon Lee,2   and Sung-Cheol Yun3  1Department of Internal Medicine, Samsung  Medical Center, Sungkyunkwan University School of  Medicine, Seoul; 2Department of Internal Medicine,  Konkuk University Medical Center, Konkuk University  School of Medicine, Seoul; 3Department of Clinical  Epidemiology and Biostatistics, Asan Medical  Center, University of Ulsan College of Medicine,  Seoul, Korea  Received: 16 January 2015 Accepted: 3 June 2015 Address for Correspondence: Tae Yoon Lee, MD Department of Internal Medicine, Konkuk University School of  Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729,  Korea Tel: +82.2-2030-7497, Fax: +82.2-2030-7748 E-mail: widebrow@empal.com Funding:  This paper was written as part of Konkuk University’s  research support program for its faculty on sabbatical leave in  2013.http://dx.doi.org/10.3346/jkms.2015.30.9.1288  • J Korean Med Sci 2015; 30: 1288-1294 INTRODUCTION Colorectal cancer is potentially preventable if premalignant ad - enomas are detected and removed during colonoscopy before  they become malignant (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
• Colorectal Neoplasia and Gallbladder Disease http://jkms.org   1289 http://dx.doi.org/10.3346/jkms.2015.30.9.1288formation about the program and/or to schedule an appoint - ment for screening.,Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
• Colorectal Neoplasia and Gallbladder Disease 1290  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1288and gallbladder disease in 523 (11.3%).,Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
"• Colorectal Neoplasia and Gallbladder Disease http://jkms.org   1291 http://dx.doi.org/10.3346/jkms.2015.30.9.1288between gallstones and CRN (adjusted OR, 1.14; 95% CI, 0.79- 1.63).",Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
• Colorectal Neoplasia and Gallbladder Disease 1292  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1288showed only a statistical trend ( P= 0.065).,Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
• Colorectal Neoplasia and Gallbladder Disease http://jkms.org   1293 http://dx.doi.org/10.3346/jkms.2015.30.9.1288 Our study had several limitations.,Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
ORCID Sung Noh Hong http://orcid.org/0000-0002-4140-3717 Tae Yoon Lee http://orcid.org/0000-0003-1008-9814 Sung-Cheol Yun http://orcid.org/0000-0001-8503-109X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
• Colorectal Neoplasia and Gallbladder Disease 1294  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.128821.,Non-OADS,/arxiv_data1/oa_pdf/d0/cd/jkms-30-1288.PMC4553676.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Deferoxamine Improves Alveolar and Pulmonary Vascular  Development by Upregulating Hypoxia-inducible Factor-1 α in a  Rat Model of Bronchopulmonary Dysplasia Fetal lung development normally occurs in a hypoxic environment.",Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
03-2007-007) and by Basic Research Program  through the National Research Foundation of Korea (NRF)  funded by the Ministry of Education (2010-0021644).http://dx.doi.org/10.3346/jkms.2015.30.9.1295  • J Korean Med Sci 2015; 30: 1295-1301 INTRODUCTION Fetal lung development occurs in a hypoxic environment (3%- 5% O 2) (1).,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
• Deferoxamine alleviates BPD by Inducing HIF-1 α 1296  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1295MATERIALS AND METHODS Animal experiment A rat model of BPD was produced as previously described (13).,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
• Deferoxamine alleviates BPD by Inducing HIF-1 α http://jkms.org   1297 http://dx.doi.org/10.3346/jkms.2015.30.9.1295ed.,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
• Deferoxamine alleviates BPD by Inducing HIF-1 α 1298  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1295 No BPD+V No BPD+DFX BPD+V BPD+DFXBlood vessels/HPF  No BPD+V No BPD+DFX BPD+V BPD+DFX7 6 5 4 3 2 1 0** * * Area of PECAM-1(+) cells/Area of total  lung parenchymal cells (%)  No BPD+V No BPD+DFX BPD+V BPD+DFX25 20 15 10 5 0* **A B C Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
• Deferoxamine alleviates BPD by Inducing HIF-1 α http://jkms.org   1299 http://dx.doi.org/10.3346/jkms.2015.30.9.1295Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
• Deferoxamine alleviates BPD by Inducing HIF-1 α 1300  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1295Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
ORCID Chang Won Choi http://orcid.org/0000-0003-1911-0253 Beyong Il Kim http://orcid.org/0000-0002-1558-7567,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
• Deferoxamine alleviates BPD by Inducing HIF-1 α http://jkms.org   1301 http://dx.doi.org/10.3346/jkms.2015.30.9.1295REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c7/67/jkms-30-1295.PMC4553677.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Evaluation of the Forearm Dominancy Artery for Invasive  Vascular Procedure with 3D-CT Angiography  The aim of this study was to evaluate the vascular dominance in the forearm as a factor in  determining the choice of invasive vascular procedures in arteries of the forearm, using   3D-computerized tomography (3D-CT) angiographies of 92 forearms.",Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1302.PMC4553678.pdf
"Keywords:  Radial Artery; Ulnar Artery; Vascular Dominance; 3D-CT AngiographySae Hwi Ki and Jong Hwan Choi Department of Plastic Surgery, Inha University  School of Medicine, Incheon, Korea Received: 15 January 2015 Accepted: 20 May 2015 Address for Correspondence: Sae Hwi Ki, MD Department of Plastic Surgery, Inha University School of  Medicine, 27 Inhang-ro, Jung-gu, Incheon 400-711, Korea Tel: +82.32-890-3619, Fax: +82.32-890-2918 E-mail: mdki67@naver.com Funding:  This study was supported by the Inha University  Research Grant 2013.http://dx.doi.org/10.3346/jkms.2015.30.9.1302  • J Korean Med Sci 2015; 30: 1302-1307 INTRODUCTION  According to the classic teaching based on anatomical studies  the ulnar artery is the dominant artery of the human forearm.",Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1302.PMC4553678.pdf
"• Forearm Dominancy Artery http://jkms.org   1303 http://dx.doi.org/10.3346/jkms.2015.30.9.1302tical significance was evaluated using an ANOVA 2-way test, a  Mann-Whitney test and a linear regression analysis.",OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1302.PMC4553678.pdf
• Forearm Dominancy Artery                   1304  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1302Fig.,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1302.PMC4553678.pdf
• Forearm Dominancy Artery http://jkms.org   1305 http://dx.doi.org/10.3346/jkms.2015.30.9.1302and radial forearm free flaps.,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1302.PMC4553678.pdf
• Forearm Dominancy Artery                   1306  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1302cular abnormalities (20).,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1302.PMC4553678.pdf
ORCID Sae Hwi Ki http://orcid.org/0000-0001-9194-9681 Jong Hwan Choi http://orcid.org/0000-0002-4068-4713 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1302.PMC4553678.pdf
• Forearm Dominancy Artery http://jkms.org   1307 http://dx.doi.org/10.3346/jkms.2015.30.9.13021974; 2: 270-2.,Non-OADS,/arxiv_data1/oa_pdf/23/a2/jkms-30-1302.PMC4553678.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Gestational Age-specific Cut-off Values Are Needed for Diagnosis  of Subclinical Hypothyroidism in Early Pregnancy During the first trimester of pregnancy, thyroid-stimulating hormone (TSH) > 2.5 mIU/L  has been suggested as the universal criterion for subclinical hypothyroidism.",Non-OADS,/arxiv_data1/oa_pdf/a7/f7/jkms-30-1308.PMC4553679.pdf
"Received: 2 November 2014 Accepted: 1 June 2015 Address for Correspondence: Seung Mi Lee, MD Department of Obstetrics and Gynecology, Seoul Metropolitan  Government Seoul National University Boramae Medical Center,  41 Boramae-gil, Dongjak-gu, Seoul 156-707, Korea Tel: +82.2-870-2346, Fax: +82.2-831-2826 E-mail: smleemd@hanmail.net Funding:  This work was supported by a clinical research grant- in-aid from the Seoul Metropolitan Government Seoul National  University (SMG-SNU) Boramae Medical Center (03-2014-4).http://dx.doi.org/10.3346/jkms.2015.30.9.1308  • J Korean Med Sci 2015; 30: 1308-1312 INTRODUCTION Subclinical hypothyroidism is an abnormally high thyroid-sti- mulating hormone (TSH) level with normal free thyroxine level  without symptoms of hypothyroidism (1).",Non-OADS,/arxiv_data1/oa_pdf/a7/f7/jkms-30-1308.PMC4553679.pdf
"• Concentration of TSH in First Trimester http://jkms.org   1309 http://dx.doi.org/10.3346/jkms.2015.30.9.1308MATERIALS AND METHODS Study design In this cross-sectional study, singleton pregnant women who  were tested for serum TSH during the first trimester of preg - nancy and delivered at Seoul Metropolitan Government Seoul  National University Boramae Medical Center between July 2008  and December 2013 were enrolled.",Non-OADS,/arxiv_data1/oa_pdf/a7/f7/jkms-30-1308.PMC4553679.pdf
"• Concentration of TSH in First Trimester 1310  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1308centrations of pregnant women were lower than that of non- pregnant women with marginal significance in 3+0 to 5+6 weeks  of gestation and with statistical significance in 6+0 to 6+6, 7+0  to 7+6, 8+0 to 8+6, 9+0 to 9+6, 10+0 to 13+6 weeks of gestation.",Non-OADS,/arxiv_data1/oa_pdf/a7/f7/jkms-30-1308.PMC4553679.pdf
• Concentration of TSH in First Trimester http://jkms.org   1311 http://dx.doi.org/10.3346/jkms.2015.30.9.1308ism with the use of GA-specific 95th percentile TSH value in the  current study.,Non-OADS,/arxiv_data1/oa_pdf/a7/f7/jkms-30-1308.PMC4553679.pdf
ORCID Hyesung Kim http://orcid.org/0000-0002-4831-2527 Byoung Jae Kim http://orcid.org/0000-0002-2734-997X Seung Mi Lee http://orcid.org/0000-0002-2543-0408 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a7/f7/jkms-30-1308.PMC4553679.pdf
• Concentration of TSH in First Trimester 1312  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.13082010; 95: 1699-707.,Non-OADS,/arxiv_data1/oa_pdf/a7/f7/jkms-30-1308.PMC4553679.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Effects of Moderate Alcohol Intake in the Bladder of the Otsuka  Long Evans Tokushima Fatty Diabetic Rats Diabetes is related with a number of cystopathic complications.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
"Keywords:  Alcohols; Diabetes Mellitus; Urinary Bladder DiseaseWoong Jin Bae,1 Yong Sun Choi,1   Su Jin Kim,1 Hyuk Jin Cho,1   Sung Hoo Hong,1 Sae Woong Kim,1   Tae-Kon Hwang,1 Dai Jin Kim,2   and Ji Youl Lee1,3,4 1Department of Urology, 2Department of Psychiatry,  College of Medicine, 3Catholic Prostate Institute,  4Department of Bioinformatics, The Catholic  University of Korea, Seoul, Korea Received: 10 March 2015 Accepted: 14 May 2015 Address for Correspondence: Ji Youl Lee, MD Department of Urology, College of Medicine, The Catholic  University, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea  Tel: +82.2-2258-6227, Fax: +82.2-599-7839 E-mail: uroljy@catholic.ac.kr  Funding:  This study was supported by a grant of the Korea  Health technology R &D Project, Ministry of Health & Welfare,  Republic of Korea (A111378).http://dx.doi.org/10.3346/jkms.2015.30.9.1313  • J Korean Med Sci 2015; 30: 1313-1320 INTRODUCTION Diabetic bladder dysfunction is the most common lower uri - nary tract complication of diabetes mellitus (DM).",Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
• Effects of Moderate Alcohol Intake in OLETF Rat Bladder 1314  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1313ing and experimental procedures.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
"• Effects of Moderate Alcohol Intake in OLETF Rat Bladder http://jkms.org   1315 http://dx.doi.org/10.3346/jkms.2015.30.9.1313tissue distribution, expressed as the color red.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
"• Effects of Moderate Alcohol Intake in OLETF Rat Bladder 1316  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1313 The expression of RhoA, ROCK-I, and ROCK-II in the OC group  was significantly higher than that in the LC group (RhoA, P=  0.027; ROCK-II, P= 0.015; ROCK-I, P= 0.018, Fig.",Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
• Effects of Moderate Alcohol Intake in OLETF Rat Bladder http://jkms.org   1317 http://dx.doi.org/10.3346/jkms.2015.30.9.1313but not significant.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
"• Effects of Moderate Alcohol Intake in OLETF Rat Bladder 1318  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1313teristics of bladder contractility with conflicting results (18, 19).",Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
• Effects of Moderate Alcohol Intake in OLETF Rat Bladder http://jkms.org   1319 http://dx.doi.org/10.3346/jkms.2015.30.9.1313AUTHOR CONTRIBUTION Conception and design of experiments: Lee JY.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
ORCID Woong Jin Bae http://orcid.org/0000-0001-7703-1161  Yong Sun Choi http://orcid.org/0000-0003-1067-5135  Su Jin Kim http://orcid.org/0000-0001-9799-0554 Hyuk Jin Cho http://orcid.org/ 0000-0003-2599-2950 Sung Hoo Hong http://orcid.org/0000-0002-1952-4010  Sae Woong Kim http://orcid.org/0000-0002-9127-9400  Tae-Kon Hwang http://orcid.org/0000-0001-7128-7422 Dai Jin Kim http://orcid.org/0000-0001-9408-5639 Ji Youl Lee http://orcid.org/0000-0001-6775-1157   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
• Effects of Moderate Alcohol Intake in OLETF Rat Bladder 1320  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1313Metab 2000; 26: 163-76.,Non-OADS,/arxiv_data1/oa_pdf/22/a3/jkms-30-1313.PMC4553680.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Diagnostic and Prognostic Significance of Radiologic Node- positive Renal Cell Carcinoma in the Absence of Distant  Metastases: A Retrospective Analysis of Patients Undergoing  Nephrectomy and Lymph Node Dissection The aim of this study was to evaluate the diagnostic and prognostic value of clinical- positive nodes at preoperative imaging (cN1) in patients with non-metastatic renal cell  carcinoma (RCC) treated with lymph node dissection (LND).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
"Keywords:  Carcinoma, Renal Cell; Lymph Node Dissection; Nephrectomy; Lymph Node  Metastasis; PredictorsHye Won Lee,1,2 Hwang Gyun Jeon,1  Byong Chang Jeong,1 Seong Il Seo,1  Seong Soo Jeon,1 Han Yong Choi,1   and Hyun Moo Lee1 1Department of Urology, 2Research Institute for  Future Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul, Korea Received: 19 April 2015 Accepted: 3 June 2015 Address for Correspondence: Hyun Moo Lee, MD  Department of Urology, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-6543, Fax: +82.2-3410-6992 E-mail: besthml@medimail.co.krhttp://dx.doi.org/10.3346/jkms.2015.30.9.1321  • J Korean Med Sci 2015; 30: 1321-1327 INTRODUCTION For patients with high-risk renal cell carcinoma (RCC), propos - ed beneﬁts of lymph node dissection (LND) at the time of ne - phrectomy include more precise assessment of prognosis by  accurate staging, decreased local and/or systemic recurrence,  and longer survival (1).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
"• Lymphadenectomy in Non-metastatic Renal Cell Carcinoma 1322  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1321ing LND were at high risk of harboring LNI, information need - ed to correctly stage and adequately plan treatment.",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
• Lymphadenectomy in Non-metastatic Renal Cell Carcinoma http://jkms.org   1323 http://dx.doi.org/10.3346/jkms.2015.30.9.1321the retroperitoneal lymphatic area on preoperative CT imaging.,Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
"• Lymphadenectomy in Non-metastatic Renal Cell Carcinoma 1324  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1321ysis of pN0, clinical lymphadenopathy was associated with poor  prognosis (MFS, HR 2.27, P< 0.001; CSS, HR 2.05, P= 0.02).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
"• Lymphadenectomy in Non-metastatic Renal Cell Carcinoma http://jkms.org   1325 http://dx.doi.org/10.3346/jkms.2015.30.9.1321patients with isolated regional nodal metastases from RCC are  a distinct cohort for whom resection of involved LNs might pro - vide therapeutic beneﬁts (2, 4).",Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
• Lymphadenectomy in Non-metastatic Renal Cell Carcinoma 1326  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1321Table 3.,Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
ORCID Hye Won Lee http://orcid.org/0000-0002-0303-4658 Hwang Gyun Jeon http://orcid.org/0000-0002-5613-8389 Byong Chang Jeong http://orcid.org/0000-0002-5399-2184 Seong Il Seo http://orcid.org/0000-0002-9792-7798 Seong Soo Jeon http://orcid.org/0000-0002-3265-6261 Han Yong Choi http://orcid.org/0000-0002-1980-4899 Hyun Moo Lee http://orcid.org/0000-0003-3969-4540 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
• Lymphadenectomy in Non-metastatic Renal Cell Carcinoma http://jkms.org   1327 http://dx.doi.org/10.3346/jkms.2015.30.9.13212.,Non-OADS,/arxiv_data1/oa_pdf/3c/2c/jkms-30-1321.PMC4553681.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cognitive Dysfunction in Drug-induced Parkinsonism Caused by  Prokinetics and Antiemetics The use of prokinetics/antiemetics is one of the leading causes of drug-induced  parkinsonism (DIP) observed in neurology clinics.",Non-OADS,/arxiv_data1/oa_pdf/8f/fd/jkms-30-1328.PMC4553682.pdf
"Keywords:  Drug-induced Parkinsonism; Magnetic Resonance Imaging; Prokinetics;  Volumetry; Cortical Thickness; SWEDD (Scans without Evidence of Dopaminergic Deficit)Hyun Jung Ahn,1 Woo-Kyoung Yoo,1,4  Jaeseol Park,2 Hyeo-Il Ma,2   and Yun Joong Kim2,3,4 1Department of Physical Medicine and Rehabilitation,  2Department of Neurology, 3ILSONG Institute of Life  Science, 4Hallym Institute of Translational Genomics  and Bioinformatics, Hallym University College of  Medicine, Anyang, Korea Received: 17 November 2014 Accepted: 23 June 2015 Address for Correspondence: Hyeo-Il Ma, MD  Department of Neurology, Hallym University College of  Medicine, 22 Gwanpyeong-ro 170-beon-gil, Anyang 431-796,  Korea Tel: +82.31-380-3742, Fax: +82.31-381-4659 E-mail: hima@hallym.ac.kr Funding:  This research was supported by Hallym University  Research Fund (HURF-2015-34).http://dx.doi.org/10.3346/jkms.2015.30.9.1328  • J Korean Med Sci 2015; 30: 1328-1333 INTRODUCTION Drug-induced parkinsonism (DIP) is the second most common  form of parkinsonism (1) after Parkinson’s disease (PD) and  constitutes 15%-60% of all parkinsonism cases (2) in the elderly.",Non-OADS,/arxiv_data1/oa_pdf/8f/fd/jkms-30-1328.PMC4553682.pdf
• Cognitive Dysfunction in Drug-induced Parkinsonism  http://jkms.org   1329 http://dx.doi.org/10.3346/jkms.2015.30.9.1328MATERIALS AND METHODS Subjects We analyzed magnetic resonance images and neuropsycholog - ical test results from a retrospective cohort of 14 DIP patients  recruited from the movement disorders clinic at Hallym Uni - versity Sacred Heart Hospital.,Non-OADS,/arxiv_data1/oa_pdf/8f/fd/jkms-30-1328.PMC4553682.pdf
• Cognitive Dysfunction in Drug-induced Parkinsonism  1330  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1328Table 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/fd/jkms-30-1328.PMC4553682.pdf
• Cognitive Dysfunction in Drug-induced Parkinsonism  http://jkms.org   1331 http://dx.doi.org/10.3346/jkms.2015.30.9.1328Table 4.,Non-OADS,/arxiv_data1/oa_pdf/8f/fd/jkms-30-1328.PMC4553682.pdf
"• Cognitive Dysfunction in Drug-induced Parkinsonism  1332  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1328test ( r= 0.674, P< 0.007) (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/8f/fd/jkms-30-1328.PMC4553682.pdf
• Cognitive Dysfunction in Drug-induced Parkinsonism  http://jkms.org   1333 http://dx.doi.org/10.3346/jkms.2015.30.9.1328of DIP .,Non-OADS,/arxiv_data1/oa_pdf/8f/fd/jkms-30-1328.PMC4553682.pdf
ORCID  HyunJung Ahn http://orcid.org/0000-0002-5386-3323 Woo-Kyung Yoo http://orcid.org/0000-0002-1273-0647 Jaeseol Park http://orcid.org/0000-0001-7160-3456  Hyeo-Il Ma http://orcid.org/0000-0001-6733-9779 Yun Joong Kim http://orcid.org/0000-0002-2956-1552 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8f/fd/jkms-30-1328.PMC4553682.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cross-cultural Adaptation and Linguistic Validation of the Korean  Version of the Leeds Assessment of Neuropathic Symptoms and  Signs Pain Scale Distinction between neuropathic pain and nociceptive pain helps facilitate appropriate  management of pain; however, diagnosis of neuropathic pain remains a challenge.",Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
"Keywords:  Neuralgia; Symptom Assessment; Validation StudiesCholhee Park,1 Youn-Woo Lee,1   Duck Mi Yoon,2 Do Wan Kim,3   Da Jeong Nam,4 and Do-Hyeong Kim2 1Department of Anesthesiology and Pain Medicine,  Gangnam Severance Hospital, Anesthesia and Pain  Research Institute, Yonsei University College of  Medicine, Seoul; 2Department of Anesthesiology  and Pain Medicine, Severance Hospital, Anesthesia  and Pain Research Institute, Yonsei University  College of Medicine, Seoul; 3Department of  Anesthesiology and Pain Medicine, Ajou University  Hospital, College of Medicine, Ajou University,  Suwon; 4Department of Anesthesiology and Pain  Medicine, National Health Insurance Corporation  Ilsan Hospital, Goyang, Korea Received: 5 February 2015 Accepted: 28 May 2015 Address for Correspondence: Do-Hyeong Kim, MD Department of Anesthesiology and Pain Medicine, Anesthesia  and Pain Research Institute, Yonsei University College of  Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82.2-2228-5770, Fax: +82.2-2228-7897 E-mail: breadfans@yuhs.achttp://dx.doi.org/10.3346/jkms.2015.30.9.1334  • J Korean Med Sci 2015; 30: 1334-1339 INTRODUCTION Neuropathic pain is defined as “a pain caused by a lesion or  disease of the somatosensory system” according to the Interna - tional Association for the Study of Pain (1).",Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
• Korean Version of the LANSS Pain Scale http://jkms.org   1335 http://dx.doi.org/10.3346/jkms.2015.30.9.1334to suit regional characteristics.,Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
• Korean Version of the LANSS Pain Scale 1336  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1334screened by the following criteria.,Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
• Korean Version of the LANSS Pain Scale http://jkms.org   1337 http://dx.doi.org/10.3346/jkms.2015.30.9.1334Table 3.,Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
• Korean Version of the LANSS Pain Scale 1338  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1334DISCUSSION This study demonstrated that the K-LANSS pain scale has good  reliability and validity as a neuropathic pain assessment tool.,Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
"• Korean Version of the LANSS Pain Scale http://jkms.org   1339 http://dx.doi.org/10.3346/jkms.2015.30.9.1334fore, the authors suppose this limitation not so crucial to the  findings of this study in spite of the exclusion of linguistic spe - cialists in the committee during translation and adaptation.",Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
ORCID Cholhee Park http://orcid.org/0000-0001-7247-9469 Youn-Woo Lee http://orcid.org/0000-0002-3056-9826 Duck Mi Yoon http://orcid.org/0000-0001-9215-4389 Do Wan Kim http://orcid.org/0000-0002-4176-2082 Da Jeong Nam http://orcid.org/0000-0001-9136-5272 Do-Hyeong Kim http://orcid.org/0000-0003-2018-8090 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
• Korean Version of the LANSS Pain Scale http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1334THE LANSS PAIN SCALE (LANSS  통증척도) Leeds Assessment of Neuropathic Symptoms and Signs 이름 __________________ 날짜 ___________________ A.,Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
• Korean Version of the LANSS Pain Scale http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1334B.,Non-OADS,/arxiv_data1/oa_pdf/2f/94/jkms-30-1334.PMC4553683.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Study of Reliability and Validity of the Korean Version of the  Trauma Symptom Checklist for Young Children The present study aimed to evaluate the psychometric properties of the Korean version of  the Trauma Symptom Checklist for Young Children (TSCYC) including reliability and validity.",Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
"Keywords:  Child Sexual Abuse; Preschool; Caregivers; Checklist; TSCYC; Posttraumatic  Stress SymptomJong Duk Bae,1 Jae Hoon Jeong,2   Jung Jae Lee,3 and Un-Sun Chung2 1Seodaegu Daedong Hospital, Daegu; 2Department  of Psychiatry, Kyungpook National University  Hospital, Daegu; 3Department of Psychiatry, College  of Medicine, Dankook University, Cheonan, Korea Received: 4 March 2015 Accepted: 20 May 2015 Address for Correspondence: Un-Sun Chung, MD Department of Psychiatry, Kyungpook National University,  School of Medicine, School Mental Health Resources and  Research Center, Kyungpook National University Children’s  Hospital, 807 Hoguk-ro, Buk-gu, Daegu 702-210, Korea Tel: +82.53-200-6414, Fax: +82.53-426-5361  E-mail: chungunsun@hanmail.nethttp://dx.doi.org/10.3346/jkms.2015.30.9.1340  • J Korean Med Sci 2015; 30: 1340-1346 INTRODUCTION Psychological stress after trauma has long been recognized as  an important factor in the development of mental disorders (1).",Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
"• Trauma Symptom Checklist for Young Children http://jkms.org   1341 http://dx.doi.org/10.3346/jkms.2015.30.9.1340terion of user-friendliness and time to administer, the self-re - port measures are favored because they take a shorter time to  administer than clinician-administered interview format.",Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
"• Trauma Symptom Checklist for Young Children 1342  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1340ety (ANX), Depression (DEP), Dissociation (DIS), and Anger/ Aggression (ANG).",Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
• Trauma Symptom Checklist for Young Children http://jkms.org   1343 http://dx.doi.org/10.3346/jkms.2015.30.9.1340Table 2.,Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
"• Trauma Symptom Checklist for Young Children 1344  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1340Concurrent validity In the normative group, 299 caretakers also had completed the  CBCL and the CSBI.",Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
• Trauma Symptom Checklist for Young Children http://jkms.org   1345 http://dx.doi.org/10.3346/jkms.2015.30.9.1340have a low base-rate of acknowledgment.,Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
• Trauma Symptom Checklist for Young Children 1346  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1340AUTHOR CONTRIBUTION Study design: Chung US.,Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
ORCID Jong Duk Bae http://orcid.org/0000-0002-4566-9651 Jung Jae Lee http://orcid.org/0000-0002-0828-3557 Jae Hoon Jeong http://orcid.org/0000-0003-2543-3307 Un-Sun Chung http://orcid.org/0000-0003-3871-1425  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
Available at http://www.womannchild.or.kr/sub03_1.asp [accessed on  February 28 2015].,Non-OADS,/arxiv_data1/oa_pdf/d3/a7/jkms-30-1340.PMC4553684.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Differences in Hands-off Time According to the Position of a  Second Rescuer When Switching Compression in Pre-hospital  Cardiopulmonary Resuscitation Provided by Two Bystanders:   A Randomized, Controlled, Parallel Study The change of compressing personnel will inevitably accompany hands off time when  cardiopulmonary resuscitation (CPR) is performed by two or more rescuers.",Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
"Keywords:  Cardiopulmonary Resuscitation; ManikinsYong Hwan Kim,1 Jun Ho Lee,1   Dong Woo Lee,1 Kwang Won Cho,1   Mun Ju Kang,1 Yang Weon Kim,2   Kyoung Yul Lee,3 Young Hwan Lee,4   Jin Joo Kim,5 and Seong Youn Hwang1 1Department of Emergency Medicine, Samsung  Changwon Hospital, Sungkyunkwan University  School of Medicine, Changwon; 2Department of  Emergency Medicine, Inje University, Busan Paik  Hospital, Busan; 3Department of Physical Education,  Kyungnam University, Changwon; 4Department of  Emergency Medicine, Hallym University Sacred  Heart Hospital, Hallym University, Anyang;  5Department of Emergency Medicine, Gachon  University Gil Hospital, Incheon, Korea Received: 23 July 2014 Accepted: 22 May 2015 Address for Correspondence: Seong Youn Hwang, MD Department of Emergency Medicine, Samsung Changwon  Hospital, Sungkyunkwan University School of Medicine,   158 Paryong-ro, Masanhoewon-gu, Changwon 630-723, Korea  Tel: +82.55-290-6560, Fax: +82.55-290-6117 E-mail: 3syellow@naver.comhttp://dx.doi.org/10.3346/jkms.2015.30.9.1347  • J Korean Med Sci 2015; 30: 1347-1353 INTRODUCTION Interruptions of chest compressions during cardiopulmonary  resuscitation (CPR), termed the hands-off time, should be kept  as short as possible (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
"• Hands-off Time in 2nd Rescuer’s Position 1348  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1347MATERIALS AND METHODS Design This study was a randomized, controlled, parallel mannequin  study investigating SS and OS methods of change of compres - sors.",OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
• Hands-off Time in 2nd Rescuer’s Position http://jkms.org   1349 http://dx.doi.org/10.3346/jkms.2015.30.9.134716 teams of two.,Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
"The participants were allocated to their team  by opening an opaque, sealed envelope that contained a num - ber from 1-32 that was generated randomly (http://www.ran - dom.org).",Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
• Hands-off Time in 2nd Rescuer’s Position 1350  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1347mographic characteristics of the participants allocated in the  two groups of same and opposite side are shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
• Hands-off Time in 2nd Rescuer’s Position http://jkms.org   1351 http://dx.doi.org/10.3346/jkms.2015.30.9.1347length (11-13).,Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
• Hands-off Time in 2nd Rescuer’s Position 1352  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1347of the objective of the study prior to their participation.,Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
ORCID Yong Hwan Kim http://orcid.org/0000-0003-1459-1086 Jun Ho Lee http://orcid.org/0000-0001-5779-5156 Dong Woo Lee http://orcid.org/0000-0002-4571-9137 Kwang Won Cho http://orcid.org/0000-0001-6764-2954 Mun Ju Kang http://orcid.org/0000-0001-7211-6107 Yang Weon Kim http://orcid.org/0000-0001-6580-8789 Kyoung Yul Lee http://orcid.org/0000-0002-9444-394X Young Hwan Lee http://orcid.org/0000-0002-8952-098X Jin Joo Kim http://orcid.org/0000-0002-5678-2019 Seong Youn Hwang http://orcid.org/0000-0003-3713-7855 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
• Hands-off Time in 2nd Rescuer’s Position http://jkms.org   1353 http://dx.doi.org/10.3346/jkms.2015.30.9.134718.,Non-OADS,/arxiv_data1/oa_pdf/86/34/jkms-30-1347.PMC4553685.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Epidemiological and Survival Trends of Pediatric Cardiac Arrests  in Emergency Departments in Korea: A Cross-sectional,  Nationwide Report  Cardiac arrest (CA) in children is associated with high mortality rates.",Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
"Keywords:  Pediatrics; Heart Arrest; Resuscitation; Outcome; Emergency Service, Hospital Jae Yun Ahn,1 Mi Jin Lee,1,5 Hyun Kim,2,5  Han Deok Yoon,3 and Hye Young Jang4,5 1Department of Emergency Medicine, School of  Medicine, Kyungpook National University, Daegu;  2Department of Emergency Medicine, Wonju College  of Medicine, Yonsei University, Wonju; 3National  Emergency Medical Center, Seoul; 4Department of  Emergency Medicine, Soonchunhyang University  Seoul Hospital, Seoul; 5The Korean Association of  Cardiopulmonary Resuscitation, Seoul, Korea Received: 30 January 2015 Accepted: 22 May 2015 Address for Correspondence: Mi Jin Lee, MD Department of Emergency Medicine, School of Medicine,  Kyungpook National University, 680 Gukchaebosang-ro,   Jung-gu, Daegu 700-842, Korea  Tel: +82.53-420-6400, Fax: +82.53-428-2820 E-mail: emmam@knu.ac.kr http://dx.doi.org/10.3346/jkms.2015.30.9.1354  • J Korean Med Sci 2015; 30: 1354-1360 INTRODUCTION Cardiac arrest (CA) in children is a relatively infrequent event;  however, it is often associated with death or a poor neurological  outcome (1-3).",Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
"• Survival Trends of Pediatric Cardiac Arrests in Emergency Departments  http://jkms.org   1355 http://dx.doi.org/10.3346/jkms.2015.30.9.1354logic characteristics and survival outcomes in children with re - suscitated CAs in EDs using data from a cross-sectional, nation - al ED-based registry.",OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
"50,522,478 8,905,766 10,814,628 10,232,016 10,327,028 10,243,040 NEDIS: national ER census ratio 40.4% 34.9% 35.3% 40.1% 42.9% 48.5% *Data source: 2008-2012 Yearbook of Emergency Medical Statistics (reference: http://www.nemc.or.kr/).",Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
• Survival Trends of Pediatric Cardiac Arrests in Emergency Departments  1356  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1354and P values < 0.05 were considered statistically significant.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
• Survival Trends of Pediatric Cardiac Arrests in Emergency Departments  http://jkms.org   1357 http://dx.doi.org/10.3346/jkms.2015.30.9.1354Table 2.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
"• Survival Trends of Pediatric Cardiac Arrests in Emergency Departments  1358  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1354ually improved significantly (11.8% in 2008, 11.7% in 2010, and  13.6% in 2012; P for trend = 0.001; Fig.",Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
• Survival Trends of Pediatric Cardiac Arrests in Emergency Departments  http://jkms.org   1359 http://dx.doi.org/10.3346/jkms.2015.30.9.1354ent definitions and study designs.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
ORCID Jae Yun Ahn http://orcid.org/0000-0002-1050-8575 Mi Jin Lee http://orcid.org/0000-0002-3773-8047 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
• Survival Trends of Pediatric Cardiac Arrests in Emergency Departments  1360  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1354Applied Research Network.,Non-OADS,/arxiv_data1/oa_pdf/09/4c/jkms-30-1354.PMC4553686.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Percutaneous Retrieval of Embolized Amplatzer Septal Occluder after Treatment of Double Atrial Septal Defect: A Case Report Embolization of the occlusion device after percutaneous closure of atrial septal defect  (ASD) is a potential disastrous complication.",Non-OADS,/arxiv_data1/oa_pdf/95/28/jkms-30-1361.PMC4553687.pdf
"Keywords:  Heart Septal Defects, Atrial; Septal Occluder Device; Device RemovalJae Yeong Cho,1,3 Kye Hun Kim,1,3*   Hyun Ju Yoon,1,3 Hyun Ju Seon,2,3  Youngkeun Ahn,1 Myung Ho Jeong,1  Jeong Gwan Cho,1 and Jong Chun Park1,3 1Department of Cardiovascular Medicine, 2Radiology,  3Translational Research Center on Aging, Chonnam  National University Hospital, Gwangju, Korea Received: 15 September 2014 Accepted: 16 January 2015 Address for Correspondence: Kye Hun Kim, MD Department of Cardiovascular Medicine, Chonnam National  University Hospital, 42 Jebong-ro, Dong-gu, Gwangju 501-757,  Korea  Tel: +82.62-220-6977, Fax: +82.62-223-3105 E-mail: christiankyehun@hanmail.nethttp://dx.doi.org/10.3346/jkms.2015.30.9.1361  • J Korean Med Sci 2015; 30: 1361-1366 INTRODUCTION Surgical closure has been the gold standard for the treatment of  adult patients with atrial septal defect (ASD) (1).",Non-OADS,/arxiv_data1/oa_pdf/95/28/jkms-30-1361.PMC4553687.pdf
• Embolization of Amplatzer Device in Double Atrial Septal Defect 1362  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1361 The patient experienced sudden and transient chest discom - fort on the next day.,Non-OADS,/arxiv_data1/oa_pdf/95/28/jkms-30-1361.PMC4553687.pdf
"• Embolization of Amplatzer Device in Double Atrial Septal Defect http://jkms.org   1363 http://dx.doi.org/10.3346/jkms.2015.30.9.1361DISCUSSION As the percutaneous transcatheter device closure has been ac - cepted and widely used for the treatment of ASD, several device  related safety issues or unexpected complications such as atrial  perforation, thrombus formation, hemopericardium associated  with erosion of aorta, device embolization have also been de - scribed (6-8).",Non-OADS,/arxiv_data1/oa_pdf/95/28/jkms-30-1361.PMC4553687.pdf
• Embolization of Amplatzer Device in Double Atrial Septal Defect 1364  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1361 A CB D Fig.,Non-OADS,/arxiv_data1/oa_pdf/95/28/jkms-30-1361.PMC4553687.pdf
• Embolization of Amplatzer Device in Double Atrial Septal Defect http://jkms.org   1365 http://dx.doi.org/10.3346/jkms.2015.30.9.1361Fig.,Non-OADS,/arxiv_data1/oa_pdf/95/28/jkms-30-1361.PMC4553687.pdf
Manuscript approval: all authors.ORCID Jae Yeong Cho http://orcid.org/0000-0002-9393-2821 Kye Hun Kim http://orcid.org/0000-0002-6885-1501 Hyun Ju Yoon http://orcid.org/0000-0003-1285-3660 Hyun Ju Seon http://orcid.org/0000-0003-1146-8875 Youngkeun Ahn http://orcid.org/0000-0003-2022-9366 Myung Ho Jeong http://orcid.org/0000-0003-4173-1494 Jeong Gwan Cho http://orcid.org/0000-0001-7855-4490 Jong Chun Park http://orcid.org/0000-0002-1637-7991  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/95/28/jkms-30-1361.PMC4553687.pdf
• Embolization of Amplatzer Device in Double Atrial Septal Defect 1366  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.136113.,Non-OADS,/arxiv_data1/oa_pdf/95/28/jkms-30-1361.PMC4553687.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Pathological Substratum for a Case of Fulminant Myocarditis  Treated with Extracorporeal Membrane Oxygenation and  Subsequent Heart Transplantation Fulminant myocarditis has been defined as the clinical manifestation of cardiac  inflammation with rapid-onset heart failure and cardiogenic shock.",Non-OADS,/arxiv_data1/oa_pdf/04/a9/jkms-30-1367.PMC4553688.pdf
"Keywords:  Fulminant Myocarditis; Complete Atrioventricular Block; Extracorporeal  Membrane Oxygenation; Orthotopic Heart TransplantationIn Ae Kim,1 Hyun Suk Yang,2   Wan Seop Kim,3 and Hyun Keun Chee4 1Department of Medicine, 2Division of Cardiology,  Department of Medicine, 3Department of Pathology,  4Department of Thoracic and Cardiovascular  Surgery, Konkuk University Medical Center, Konkuk  University School of Medicine, Seoul, Korea Received: 26 January 2015 Accepted: 15 April 2015 Address for Correspondence: Hyun Suk Yang, MD Division of Cardiology, Department of Medicine, Konkuk  University Medical Center, Konkuk University School of  Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729,  Korea Tel: +82.2-2030-7747, Fax: +82.2-2030-7748 E-mail: yang.hyun@gmail.comhttp://dx.doi.org/10.3346/jkms.2015.30.9.1367  • J Korean Med Sci 2015; 30: 1367-1372 INTRODUCTION The clinical manifestations of acute myocarditis vary from as - ymptomatic changes in an electrocardiogram to fulminant heart  failure with life-threatening arrhythmia.",Non-OADS,/arxiv_data1/oa_pdf/04/a9/jkms-30-1367.PMC4553688.pdf
• Fulminant Myocarditis Bridge to Orthotopic Heart Transplantation 1368  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1367agnosis of acute fulminant myocarditis she was admitted to the  medical intensive care unit.,Non-OADS,/arxiv_data1/oa_pdf/04/a9/jkms-30-1367.PMC4553688.pdf
"• Fulminant Myocarditis Bridge to Orthotopic Heart Transplantation http://jkms.org   1369 http://dx.doi.org/10.3346/jkms.2015.30.9.1367DISCUSSION Fulminant myocarditis is a rare clinical syndrome of all types of  myocarditis, presenting acute heart failure and severe hemody - namic compromise requiring pharmacological or mechanical  support.",Non-OADS,/arxiv_data1/oa_pdf/04/a9/jkms-30-1367.PMC4553688.pdf
"• Fulminant Myocarditis Bridge to Orthotopic Heart Transplantation 1370  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1367have histopathologic findings to treat rare but specific cases of  fulminant myocarditis, such as giant cell myocarditis, cardiac  sarcoidosis, or eosinophilic heart disease (10).",Non-OADS,/arxiv_data1/oa_pdf/04/a9/jkms-30-1367.PMC4553688.pdf
• Fulminant Myocarditis Bridge to Orthotopic Heart Transplantation http://jkms.org   1371 http://dx.doi.org/10.3346/jkms.2015.30.9.1367able cardiac donor – weeks to months.,Non-OADS,/arxiv_data1/oa_pdf/04/a9/jkms-30-1367.PMC4553688.pdf
ORCID In Ae Kim http://orcid.org/0000-0002-8994-2891 Hyun Suk Yang http://orcid.org/0000-0002-7056-3648 Wan Seop Kim http://orcid.org/0000-0001-7704-5942 Hyun Keun Chee http://orcid.org/0000-0001-7041-352X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/04/a9/jkms-30-1367.PMC4553688.pdf
• Fulminant Myocarditis Bridge to Orthotopic Heart Transplantation 1372  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.9.1367Sci 2009; 24: 1064-70.,Non-OADS,/arxiv_data1/oa_pdf/04/a9/jkms-30-1367.PMC4553688.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2015.30.9.1373  • J Korean Med Sci 2015; 30: 1373CORRESPONDENCE Erratum: A Phase 2 Multi-center, Open-label, Switch-over Trial to Evaluate the  Safety and Efficacy of Abcertin® in Patients with Type 1 Gaucher Disease Jin-Ho Choi, Beom Hee Lee, Jung Min Ko, Young Bae Sohn, Jin-Sung Lee, Gu-Hwan Kim, Sun Hee Heo, June-Young Park,   Yoo-Mi Kim, Ja-Hye Kim, and Han-Wook Yoo To the Editor: The authors want to clarify the definition of “biosimilar” based on “Regulatory expectations and risk assessment for biotherapeutic  products.",Non-OADS,/arxiv_data1/oa_pdf/d5/62/jkms-30-1373.PMC4553689.pdf
"World Health Organization 2014. available from http://www.who.int/biologicals/WHO_Risk_Assessment_for_Biothera­ peutics_1st_PC_24_Jan_2014.pdf” In this article (J Korean Med Sci 2015;30:378­384), as Abcertin® does not meet the exact definition of biosimilar, the authors would  like to delete the phrases “a biosimilar of imiglucerase” in Page 379 and “a new biosimilar to imiglucerase” in Page 382.",Non-OADS,/arxiv_data1/oa_pdf/d5/62/jkms-30-1373.PMC4553689.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/e5/ehv125.PMC4553715.pdf
"Or- ganisation for Economic and Cooperation and Development, Paris, France; 2012.http://www.oecd.org/std/prices-ppp/purchasingpowerparitiespppsdata.htm .",Non-OADS,/arxiv_data1/oa_pdf/ce/e5/ehv125.PMC4553715.pdf
"Availability and implementation: Our method is publicly available in a software package called ADAPT-Mix available at https://github.com/dpark27/adapt_mix.Contact: noah.zaitlen@ucsf.edu 1 Introduction Summary statistics of association tests, such as effect size estimates and their standard errors, are becoming the datatype of choice inmany genetic analyses due to two significant advantages.",Non-OADS,/arxiv_data1/oa_pdf/7f/6c/btv230.PMC4553832.pdf
"i181 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/6c/btv230.PMC4553832.pdf
MULTICOM’s outstanding performance in the extremelycompetitive 2014 CASP11 experiment proves th at our large-scale QA approach together with model clustering is a promising solution to one of the two major problems in protein structure modeling.Availability and implementation : The web server is available at: http://sysbio.rnet.missouri.edu/ multicom_cluster/human/.,OADS,/arxiv_data1/oa_pdf/6e/c3/btv235.PMC4553833.pdf
"i116 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/c3/btv235.PMC4553833.pdf
2.2 Evaluation of top-ranked models We downloaded publically available native structures for 42 CASP11 human targets from the CASP’s website (http://www.predictioncenter.org/casp11/index.cgi).,OADS,/arxiv_data1/oa_pdf/6e/c3/btv235.PMC4553833.pdf
The PAGER database can be access ible openly at http://discovery.informatics.,OADS,/arxiv_data1/oa_pdf/88/d1/btv265.PMC4553834.pdf
"i250 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/d1/btv265.PMC4553834.pdf
"protein interactions, reactions, or generegulations, are available (Biological Pathway, http://www.genome.gov/27530687).",OADS,/arxiv_data1/oa_pdf/88/d1/btv265.PMC4553834.pdf
The PAGER database is accessible at http://discovery.informatics.iupui.edu/PAGER/ and thedatabase content for PAGs may be downloaded for separate GNPAtools such as GSEA.,OADS,/arxiv_data1/oa_pdf/88/d1/btv265.PMC4553834.pdf
"2 Methods 2.1 Source data collection and preprocessing of PAGs In the PAGER database, we compiled PAGs from the followingdata sources (for download date and description details, refer toSupplementary Data S1 ): WikiPathway ( Pico et al., 2008 ), from which we collected 202 public validated pathways; Reactome(Croft et al., 2011 ), from which we collected 651 peer-reviewed pathways via the HPD ( Chowbina et al., 2009 ); BioCarta (Nishimura, 2001 ), from which we collected 253 pathways via the HPD; KEGG ( Ogata et al., 1999 ), from which we collected 200 pathways via the HPD; PID ( Schaefer et al., 2009 ), from which we collected 132 NCI-Nature curated pathways via the HPD; ProteinLounge (http://www.proteinlounge.com/Pathway), from which wecollected 393 pathways; OMIM ( Baxevanis, 2012 ), from which we collected 4409 manually-curated gene lists associating with pheno-type terms; SPIKE ( Elkon et al., 2008 ), from which we collected 28 signaling pathways from the Genetic Association Database; GAD(Becker et al., 2004 ), from which we collected 1679 unique pheno- type/disease-related protein records; PharmGKB ( Thorn et al., 2010 ), from which we collected 102 chemical-associated pathways; MSigDB ( Liberzon et al., 2011 ), from which we collected 10 295 gene sets; GeneSigDB ( Culhane et al., 2012 ), from which we col- lected 3515 gene signatures; NHGRI GWAS Catalog ( Welter et al., 2014 ), from which we collected 1754 curated publications of 11 912 SNPs; and NGS Catalog ( Xiaet al., 2012 ), from which we collected 69 annotated gene list curated from next generation sequencing data analysis literature.",OADS,/arxiv_data1/oa_pdf/88/d1/btv265.PMC4553834.pdf
"2.4 Developing the web application and user interface We developed a web interface for the PAGER database, which is located at http://discovery.informatics.iupui.edu/PAGER/, forusers to retrieve PAGs and PAG–PAG relationships with gene orkeyword based queries.",OADS,/arxiv_data1/oa_pdf/88/d1/btv265.PMC4553834.pdf
"Cytoscape.js (http://js.cytoscape.org), an open-source graph li-brary, and jQuery were used to visualize gene and PAG networks.D3.js (http://d3js.org/) was used to perform matrix visualizations.We also implemented advanced features such as batch gene search,matrix or network visualization, gene or PAG transaction manage-ment to hold temporary user-selected contents, and data bulkdownload.",OADS,/arxiv_data1/oa_pdf/88/d1/btv265.PMC4553834.pdf
Available from: http://www.unaids.org/en/media/unaids/ contentassets/documents/data‑and‑analysis/tools/spectrum/ India2012report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/65/33/IJSTD-35-104.PMC4553836.pdf
Available from: http://www.nacoonline.,Non-OADS,/arxiv_data1/oa_pdf/65/33/IJSTD-35-104.PMC4553836.pdf
Available from:  http://www.data.unaids.org/pub/Report/2010/india_2010_country_ progress_report_en.pdf.,OADS,/arxiv_data1/oa_pdf/65/33/IJSTD-35-104.PMC4553836.pdf
Available from: http://www.nacoonline.org/NACO/.,Non-OADS,/arxiv_data1/oa_pdf/bd/6d/IJSTD-35-109.PMC4553837.pdf
Available from:  http://www.unaids.org.,Non-OADS,/arxiv_data1/oa_pdf/a2/3c/IJSTD-35-114.PMC4553838.pdf
Available from: http://www.cdc.gov/hiv/malecircumcision.,Non-OADS,/arxiv_data1/oa_pdf/a2/3c/IJSTD-35-114.PMC4553838.pdf
Available from: http://www.rmrct.org.,Non-OADS,/arxiv_data1/oa_pdf/a2/3c/IJSTD-35-114.PMC4553838.pdf
Available from: http://www.nap.edu/openbook.,Non-OADS,/arxiv_data1/oa_pdf/9b/95/IJSTD-35-118.PMC4553839.pdf
Available from: http://www.nacoonline.org/upload/Policies%20  and %20Guidelines/1.%20Antiretroviral%20Therapy%20 Guidelines%20for%20HIV‑Infected% 20Adults %20and %  20 Adolescents%20 Including%20Post‑exposure.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/IJSTD-35-124.PMC4553840.pdf
Available from: http://www.nacoonline.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/IJSTD-35-124.PMC4553840.pdf
"Available from: http://www.naco.gov.in/upload/Publication/2014/ Antiretroviral%20Therapy%20Guidelines%20for%20 HIV‑Infected%20Adults%20and%20Adolescents%20May%20 2013.pdf [Last cited August 22, 2013].",Non-OADS,/arxiv_data1/oa_pdf/9a/87/IJSTD-35-124.PMC4553840.pdf
Available from: http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/9a/87/IJSTD-35-124.PMC4553840.pdf
Article ID 307950. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/46/d2/IJSTD-35-158.PMC4553849.pdf
Available from http://www.sciencedirect.com/science/ article/pii/S1110569014000338 [Last accessed on  2014 May 19].,Non-OADS,/arxiv_data1/oa_pdf/46/d2/IJSTD-35-158.PMC4553849.pdf
Box plots were generated using a web tool for generation of box plots (http://boxplot.tyerslab.com/).,OADS,/arxiv_data1/oa_pdf/75/58/bmjdrc-2015-000095.PMC4553907.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2015- 000122).,Non-OADS,/arxiv_data1/oa_pdf/58/0b/bmjdrc-2015-000122.PMC4553908.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjdrc-2014- 000069).,Non-OADS,/arxiv_data1/oa_pdf/4e/c8/bmjdrc-2014-000069.PMC4553909.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4e/c8/bmjdrc-2014-000069.PMC4553909.pdf
http://www.idf.,Non-OADS,/arxiv_data1/oa_pdf/4e/c8/bmjdrc-2014-000069.PMC4553909.pdf
"Model of care for the diabetic foot [article online], 2011. http://www.hse.ie/eng/about/Who/clinical/natclinprog/diabetesprogramme/modelofcarediabetes.pdf 24.",Non-OADS,/arxiv_data1/oa_pdf/4e/c8/bmjdrc-2014-000069.PMC4553909.pdf
"Guidelines on prevention & management of foot problems in type 2 diabetes [article online], 2004. http://guidance.nice.org.uk/CG10 25.",Non-OADS,/arxiv_data1/oa_pdf/4e/c8/bmjdrc-2014-000069.PMC4553909.pdf
2008. http://www.hse.ie/eng/services/Publications/topics/Diabetes/A_Practical_Guide_to_Integrated_Type_II_Diabetes_Care.pdf 39.,Non-OADS,/arxiv_data1/oa_pdf/4e/c8/bmjdrc-2014-000069.PMC4553909.pdf
5th edn: 2011. http://www.diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/c2/c8/bmjdrc-2015-000112.PMC4553910.pdf
Global tuberculosis control http://www.who.int/tb/publications/2011/ en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/c2/c8/bmjdrc-2015-000112.PMC4553910.pdf
"The workflow of patient selection was summarized as Figure 1, and the patients’ age distributionwas described in supplementary Table 1, http://links.lww.com/MD/A223.",Non-OADS,/arxiv_data1/oa_pdf/a9/7a/medi-94-e610.PMC4553951.pdf
"The distributions of clinicopathological findings, exclud- ing serosal invasion, were investigated according to the pre- sence or absence of serosal invasion (see Supplemental Table 1, http://links.lww.com/MD/A220).",Non-OADS,/arxiv_data1/oa_pdf/dd/a1/medi-94-e602.PMC4553956.pdf
"In addition, the tumors with serosal invasion were significantly larger than tumors without serosal invasion ( P¼0.0008) (see Supplemental Figure, http://links.lww.com/MD/A220, whichTABLE 1.",Non-OADS,/arxiv_data1/oa_pdf/dd/a1/medi-94-e602.PMC4553956.pdf
"The definition of T4 according to the Japanese staging system has been presented in the supplemental table (see Supplemental Table 2, http://links.lww.com/MD/A220, whichshows the definition of the T factor as per the Japanese stagingsystem).",Non-OADS,/arxiv_data1/oa_pdf/dd/a1/medi-94-e602.PMC4553956.pdf
"The number of observed events for groups A and B by antihypertensivetreatment group is summarize d in Supplementary Table 1, http://links.lww.com/MD/A217.",OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
"Detailedinformation on the QALYs gained and costs for the ACEI-based and diuretic-based treatment by year for group A andgroup B cost-effectiveness analysis is summarized in Supple-mentary Table 2, http://links.lww.com/MD/A217.Sensitivity Analyses The findings of the 1-way sensitivity analyses are presented in Table 4.",Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
Australian Bureau of Statistics;2013. http://www.abs.gov.au/AUSSTATS/abs@.nsf/2f762f95845417aeca25706c00834efa/322DB1B539ACCC6C-CA257B39000F316C?opendocument.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
Canberra: PBS Information Management Section Pharmaceutical PolicyBranch; 2013. http://www.pbs.gov.au/info/statistics/expenditure-and-prescriptions-30-06-201211.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
http://www.ncbi.nlm.nih.gov/books/NBK45886/.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
http://www.pbs.gov.au.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
Public Sector Estimated Cost Weights Round 13 AR-DRG v5.2 http://www.health.gov.au/internet/main/publishing.nsf/Content/Round_13-cost-reports.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
http://www.mbsonline.gov.au/.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
http://www.ncbi.nlm.nih.gov/books/NBK83274/.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
"Decision Support Unit, School of Health and Related Research, University ofSheffield; 2011. http://www.nicedsu.org.uk.",Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
Canberra: AIHW; 2013. https://www.aihw.,Non-OADS,/arxiv_data1/oa_pdf/3f/a6/medi-94-e590.PMC4553958.pdf
"Women who were included and excluded from the study had similar ages, education levels, and body mass index (BMI), but the excludedwomen were more likely to be smokers and alcohol drinkers before or during pregnancy than women who were included (17.2% vs 12.7%; 40.2% vs 33.5%, respectively; SupplementalTable 1, http://links.lww.com/MD/A216).",Non-OADS,/arxiv_data1/oa_pdf/09/c1/medi-94-e571.PMC4553961.pdf
"Furthermore, women who took fish oil supplements tended to have higher total n-3 PUFAs (6.8% vs 6.0%), higher long-chain n-3 PUFAs (6.4% vs5.7%), and lower n-6 PUFAs (33.9% vs 34.4%) compared withwomen who did not take fish oil supplements (Supplemental Table 2, http://links.lww.com/MD/A216).",Non-OADS,/arxiv_data1/oa_pdf/09/c1/medi-94-e571.PMC4553961.pdf
"The results were not materially changed in thesensitivity analyses: further adjustment or exclusion of women with hypertension before pregnancy, or further adjustment for plasma MUFAs (Supplemental Table 3, http://links.lww.com/MD/A216); and in women without fish oil supple- mentation (Supplemental Table 4, http://links.lww.com/MD/ A216).",Non-OADS,/arxiv_data1/oa_pdf/09/c1/medi-94-e571.PMC4553961.pdf
"The results were not materially differentwith further adjustment for maternal hypertension before preg- nancy or plasma MUFAs (Supplemental Table 5, http:// links.lww.com/MD/A216) and in subgroup analysis of womenwho were not supplemented with fish oil (Supplemental Table 6, http://links.lww.com/MD/A216).",Non-OADS,/arxiv_data1/oa_pdf/09/c1/medi-94-e571.PMC4553961.pdf
"The inverse associations tended to be stronger in Chinese women and weaker in Indian women, but nonsignifi- cantly positive in Malay women (Supplemental Table 7, http://links.lww.com/MD/A216).",Non-OADS,/arxiv_data1/oa_pdf/09/c1/medi-94-e571.PMC4553961.pdf
"The positive relations of linoleic acid with SBP and total n- 6 PUFAs with DBP were stronger in Indian women compared with Chinese or Malay women ( Pfor interaction ¼0.02 and 0.05, respectively; Supplemental Table 8, http://links.lww.com/MD/A216).",Non-OADS,/arxiv_data1/oa_pdf/09/c1/medi-94-e571.PMC4553961.pdf
"Using the cutoff value of ALT >40, a significant association was found between VAT and elevated ALT in the ultrasonographically diagnosed NAFLD group ( Pfor trend 0.017 for men and <0.001 for women, Supplementary Table 1, http://links.lww.",OADS,/arxiv_data1/oa_pdf/6f/25/medi-94-e573.PMC4553965.pdf
"When the cutoff value of ALT was set at >2 times the upper normal limit, VAT had an association with elevated ALT only in women in the ultrasonographically diag- nosed NAFLD group (Supplementary Table 2, http://links.lww.com/MD/A212).",Non-OADS,/arxiv_data1/oa_pdf/6f/25/medi-94-e573.PMC4553965.pdf
"METHODS Patients The SEER Cancer Statistics Review (http://seer.cancer.- gov/data/citation.html), a report on the most recent cancerincidence, mortality, survival, prevalence, and lifetime riskstatistics, is published annually by the Data Analysis and Interpretation Branch of the National Cancer Institute (NCI; Bethesda, MD).",Non-OADS,/arxiv_data1/oa_pdf/26/c0/medi-94-e684.PMC4554000.pdf
"At first, as shown in Table S1, http://links.lww.com/MD/A233, these young patients were divided into 4 age groups: 294 patients in Group I ( /C2030 years), 282 in Group II (31–35 years), 610 in Group III (36–40 years),and 1455 in Group IV (41–45 years).",Non-OADS,/arxiv_data1/oa_pdf/26/c0/medi-94-e684.PMC4554000.pdf
"The mean values of the CAVI for the subjects with and without NAFLD are shown in Table 3 and SupplementaryFigure 1, http://links.lww.com/MD/A231.",Non-OADS,/arxiv_data1/oa_pdf/d9/e2/medi-94-e654.PMC4554011.pdf
"The risk for arterial stiffness increased according to the severity of NAFLD (adjusted odds ratio [OR] [95% confidence interval, CI],1.27 [1.02 /C01.57] vs 1.78 [1.37 /C02.31], mild vs moderate- to-severe NAFLD, respectively, as shown in Table 4 and Supplementary Table 1, http://links.lww.com/MD/A231).",Non-OADS,/arxiv_data1/oa_pdf/d9/e2/medi-94-e654.PMC4554011.pdf
"MATERIALS AND METHODS Guideline Searching We systematically searched electronic databases and guide- line websites or databases, including PubMed, Embase, theChinese National Knowledge Infrastructure, the Chinese Biome-dical Literature Database, the Chinese National Knowledge Infrastructure WanFang Database, the Guidelines International Network database (http://www.g-i-n. net/library), the NationalGuideline Clearinghouse (http://www.guideline.gov), theNational Institute for Health and Care Excellence (http://www.ni ce.org.uk/), the Scottish Intercollegiate Guidelines Network (http://www.sign.ac.uk/), the Canadian Medical AssociationCPG Infobase (http://www.cma.ca/cpgs/), and the National Com- prehensive Cancer Network (http://www.nccn.org).",Non-OADS,/arxiv_data1/oa_pdf/4e/6d/medi-94-e635.PMC4554013.pdf
http://www.gradeworkinggroup.org/ news.htm.,Non-OADS,/arxiv_data1/oa_pdf/4e/6d/medi-94-e635.PMC4554013.pdf
Detailed information about TCRP isavailable at http://www.pentacam.com/sites/calc_corneal_po- wer.php#ptop.,Non-OADS,/arxiv_data1/oa_pdf/7a/b9/medi-94-e677.PMC4554023.pdf
"By age stratifica- tion, GT3 was also the highest proportion in all age groups andthis was more pronounced in the 46–60 years age group(31.6%) (Supporting Table S1, http://links.lww.com/MD/ A349).",Non-OADS,/arxiv_data1/oa_pdf/b9/8a/medi-94-e1234.PMC4554122.pdf
"In stratified analysis, the RVR rates were highest among patients with HCV-GT2 (3/4, 75%), followed by HCV-GT3 (99/178, 55.6%)(Supporting Table S2, http://links.lww.com/MD/A349).",Non-OADS,/arxiv_data1/oa_pdf/b9/8a/medi-94-e1234.PMC4554122.pdf
"2009. http://www.clinicaloptions.com/Hepatitis/Management%20Series/2009%20AASLD%20HCV%20Gui-delines.aspx [January 12, 2015] 7.",Non-OADS,/arxiv_data1/oa_pdf/b9/8a/medi-94-e1234.PMC4554122.pdf
"All variables, definitions, and inclusion criteriaregarding the NCD are accessible to participating institutions on its website (http://www.ncd.or.jp/), which also features an E-learning system to instruct participants in how to input con-sistent data.",OADS,/arxiv_data1/oa_pdf/36/59/medi-94-e1224.PMC4554124.pdf
"Model Results and Performance We developed risk models for postoperative morbidities with a relatively high incidence associated with high mortality (Table 4; Supplemental Table, http://links.lww.com/MD/A344,with 95% confidence intervals [CIs]).",Non-OADS,/arxiv_data1/oa_pdf/36/59/medi-94-e1224.PMC4554124.pdf
"The morbidities with a 95% CI showingstatistical significance are shown in the Supplemental Table, http://links.lww.com/MD/A344.",Non-OADS,/arxiv_data1/oa_pdf/36/59/medi-94-e1224.PMC4554124.pdf
"A comparison of the outcomes of patients with ADP registered with the NCD in 2011 with those registered in 2012 revealedthat mortality and morbidities were highly correlated betweenthese years ( r¼0.9932; Supplemental Figure, http://links.lww.- com/MD/A344).",Non-OADS,/arxiv_data1/oa_pdf/36/59/medi-94-e1224.PMC4554124.pdf
"Available at: http://www.uroweb.org/gls/pdf/10_Renal_Cell_Carcinoma_LRV2.pdf [Accessed January 28, 2014].",Non-OADS,/arxiv_data1/oa_pdf/a1/57/medi-94-e1228.PMC4554132.pdf
"Additionally, race, gender, age, location, histological type, differentiated grade, T-stage, and the level of CEA could predict the outcome, whereas the year of diagnosis could not (Table 1) (Appendix 1, http://links.lww.com/MD/A347).",Non-OADS,/arxiv_data1/oa_pdf/62/94/medi-94-e1215.PMC4554134.pdf
"The Distinction of the mRNA Proﬁle The detailed characteristics of 15 patients with resectable mCRC selected in our center are provided in Appendix 2, http://links.lww.com/MD/A347.",Non-OADS,/arxiv_data1/oa_pdf/62/94/medi-94-e1215.PMC4554134.pdf
"Patients never admitted to the ICU were younger, had a lower ASA PS, had more often elective surgery, had lessoften intracranial, intrathoracic, or intraabdominal surgery, less comorbidities, a shorter hospital stay, and died less often (0.1% vs 4.4%; P<0.001 for all variables; see Table 5, Supplemental Content, http://links.lww.com/MD/A215, which describes thestudy population divided by ICU admission).",Non-OADS,/arxiv_data1/oa_pdf/9c/6d/medi-94-e576.PMC4554144.pdf
"Admission to ICU remained independently associated with a higher SMS in multi- variate analysis (see Table 6, Supplemental Content, http://links.lww.com/MD/A215, which shows the results of a linearregression model for the new SMS including ICU admission as independent variable).",Non-OADS,/arxiv_data1/oa_pdf/9c/6d/medi-94-e576.PMC4554144.pdf
"In Asia, a substantial pro- portion of women are diagnosed with estrogen receptor (ER)- negative tumors, in part owing to the younger age at diagnosis ofbreast cancer in the population.7–9It has been previously shown that almost half of the breast cancers in several Asian settings including Hong Kong, Singapore, and India occurred in pre-menopausal women7–9and approximately 45% of patients had ER-negative breast cancers.7,8 Online prognostication tools may therefore be valuable in clinical practice and have been proposed to guide adjuvantchemotherapy decision making, at institutional and even atnational levels in affluent countries (http://www.predict.nh- s.uk/technical.html).",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/medi-94-e593.PMC4554151.pdf
"PREDICT is a web-based prognostication tool, which estimates the probability of survival for individual patients with breast cancer and the impact of systemic treatment choices ontheir survival probability (http://www.predict.nhs.uk/).",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/medi-94-e593.PMC4554151.pdf
"For instance, life expectancy in 2010 for a female at 50 years of age in Malaysia was 78.4 years, whereas in the United Kingdom and United States, it was83.9 and 83.1 years, respectively (http://www.worldlifeexpec-tancy.com/world-healthrankings).",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/medi-94-e593.PMC4554151.pdf
"Although PRE-DICT was recently adapted to include Ki67 status in its algorithm, it is important to note that the added prognostic value of Ki67 is yet to be externally validated due to lack ofappropriate populations (http://www.predict.nhs.uk/techni- cal.shtml).",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/medi-94-e593.PMC4554151.pdf
2005;2:http://www.patternsofcare.- com/2005/3/adjuvant.htm.,OADS,/arxiv_data1/oa_pdf/6e/5c/medi-94-e593.PMC4554151.pdf
"Technical report for the paper: improved web-based calculators for predicting breast carcinoma outcomes.Laboratory for Quantitative Medicine, Technical Report #12. http://cancer.lifemath.net/about/techreports/index.php.",Non-OADS,/arxiv_data1/oa_pdf/6e/5c/medi-94-e593.PMC4554151.pdf
Kuala Lumpur:National Cancer Registry; 2004:http://www.care.upm.edu.my/doku-men/13603_2ndNCR2003.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6e/5c/medi-94-e593.PMC4554151.pdf
"Among experienced surgeons worldwide, extended D2 lymph node (LN) dissection is considered the essential part of curative gastrectomy.2–4However, approximately 25% to 40% of patients inevitably experience tumor recurrence within5 years after curative surgery.2–4 LN metastasis is the most important survival predictor for GC.5,6To date, 3 main classifications of LN metastasis have been applied to predict the prognosis of GC patients worldwide, including classifications based on the number and location of positive nodes and on the ratio between the metastatic andexamined nodes.5,7,8The precise evaluation of LN metastasis is the most important guarantee of the accurate prediction of the prognosis of patients with GC.9–11The latest revision of the American Joint Committee on Cancer (AJCC) TNM stagingsystem was presented in the seventh edition in 2009 (Supple-mentary Table 1, http://links.lww.com/MD/A213).",Non-OADS,/arxiv_data1/oa_pdf/76/96/medi-94-e575.PMC4554155.pdf
Statistical procedures and figures were operated andproduced by using the statistical software packages of rms andsurvival in Rstudio version 0.98.945 with R core version 3.0.2 (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/76/96/medi-94-e575.PMC4554155.pdf
"Lyon, France: International Agency for Research onCancer; 2013:Available from: http://globocan.iarc.fr, accessed on 11/07/2014.",Non-OADS,/arxiv_data1/oa_pdf/16/84/medi-94-e533.PMC4554157.pdf
"A final total of 89,428 newly diagnosed type 2 DM patients without DMassociated complications or catastrophic diseases were eligible and were analyzed in this study (Appendix 1, http://links.lww.- com/MD/A209).",Non-OADS,/arxiv_data1/oa_pdf/1d/6f/medi-94-e554.PMC4554162.pdf
"R software, version 2.15.1 (http://www.R-project.org) was used to perform all statisticalanalyses.",OADS,/arxiv_data1/oa_pdf/88/a1/medi-94-e563.PMC4554163.pdf
"Next, wecompared the time-dependent 1-year serial changes in echo-cardiographic parameters between the ‘‘faster’’ and ‘‘slower’’RRF decline groups (Table 5; Figure 1; Supplementary Figure 1, http://links.lww.com/MD/A167).",Non-OADS,/arxiv_data1/oa_pdf/2f/45/medi-94-e427.PMC4554171.pdf
"In contrast, the changes in echocardiographic parameters during the first year of PD showed no differences between patients who were grouped by median values of baseline RRF (Supplementary Table 1, http://links.lww.com/MD/A168).",Non-OADS,/arxiv_data1/oa_pdf/2f/45/medi-94-e427.PMC4554171.pdf
"However, the signifi- cant impact of RRF decline rate on CV composite and technique failure was no longer observed when further adjustments weremade with 1-year changes in echocardiographic parameters (Supplementary Table 2, http://links.lww.com/MD/A169).",Non-OADS,/arxiv_data1/oa_pdf/2f/45/medi-94-e427.PMC4554171.pdf
2003; http://www.mhlw.go.jp/topics/kaigo/kentou/15kourei/index.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/80/medi-94-e525.PMC4554179.pdf
"2004;http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa04/4–2.html.Accessed September 17, 2013.",OADS,/arxiv_data1/oa_pdf/e6/80/medi-94-e525.PMC4554179.pdf
"2007;http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa07/4–2.html.Accessed September 17, 2013.",OADS,/arxiv_data1/oa_pdf/e6/80/medi-94-e525.PMC4554179.pdf
"2010;http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa10/4-2.html.Accessed September 17, 2013.",OADS,/arxiv_data1/oa_pdf/e6/80/medi-94-e525.PMC4554179.pdf
2012; http://www.mhlw.go.jp/english/database/db-hss/soltc-be2012.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/80/medi-94-e525.PMC4554179.pdf
2010; http://www.mhlw.go.jp/stf/hou-dou/2r98520000003byd.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/80/medi-94-e525.PMC4554179.pdf
"(See supple- mental video, http://links.lww.com/MD/A211, which demon-strates a short sample of an operation.)",Non-OADS,/arxiv_data1/oa_pdf/3d/a2/medi-94-e529.PMC4554183.pdf
"An etiological screening was done to classify them into the C (n ¼29) or NC group (n ¼34) (supplementary S1, http://links.lww.com/MD/A208).",Non-OADS,/arxiv_data1/oa_pdf/e8/62/medi-94-e544.PMC4554184.pdf
"Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or trans- formed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/19/piu098.PMC4554197.pdf
Available at: http://www.who.int/in ﬂuenza/vaccines/virus/en/ .,Non-OADS,/arxiv_data1/oa_pdf/f7/19/piu098.PMC4554197.pdf
Available at: http://www.fda.gov/downloads/biologicsbloodvaccines/ guidancecomplianceregulatoryi nformation/quidances/vaccines/ ucm091990.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f7/19/piu098.PMC4554197.pdf
Retrieved from https://www.escholar.manchester.ac.uk/uk-ac-man- scw:133158.,Non-OADS,/arxiv_data1/oa_pdf/33/34/10.1177_0143034313485849.PMC4554210.pdf
Retrieved from http://decp.bps.org.uk/decp/educational-and- child-psychology/back-issues.cfm.,Non-OADS,/arxiv_data1/oa_pdf/33/34/10.1177_0143034313485849.PMC4554210.pdf
Retrieved from http://decp.bps.org.uk/decp/educational-and-child-psychology/back- issues.cfm.,Non-OADS,/arxiv_data1/oa_pdf/33/34/10.1177_0143034313485849.PMC4554210.pdf
"Procedures The study was approved by the Norwegian South-East Regional Committee for Medical and Health Research Ethics (REK, South-East; https://helseforskning.etikkom.no) and was conducted according to the Declaration of Helsinki: Ethical Principles for Medical Research In- volving Human Subjects (World Medical Association, 2013).",Non-OADS,/arxiv_data1/oa_pdf/d1/cf/nmd-203-684.PMC4554230.pdf
http://hprt-cambridge.org/.,Non-OADS,/arxiv_data1/oa_pdf/d1/cf/nmd-203-684.PMC4554230.pdf
http://www.ssb.no/en/befolkning/statistikker/innvgrunn/aar/2014-09-04.,OADS,/arxiv_data1/oa_pdf/d1/cf/nmd-203-684.PMC4554230.pdf
Retrieved from http://www.wma.net.,Non-OADS,/arxiv_data1/oa_pdf/d1/cf/nmd-203-684.PMC4554230.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence  (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work,  in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/ea/djv124.PMC4554256.pdf
We used the software packages IBIS v7  (http://www.ems-trials.org/riskevaluator/ ) (8) and BOADICEA  (https://pluto.srl.cam.ac.uk/cgi-bin/bd3/v3/bd.cgi ) (10–12 ) to  assign RLRs and 10-year risks.,OADS,/arxiv_data1/oa_pdf/ab/ea/djv124.PMC4554256.pdf
All calibration and dis - crimination statistics were computed using the freely available  software RMAP ( http://www.stanford.edu/~ggong/rmap/index.,OADS,/arxiv_data1/oa_pdf/ab/ea/djv124.PMC4554256.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org /licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/ae/main.PMC4554290.pdf
"Consent n/a Direct link to deposited data Deposited data can be found here: http://www.ebi.ac.uk/arrayexpress/ experiments/ E-MTAB-1744/ (Microarray; differential expression), http:// www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1745/ (TranscriptomeGenomics Data 2 (2014) 32 –36 ⁎Corresponding author.",OADS,/arxiv_data1/oa_pdf/44/ae/main.PMC4554290.pdf
of control TS23 humerus) and http://www.ebi.ac.uk/arrayexpress/ experiments/E-MTAB-1746/ (RNA-sequencing; differential expression).,OADS,/arxiv_data1/oa_pdf/44/ae/main.PMC4554290.pdf
Tissue was mechanically homogenised using a motor operat- ed pestle and mortar system in appropriate extraction buffer and total http://dx.doi.org/10.1016/j.gdata.2014.03.003 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/ae/main.PMC4554290.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/ae/main.PMC4554290.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/44/ae/main.PMC4554290.pdf
The Tophat aligner ( http://tophat.cbcb.umd.edu/ ) was used to align the reads to the mouse reference genome (mm9).,OADS,/arxiv_data1/oa_pdf/44/ae/main.PMC4554290.pdf
V .T h i si sa no p e na c c e s sa r t i c l eu n d e rt h eC CB Y - N C - N Dl i c e n s e (http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/d4/main.PMC4554294.pdf
The catalytic reaction pathway of sucrose phosphorylase is identical to those of other sucrose-converting enzymes in familyContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2015.04.001 2405-5808/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/d4/main.PMC4554294.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: αGlc 1- P,α-D-glucose 1-phosphate; SPase, sucrose phosphorylase; LmSPase, SPase from Leuconostoc mesenteroides nCorresponding author at: Institute of Biotechnology and Biochemical Engineering, Graz University of Technology, NAWI Graz, Petersgasse 12, A-8010 Graz, Austria.Tel.",Non-OADS,/arxiv_data1/oa_pdf/ac/d4/main.PMC4554294.pdf
3D coordinates of the ligand were generated from SMILES strings using Chimera ( http://www.cgl.ucsf.edu/chimera ).,OADS,/arxiv_data1/oa_pdf/ac/d4/main.PMC4554294.pdf
PyMOL ( http://pymol.sourceforge.net ) was used for visualization.,OADS,/arxiv_data1/oa_pdf/ac/d4/main.PMC4554294.pdf
Supporting information Supporting data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.2015.04.001 .,OADS,/arxiv_data1/oa_pdf/ac/d4/main.PMC4554294.pdf
Appendix B. Transparency document Transparency document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.,Non-OADS,/arxiv_data1/oa_pdf/ac/d4/main.PMC4554294.pdf
This is an open access  article  under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/a6/main.PMC4554296.pdf
http://dx.doi.org/10.1016/j.jcp.2015.07.002 0021-9991/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/a6/main.PMC4554296.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/a6/main.PMC4554296.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/37/main.PMC4554329.pdf
"measured skeletal muscle GLUT4 protein content before, 8 h, and 22 h after a single bout of exercise and were the ﬁrst to report that a single bout of exercise increases human skeletal muscle GLUT4 proteinContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2015.05.002 2405-5808/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/5e/37/main.PMC4554329.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/37/main.PMC4554329.pdf
Appendix A. Transparency document Transparency document associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/main.PMC4554329.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/07/main.PMC4554331.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.05.0052211-3355/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/07/main.PMC4554331.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/07/main.PMC4554331.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/fa/07/main.PMC4554331.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/9f/ijn-10-5423.PMC4554392.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5423–5434International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5423OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9001 4Identification of a cell-penetrating peptide domain  from human beta-defensin 3 and characterization  of its anti-inflammatory activity Jue Yeon lee1,* Jin sook suh2,* Jung Min Kim1 Jeong Hwa Kim1 Hyun Jung Park1 Y oon Jeong Park1,2 Chong Pyoung Chung1 1central research Institute,   Nano Intelligent Biomedical  Engineering Corporation (NIBEC),   Chungcheongbuk-do, Republic  of Korea; 2Dental Regenerative  Biotechnology, Dental Research  Institute, School of Dentistry, Seoul  National University, Seoul, Republic  of Korea *These authors contributed equally  to this workAbstract:  Human beta-defensins (hBDs) are crucial factors of intrinsic immunity that function  in the immunologic response to a variety of invading enveloped viruses, bacteria, and fungi.",Non-OADS,/arxiv_data1/oa_pdf/a7/9f/ijn-10-5423.PMC4554392.pdf
"AMPs are capable of eliminating pathogens, such as bacteria, viruses, and  fungi, by directly binding their membranes to prevent the colonization of host tissues.2  AMPs fall into several categories based on their secondary structural features, namely,  linear α-helix structures, extended structures, loop structures, and β-sheet structures,  such as human defensins.3 Among the known defensins, β-defensins (hBDs) possess Correspondence: Yoon Jeong Park Dental Regenerative Biotechnology,  School of Dentistry, Seoul National  University, 101 Daehak-ro, Jongno-gu,  Seoul 110-749, Republic of Korea Tel +82 2 740 8651 Fax +82 2 744 8732 email parkyj@snu.ac.k r  Chong Pyoung Chung central research Institute, Nano  Intelligent Biomedical Engineering  Corporation (NIBEC), Iwol Electricity- electronic Agro-industrial Complex,  116, Bamdi-gil, Iwol-myeon, Jincheon-gun,  Chungcheongbuk-do 27816, Republic  of Korea Tel +82 43 532 7458 Fax +82 43 537 1714 email ccpperio@snu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lee et al Running head recto: An anti-inflammatory peptide penetrating macrophages DOI: http://dx.doi.org/10.2147/IJN.S90014",Non-OADS,/arxiv_data1/oa_pdf/a7/9f/ijn-10-5423.PMC4554392.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a7/9f/ijn-10-5423.PMC4554392.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/9f/ijn-10-5423.PMC4554392.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-10-129.PMC4554393.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 129–136International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  129OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8828 2Bone dynamics in the upward direction after  a maxillary sinus floor elevation procedure:  serial segmentation using synchrotron radiation  micro-computed tomography Seung-Jun Seo1,* chung Wung Bark2,* Jae-hong lim1 Y ong-gun Kim3 1Industrial Technology convergence  center, Pohang accelerator  laboratory, POSTech, Pohang,   gyeongbuk, 2Department of  electrical engineering, gachon  University, Seongnam, 3Department of  Periodontology, School of Dentistry,   Kyungpook National University,   Daegu, republic of Korea *These authors contributed equally  to this workObjective:  Maxillary sinus floor augmentation has been shown to be the most predictable  surgical technique for enhancing the bone volume in the posterior area of the maxilla.",Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-10-129.PMC4554393.pdf
"To observe and estimate the amount of NB after a surgical treat - ment, hematoxylin–eosin (H&E) photomicrography is one of the most widely used  techniques in histology, because the conventional dye-stained photomicrographs are  exceptionally good for highlighting biological structures, including bulk tissues and correspondence: Yong-gun Kim Department of Periodontology, School  of Dentistry, Kyungpook National  University, 2177 Dalgubeol-daero,  Jung-gu, Daegu 700-412,  republic of Korea Tel +82 53 600 7524 Fax +82 53 427 3263 email periokyg@knu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Seo et al Running head recto: Bone dynamics in the upward direction DOI: http://dx.doi.org/10.2147/IJN.S88282",Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-10-129.PMC4554393.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-10-129.PMC4554393.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/ff/ijn-10-129.PMC4554393.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/ccid-8-455.PMC4554394.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 455–461Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  455RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S8476 5Salicylic acid as a peeling agent: a comprehensive  review Tasleem Arif Postgraduate Department of  Dermatology, STD and Leprosy,   Government Medical College,   Srinagar, Jammu and Kashmir, India Correspondence: Tasleem Arif   Postgraduate Department of  Dermatology, STD and Leprosy,  Government Medical College, Srinagar,  Jammu and Kashmir 190011, India   Tel +91 95 5748 0345   email dr_tasleem_arif@yahoo.co mAbstract:  Salicylic acid has been used to treat various skin disorders for more than  2,000 years.",Non-OADS,/arxiv_data1/oa_pdf/a7/b6/ccid-8-455.PMC4554394.pdf
Or use: http://youtu.be/mH7WxyJn4d Q,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/ccid-8-455.PMC4554394.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/a7/b6/ccid-8-455.PMC4554394.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/b6/ccid-8-455.PMC4554394.pdf
"Available from: http://www.skininc.com/skinscience/physiol - ogy/10764816.htm l. Accessed January 7,  2014.",Non-OADS,/arxiv_data1/oa_pdf/a7/b6/ccid-8-455.PMC4554394.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/bf/ijn-10-5397.PMC4554395.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5397–5405International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5397OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8647 4Modification of paclitaxel-loaded solid lipid  nanoparticles with 2-hydroxypropyl- β-cyclodextrin  enhances absorption and reduces nephrotoxicity  associated with intravenous injection Jong-Suep Baek* Ju-Heon Kim* Jeong-Sook Park Cheong-Weon Cho College of Pharmacy and Institute  of Drug research and Development,   Chungnam National University,   Daejeon, South Korea *These authors contributed equally  to this workBackground:  Paclitaxel (PTX) solid lipid nanoparticles (SLNs) modified with 2-hydroxypropyl- β-cyclodextrin (HPCD) were evaluated for their ability to enhance PTX absorption and reduce  the nephrotoxicity accompanying intravenous administration.",Non-OADS,/arxiv_data1/oa_pdf/25/bf/ijn-10-5397.PMC4554395.pdf
"SLNs have several advantages, including high biocompatibility, high bioavailability,  and controlled release.13–18Correspondence: Cheong-Weon Cho College of Pharmacy, Chungnam National  University, 220 Gung-dong, Yuseong-gu,  Daejeon 305 764, South Korea Tel +82 42 821 5934 Fax +82 42 823 6566 email chocw@cnu.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Baek et al Running head recto: PTX formulation for enhancing bioavailability and reducing nephrotoxicity DOI: http://dx.doi.org/10.2147/IJN.S86474",Non-OADS,/arxiv_data1/oa_pdf/25/bf/ijn-10-5397.PMC4554395.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/25/bf/ijn-10-5397.PMC4554395.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/bf/ijn-10-5397.PMC4554395.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/d9/ijn-10-5301.PMC4554396.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5301–5308International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5301OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8694 7The effect of aspirin nanoemulsion on TNF α   and iNOs in gastric tissue in comparison with  conventional aspirin Fatma abd elhalim  Mahmoud1,2 Khalid s hashem3 asmaa Mohammed M  hussein elkelawy2 1Medical Pharmacology Department,   Faculty of Medicine, cairo University,   giza, 2clinical Pharmacology  Department, Faculty of Medicine,   3Biochemistry Department, Faculty  of Veterinary Medicine, Beni-suef  University, Beni-suef, egyptBackground:  No dose of aspirin is free of bleeding risk.",Non-OADS,/arxiv_data1/oa_pdf/c9/d9/ijn-10-5301.PMC4554396.pdf
email khalid_hashem@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mahmoud et al Running head recto: Aspirin NE effect on gastric TNF α and iNOS DOI: http://dx.doi.org/10.2147/IJN.S86947,Non-OADS,/arxiv_data1/oa_pdf/c9/d9/ijn-10-5301.PMC4554396.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c9/d9/ijn-10-5301.PMC4554396.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/d9/ijn-10-5301.PMC4554396.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/e5/ijn-10-5263.PMC4554397.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5263–5271International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5263OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8836 3cationic Plga/eudragit rl nanoparticles for  increasing retention time in synovial cavity after  intra-articular injection in knee joint sung rae Kim1 Myoung Jin ho2 eugene lee3 Joon Woo lee3 Y oung Wook choi1 Myung Joo Kang2 1college of Pharmacy, chung- ang  University, Dongjak-gu, seoul, 2college  of Pharmacy, Dankook University,   Dongnam-gu, cheonan, chungnam,   3Department of radiology, seoul  National University Bundang hospital,   Bundang-gu, seongnam, gyeonggi-do,   south KoreaAbstract:  Positively surface-charged poly(lactide- co-glycolide) (PLGA)/Eudragit RL  nanoparticles (NPs) were designed to increase retention time and sustain release profile in  joints after intra-articular injection, by forming micrometer-sized electrostatic aggregates with  hyaluronic acid, an endogenous anionic polysaccharide found in high amounts in synovial fluid.",Non-OADS,/arxiv_data1/oa_pdf/2d/e5/ijn-10-5263.PMC4554397.pdf
"The various polymers that have been explored include poly(lactide),  poly(lactide- co-glycolide) (PLGA), albumin, and chitosan.8–12 However, NPs smaller correspondence: Young Wook choi college of Pharmacy, chung-ang  University, 221 heuksuk-dong,  Dongjak-gu, seoul 156-756, south Korea Tel +82 2 820 5609 Fax +82 2 826 3781 email ywchoi@cau.ac.k r  Myung Joo Kang college of Pharmacy, Dankook  University, 119 Dandae-ro, Dongnam-gu,  cheonan, chungnam 330-714,  south Korea Tel +82 41 550 1446 Fax +82 41 550 7899 email kangmj@dankook.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Kim et al Running head recto: Cationic nanoparticles for prolonged joint retention DOI: http://dx.doi.org/10.2147/IJN.S88363",Non-OADS,/arxiv_data1/oa_pdf/2d/e5/ijn-10-5263.PMC4554397.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2d/e5/ijn-10-5263.PMC4554397.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/e5/ijn-10-5263.PMC4554397.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4639–4647Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4639Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7776 0eliglustat tartrate for the treatment of adults with  type 1 Gaucher disease Lunawati L Bennett Kelsey T urcotte School of Pharmacy, Union University,   Jackson, TN, USAAbstract:  The purpose of this article is to review eliglustat tartrate, a substrate reduction  therapy, for the treatment of Gaucher disease type 1 (GD1).",Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
"These cells are the hallmark of the disease and are found in many organs, Correspondence: Lunawati L Bennett School of Pharmacy, Union University,  1050 Union University Drive, Jackson,  TN 38305, USA Tel +1 731 661 5921 Fax +1 731 661 5980 email llbennett@uu.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Bennett and Turcotte Running head recto: Eliglustat tartrate for type 1 Gaucher disease DOI: http://dx.doi.org/10.2147/DDDT.S77760",Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
"Available  from: http://www.rarediseases.org/rare-disease-information/rare- diseases/byID/12/viewFullRepor t. Accessed June 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
50. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca02f7a4- ae4f-43c1-a06a-259fe4fcf9cf.,Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
51. http://dailymed.nlm.gov/dailymed/lookup.cfm?,Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
55. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=817892d1- ee12-4632-85fc-57ccdf16d7b8.,Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
"Available from:  http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm302549.ht m. Accessed July 12, 2015.",Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
Available from:  http://www.clinicaltrials.gov/ct2/eliglusat.,Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
Available from: http://www.goodrx.com/cerdelga.,Non-OADS,/arxiv_data1/oa_pdf/46/06/dddt-9-4639.PMC4554398.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/11/tcrm-11-1265.PMC4554399.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1265–1271Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1265Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8778 9virus-induced secondary bacterial infection: a   concise review Mohamed A Hendaus1 Fatima A Jomha2 Ahmed H Alhammadi3 1Department of Pediatrics, Academic  General Pediatrics Division, weill- Cornell Medical College, Hamad  Medical Corporation, Doha, Qatar;   2School of Pharmacy, Lebanese  international University, Khiara,   Lebanon; 3Department of Pediatrics,   Academic General Pediatrics Division,   weill-Cornell Medical College, Hamad  Medical Corporation, Doha, QatarAbstract:  Respiratory diseases are a very common source of morbidity and mortality among  children.",Non-OADS,/arxiv_data1/oa_pdf/ef/11/tcrm-11-1265.PMC4554399.pdf
"We then reviewed abstracts and titles and included studies that were Correspondence: Mohamed A Hendaus Department of Pediatrics, Academic  General Pediatrics Division, weill- Cornell Medical College, Hamad Medical  Corporation, Doha, Qatar 3050 Tel +974 4439 2239 Fax +974 4443 9571 email mhendaus@yahoo.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Hendaus et al Running head recto: Virus-induced secondary bacterial infection DOI: http://dx.doi.org/10.2147/TCRM.S87789",Non-OADS,/arxiv_data1/oa_pdf/ef/11/tcrm-11-1265.PMC4554399.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ef/11/tcrm-11-1265.PMC4554399.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/11/tcrm-11-1265.PMC4554399.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/6d/ijn-10-5421.PMC4554400.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 5421International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d4/6d/ijn-10-5421.PMC4554400.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 5421CorrIgeNdumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8713 3Role of lipegfilgrastim in the management of chemotherapy-induced  neutropenia [Corrigendum] Hoggatt J, Tate TA, Pelus LM.",Non-OADS,/arxiv_data1/oa_pdf/d4/6d/ijn-10-5421.PMC4554400.pdf
"Rather, lipegfilgrastim has an active substance that is similar  to filgrastim, with similar pharmacokinetics, receptor binding  affinity, safety and efficacy as pegfilgrastim.Journal name: International Journal of Nanomedicine Article Designation: Corrigendum Y ear: 2015 Volume: 10 Running head verso: Hoggatt et al Running head recto: Role of lipegfilgrastim in the management DOI: http://dx.doi.org/10.2147/IJN.S87133",Non-OADS,/arxiv_data1/oa_pdf/d4/6d/ijn-10-5421.PMC4554400.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/db/ijn-10-5355.PMC4554401.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5355–5366International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5355OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8476 0evolution of availability of curcumin inside   poly-lactic-co-glycolic acid nanoparticles: impact  on antioxidant and antinitrosant properties Didier Betbeder1–4 emmanuelle lipka1,2,5 Mike howsam6 rodolphe carpentier1–3 1U995-lIrIc , Inserm (Institut  National de la recherche Médicale),   lille, France; 2U995- lIrIc, chr U  de lille, lille, France; 3U995-lIrIc ,   Faculté de Médecine, Université  de lille, lille, France; 4Faculté des  sciences du sport, Université d’artois,   arras, France; 5Faculté de Pharmacie,   Université de lille, lille, France;  6Faculté de Pharmacie, Université de  lille, centre Universitaire de Mesures  et d’analyses, lille, FrancePurpose:  Curcumin exhibits antioxidant properties potentially beneficial for human health;  however, its use in clinical applications is limited by its poor solubility and relative instability.",Non-OADS,/arxiv_data1/oa_pdf/72/db/ijn-10-5355.PMC4554401.pdf
"Low  doses of curcumin appeared protective for reactive oxygen species (ROS) induction  or ROS-induced DNA damage, while higher doses were deleterious.4,5correspondence: Didier Betbeder U995-lIrIc, Inserm (Institut National de  la recherche Médicale), Nanomedicine  group, laboratory of Physiology,  Faculty of Medicine henry Warembourg,  research Building, 1 Place de Verdun,  59045 lille cedex, France Tel +33 3 2062 6883 email betbederdidier985@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Betbeder et al Running head recto: Evolution of antioxidant activity of curcumin in PLGA nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S84760",Non-OADS,/arxiv_data1/oa_pdf/72/db/ijn-10-5355.PMC4554401.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/72/db/ijn-10-5355.PMC4554401.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/db/ijn-10-5355.PMC4554401.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/41/ce-10-075.PMC4554402.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCore Evidence 2015:10 75–87Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  75REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S6555 5Palonosetron in the prevention of chemotherapy- induced nausea and vomiting: an evidence-based  review of safety, efficacy, and place in therapy Luigi Celio Monica Niger Francesca Ricchini Francesco Agustoni Medical Oncology Unit 1, Department  of Medical Oncology, Fondazione  iRCCS istituto Nazionale T umori,   Milan, italy Correspondence: Luigi Celio   Medical Oncology Unit 1, Department  of Medical Oncology, Fondazione iRCCS  istituto Nazionale T umori, via venezian 1,  20133 Milan, italy   T el +39 02 2390 2597   Fax +39 02 2390 3678   Email luigi.celio@istitutotumori.mi.i tIntroduction:  The second-generation 5-hydroxytryptamine-3 (5-HT3) receptor antagonist  palonosetron is effective in the prevention of chemotherapy-induced nausea and vomiting  (CINV) associated with highly and moderately emetogenic chemotherapy (HEC and MEC,  respectively).",Non-OADS,/arxiv_data1/oa_pdf/4d/41/ce-10-075.PMC4554402.pdf
"Available from: http://www.fda.gov/Drugs/ DrugSafety/ucm237081.ht m. Accessed on February 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4d/41/ce-10-075.PMC4554402.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm310190.,Non-OADS,/arxiv_data1/oa_pdf/4d/41/ce-10-075.PMC4554402.pdf
Available from: http://dailymed.nlm.nih.gov/dailymed/lookup.,OADS,/arxiv_data1/oa_pdf/4d/41/ce-10-075.PMC4554402.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/4d/41/ce-10-075.PMC4554402.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/41/ce-10-075.PMC4554402.pdf
"Available from: http://nccn.or g.  Accessed January 30, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4d/41/ce-10-075.PMC4554402.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/ba/ijwh-7-783.PMC4554403.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 783–790International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  783OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S9055 6Utilization of maternal health care services in   post-conflict Nepal T ulsi ram Bhandari Prabhakaran sankara sarma Vellappillil raman Kutty achutha Menon centre for Health  science studies, sree chitra Tirunal  Institute for Medical sciences and  T echnology, Trivandrum, Kerala, IndiaBackground:  Despite a decade-long armed conflict in Nepal, the country made progress in  reducing maternal mortality and is on its way to achieve the Millennium Development Goal  Five.",Non-OADS,/arxiv_data1/oa_pdf/a2/ba/ijwh-7-783.PMC4554403.pdf
"Available from: http://nepalpolicynet.com/ images/NewAngle/Vol1/8_Ghimire_Revolutionary%20Rolpa%20 in%20post%20conflict%20context.pd f. Accessed May 10, 2014;  May 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a2/ba/ijwh-7-783.PMC4554403.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a2/ba/ijwh-7-783.PMC4554403.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/ba/ijwh-7-783.PMC4554403.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/6e/ijn-10-137.PMC4554404.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 137–142International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  137OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9027 4Ultrafast sonochemical synthesis of protein- inorganic nanoflowers Bhagwan S Batule1 Ki Soo Park1 Moon Il Kim2 hyun gyu Park1 1Department of chemical and  Biomolecular engineering (BK21 +  Program), Korea advanced Institute  of Science and T echnology (K aIST),   Daejeon, 2Department of BioNano  T echnology, gachon University,   Seongnam, republic of KoreaAbstract:  We developed a simple but efficient method to synthesize protein-inorganic hybrid  nanostructures with a flower-like shape (nanoflowers), which relies on sonication to facilitate  the synthesis of the nanoflowers.",Non-OADS,/arxiv_data1/oa_pdf/b0/6e/ijn-10-137.PMC4554404.pdf
"The nanoflowers made from laccase and copper  phosphate were also successfully applied to detect phenol in an aqueous solution with  the enhanced activity and stability.14 Furthermore, several groups have utilized enzyme- inorganic hybrid nanoflowers for different applications such as detection of hydrogen  peroxide,15 glucose,16 and protein digestion.17 Although the enzyme-inorganic hybrid  nanoflowers resulted in greatly enhanced activity and stability, their synthesis was so slow  that they had to be incubated in the reaction mixture for up to 3 days at room temperature correspondence: hyun gyu Park Department of chemical and  Biomolecular engineering (BK21 +  Program), KaIST, 291 Daehak-ro,  Yuseong-gu, Daejeon 305-701, republic  of Korea Tel +82 42 350 3932 Fax +82 42 350 3910 email hgpark@kaist.ac.k r  Moon Il Kim Department of BioNanoTechnology,  gachon University, 1342 Seongnamdae-ro,  Sujeong-gu, Seongnam, gyeonggi 461-701,  republic of Korea Tel +82 31 750 8563 Fax +82 31 750 8774 email moonil@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Batule et al Running head recto: Ultrafast sonochemical synthesis of protein-inorganic nanoflowers DOI: http://dx.doi.org/10.2147/IJN.S90274",Non-OADS,/arxiv_data1/oa_pdf/b0/6e/ijn-10-137.PMC4554404.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b0/6e/ijn-10-137.PMC4554404.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/6e/ijn-10-137.PMC4554404.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/1d/ijn-10-5327.PMC4554405.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5327–5342International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5327OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8447 8Dual actions of albumin packaging and tumor  targeting enhance the antitumor efficacy and  reduce the cardiotoxicity of doxorubicin in vivo Ke Zheng1 rui li2 Xiaolei Zhou2 Ping hu2 Yaxin Zhang2 Yunmei huang3 Zhuo chen2 Mingdong huang2 1College of Chemistry, Fuzhou  University, Fuzhou, People’s Republic  of china; 2State Key Laboratory of  Structural Chemistry, Fujian Institute  of research on the structure of  Matter, Chinese Academy of Sciences,   Fuzhou, People’s Republic of China;   3Fujian Academy of Integrative  Medicine, Fujian University of  Traditional Chinese Medicine, Fuzhou,   People’s Republic of ChinaAbstract:  Doxorubicin (DOX) is an effective chemotherapy drug used to treat different types  of cancers.",Non-OADS,/arxiv_data1/oa_pdf/2e/1d/ijn-10-5327.PMC4554405.pdf
"Epirubicin (4 ′-hydroxyl derivative of doxorubicin, Farmorubicin®)7  and pirarubicin (4 ′-tetrahydropyranyl-doxorubicin, Theprubicin®)1 have been correspondence: Mingdong huang;   Zhuo chen State Key Laboratory of Structural  Chemistry, Fujian Institute of Research  on the Structure of Matter, Chinese  Academy of Sciences, 155 Yangqiao Road  West, Fuzhou, 350002, People’s Republic  of china Tel +86 591 6317 3094 email mhuang@fjirsm.ac.c n;   zchen@fjirsm.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zheng et al Running head recto: Albumin packaging and tumor targeting of DOX to reduce cardiotoxicity DOI: http://dx.doi.org/10.2147/IJN.S84478",Non-OADS,/arxiv_data1/oa_pdf/2e/1d/ijn-10-5327.PMC4554405.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2e/1d/ijn-10-5327.PMC4554405.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/1d/ijn-10-5327.PMC4554405.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b2/eb/dddt-9-4909.PMC4554406.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4909–4915Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4909Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5600 4Profile of omalizumab in the treatment of chronic  spontaneous urticaria Moises Labrador-Horrillo1 Marta Ferrer2 1Allergy Section, internal Medicine  Department, Vall d’Hebron Hospital,   Universitat Autònoma de Barcelona,   Barcelona, 2Department of Allergy  and Clinical immunology, Clínica  Universidad de Navarra, iDiSNA,   instituto de investigación de Navarra,   Pamplona, SpainAbstract:  Chronic spontaneous urticaria (CSU) is a disease with significant morbidity and  relative prevalence that has important effects on the quality of life (QoL) of those who suffer  from it.",Non-OADS,/arxiv_data1/oa_pdf/b2/eb/dddt-9-4909.PMC4554406.pdf
"The joint initiative of the Dermatology Section of the European Academy of  Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the  Global Allergy and Asthma European Network (GA2LEN), the European Dermatology  Forum (EDF), and the World Allergy Organization (WAO) in the EAACI/GA2LEN/ EDF/WAO guideline published in 2014, as well as the British Society for Allergy  and Clinical Immunology (BSACI) guideline for the management of CU prefers the  use of the term CSU because it implies an underlying endogenous cause.1,2 The Joint  Task Force on Practice Parameters (JTFPP), representing the  American Academy Correspondence: Moises Labrador- Horrillo Allergy Section, internal Medicine  Department, Vall d’Hebron Hospital,  Passeig Vall d’Hebron, 119-129, 08035  Barcelona, Spain Tel/fax +34 93 274 6169 email mlabrador@vhebron.ne tJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Labrador-Horrillo and Ferrer Running head recto: Omalizumab in CSU DOI: http://dx.doi.org/10.2147/DDDT.S56004",Non-OADS,/arxiv_data1/oa_pdf/b2/eb/dddt-9-4909.PMC4554406.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/   2014/103976s5211lbl.pd f  17.,Non-OADS,/arxiv_data1/oa_pdf/b2/eb/dddt-9-4909.PMC4554406.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b2/eb/dddt-9-4909.PMC4554406.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/eb/dddt-9-4909.PMC4554406.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/c7/copd-10-1685.PMC4554407.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1685–1694International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1685OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8725 9Distribution of body mass index among subjects  with COPD in the Middle east and north africa  region: data from the Brea The study Marie-louise Koniski1 hocine salhi2 aïcha lahlou3 nauman rashid4 abdelkader el hasnaoui4 1respiratory Division, lebanese  american University Medical Center –   rizk hospital, Beirut, lebanon;   2Foxymed, Paris, France; 3Ms health,   rabat, Morocco; 4glaxo smithKline,   Dubai, United arab emiratesBackground:  Data describing the potential relationship between chronic obstructive pulmo - nary disease (COPD) and body mass index (BMI) are limited within the Middle East and North  Africa (MENA) region.",Non-OADS,/arxiv_data1/oa_pdf/fe/c7/copd-10-1685.PMC4554407.pdf
"Box 11-3288, Beirut, lebanon Tel +961 3 279 030 Fax +961 1 203 324 email marielouise.coussa@umcrh.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Koniski et al Running head recto: BMI and COPD in the Middle East and Africa region DOI: http://dx.doi.org/10.2147/COPD.S87259",Non-OADS,/arxiv_data1/oa_pdf/fe/c7/copd-10-1685.PMC4554407.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fe/c7/copd-10-1685.PMC4554407.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/c7/copd-10-1685.PMC4554407.pdf
Available  from: http://www.idf.org/diabetesatlas.,Non-OADS,/arxiv_data1/oa_pdf/fe/c7/copd-10-1685.PMC4554407.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/07/ijn-10-5343.PMC4554408.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5343–5353International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5343OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8877 4Polyethyleneimine-functionalized boron nitride  nanospheres as efficient carriers for enhancing  the immunostimulatory effect of cpg  oligodeoxynucleotides Huijie Zhang1 Shini Feng1 Ting Yan1 chunyi Zhi2 Xiao-Dong Gao1 Nobutaka Hanagata3,4 1The Key laboratory of carbohydrate  Chemistry and Biotechnology,   Ministry of education, school of  Biotechnology, Jiangnan University,   Wuxi, People’s republic of china;   2Department of Physics and Materials  Science, City University of Hong Kong,   Kowlong, Hong Kong SAR, People’s  republic of china; 3Biomaterials Unit,   International center for Materials  Nanoarchitectonics, National Institute  for Materials science, Ibaraki, Japan;   4Nanotechnology Innovation Station,   National Institute for Materials  science, Ibaraki, JapanAbstract:  CpG oligodeoxynucleotides (ODNs) stimulate innate and adaptive immune responses.",Non-OADS,/arxiv_data1/oa_pdf/93/07/ijn-10-5343.PMC4554408.pdf
"Therefore, BNNS–PEI complexes can be used to enhance the immunostimulatory  effect and therapeutic activity of CpG ODNs and the treatment of diseases requiring interleukin-6,  tumor necrosis factor- α, and interferon- α. Keywords:  CpG oligodeoxynucleotide, boron nitride nanosphere, polyethyleneimine, immu - nostimulatory effect, cytokine Introduction Bacterial DNA exerts immunostimulatory effects by activating the host defense system  and inducing innate and adaptive immune responses.1–4 Unmethylated CpG motif is  the specific sequence present in bacterial DNA that is responsible for the aforemen - tioned effects.1,5 Similar to bacterial DNA, synthetic oligodeoxynucleotides (ODNs)  containing unmethylated CpG motifs exhibit immunostimulatory effects.1,6 CpG ODNs  uptaken by immune cells bind to intracellular Toll-like receptor 9 (TLR-9), a pattern- recognition receptor located mainly in the endolysosomes of B cells and plasmacytoid  dendritic cells.2,3,7 The binding process initiates an immunostimulatory cascade that  induces the maturation, differentiation, and proliferation of multiple immune cells,  such as B and T lymphocytes, natural killer cells, and monocytes/macrophages.8,9 This  mechanism further triggers cell signaling pathways, such as mitogen-activated protein  kinases and NF κB, which induce multiple proinflammatory cytokines and chemokines Correspondence: Huijie Zhang The Key laboratory of carbohydrate  Chemistry and Biotechnology,  Ministry of education, school of  Biotechnology, Jiangnan University,  No 1800 lihu avenue, Wuxi 214122,  People’s republic of china Tel +86 510 8519 7071 Fax +86 510 8519 7071 email zhj0502@jiangnan.edu.c n  Nobutaka Hanagata Nanotechnology Innovation Station,  National Institute for Materials science,  1-2-1 Sengen, Tsukuba, Ibaraki 305-0047,  Japan Tel +81 29 860 4774 Fax +81 29 859 2475 email hanagata.nobutaka@nims.go.j p Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhang et al Running head recto: PEI-functionalized BNNS as efficient carriers DOI: http://dx.doi.org/10.2147/IJN.S88774",Non-OADS,/arxiv_data1/oa_pdf/93/07/ijn-10-5343.PMC4554408.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/93/07/ijn-10-5343.PMC4554408.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/07/ijn-10-5343.PMC4554408.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/7b/dmso-8-399.PMC4554409.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 399–407Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  399Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8763 5Kinin B1 and B2 receptor deficiency protects  against obesity induced by a high-fat diet and  improves glucose tolerance in mice rafael l Morais1 elton D Silva1 Vicência M Sales1 rafael Filippelli-Silva1 Marcelo a Mori1 Michael Bader2 João B Pesquero1 1Department of Biophysics,   Universidade Federal de São Paulo,   São Paulo, Brazil; 2Max-Delbrück  center for Molecular Medicine, Berlin,   germany correspondence: João B Pesquero   Department of Biophysics,   Universidade Federal de São Paulo, Pedro  de Toledo, 669 - 9th floor,   Vila clementino 04039-034,   São Paulo, SP, Brazil   Tel +55 11 5576 4848 ext 1214   email jbpesquero@gmail.co mAbstract:  The kallikrein-kinin system is well known for its role in pain and  inflammation, and  has been shown recently by our group to have a role also in the regulation of energy  expenditure.",Non-OADS,/arxiv_data1/oa_pdf/8e/7b/dmso-8-399.PMC4554409.pdf
Available from: http://www.who.int/gho/ncd/risk_factors/ obesity_text/en /.,Non-OADS,/arxiv_data1/oa_pdf/8e/7b/dmso-8-399.PMC4554409.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/8e/7b/dmso-8-399.PMC4554409.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/7b/dmso-8-399.PMC4554409.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/09/ijn-10-5309.PMC4554410.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5309–5325International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5309OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8523 0effects of X-shaped reduction-sensitive  amphiphilic block copolymer on drug delivery haijun Xiao lu Wang state Key laboratory of Quality  research in chinese Medicine,   Institute of chinese Medical sciences,   University of Macau, Macau, People’s  republic of chinaAbstract:  To study the effects of X-shaped amphiphilic block copolymers on delivery of  docetaxel (DTX) and the reduction-sensitive property on drug release, a novel reduction-sensitive  amphiphilic copolymer, (PLGA)2-SS-4-arm-PEG2000 with a Gemini-like X-shape, was success - fully synthesized.",Non-OADS,/arxiv_data1/oa_pdf/29/09/ijn-10-5309.PMC4554410.pdf
"Even though these polymers show good biocompatibility, the sustained correspondence: haijun Xiao University of Macau, avenida da  Universidade, Taipa, Macau 99907,  People’s republic of china email navyshaw@yahoo.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Xiao and Wang Running head recto: X-shaped polymer, reduction sensitivity and drug delivery DOI: http://dx.doi.org/10.2147/IJN.S85230",Non-OADS,/arxiv_data1/oa_pdf/29/09/ijn-10-5309.PMC4554410.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/29/09/ijn-10-5309.PMC4554410.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/09/ijn-10-5309.PMC4554410.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/33/ijn-10-025.PMC4554411.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 25–32International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  25OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8828 6Optical birefringence of liquid crystals for label- free optical biosensing diagnosis Tan Tai Nguyen1 gyeo-re han2 chang-hyun Jang1,2 heongkyu Ju1,3,4 1Department of Bionano T echnology,   2Department of Nano-chemistry,   3Department of Nano-Physics,   gachon University, Seongnam-city,   4Neuroscience Institute, gil hospital,   Incheon, South KoreaPurpose:  We present a polarization-sensitive optical detection platform for label-free  quantitative optical biosensing diagnosis using liquid crystals (LCs).",Non-OADS,/arxiv_data1/oa_pdf/05/33/ijn-10-025.PMC4554411.pdf
"This optical cell was then sandwiched between two orthogonal polarizers  (the so-called source polarizer and an analyzer) for optical birefringence analysis, as  shown in Figure 1.correspondence: heongkyu Ju;   chang-hyun Jang Department of Nano-Physics, gachon  University, Seongnam-city 461-701,  South Korea Tel +82 31 750 8552; +82 31 750 8555 Fax +82 31 750 8552; +82 31 750 8774 email batu@gachon.ac.k r;   chjang4u@gachon.ac.k rJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Nguyen et al Running head recto: Optical birefringence-based biosensor technique using liquid crystals DOI: http://dx.doi.org/10.2147/IJN.S88286",Non-OADS,/arxiv_data1/oa_pdf/05/33/ijn-10-025.PMC4554411.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/05/33/ijn-10-025.PMC4554411.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/33/ijn-10-025.PMC4554411.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/24/ijn-10-143.PMC4554412.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 143–153International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  143OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8828 7anticancer activities of self-assembled molecular  bowls containing a phenanthrene-based donor  and ru(II) acceptors Inhye Kim1,* Y oung ho Song2,* Nem Singh2 Y ong Joon Jeong3 Jung eun Kwon3 hyunuk Kim4 Y oung Mi cho3 Se chan Kang3 Ki-Whan chi2 1laboratory of Bio-resources,   Y ongin-si, gyeonggi-Do, 2Department  of chemistry, University of Ulsan,   Ulsan, 3Department of life Science,   gachon University, Seongnam, 4energy  Materials lab, Korea Institute of  energy research, Daejeon, republic  of Korea *These authors contributed equally  to this workAbstract:  Nano-sized multinuclear ruthenium complexes have rapidly emerged as promising  therapeutic candidates with unique anticancer activities.",Non-OADS,/arxiv_data1/oa_pdf/3d/24/ijn-10-143.PMC4554412.pdf
"Keywords:  phenanthrene, ruthenium, coordination self-assembly, gastric cancer, Akt/mTOR Introduction Research on nano-sized Ru(II)-based self-assembled architectures as anticancer com - pounds has increased rapidly following successful assessments of Ru-based small  molecules as treatments for metastatic solid tumors in clinical trials.1–6 Thus, a growing  number of Ru(II)-based, self-assembled large two-dimensional and three-dimensional  architectures have been developed which have shown promising results in human cancer  cell lines as antitumor agents.7–14 Therrien and others exploited the self-assembly approach  to design finite, nano-sized molecular architectures by combining organometallic half- sandwich acceptor clips and pyridyl-based donors.15–18 Nanostructures based on half- sandwich arene–ruthenium complexes are promising candidates for cancer treatments, as  they possess advantageous features such as low toxicity and a balance of hydrophilicity correspondence: Ki-Whan chi Department of chemistry, University of  Ulsan, Ulsan 680-749, republic of Korea Tel +82 52 259 2344 Fax +82 52 259 2348 email kwchi@ulsan.ac.k r  Se chan Kang Department of life Science,  gachon University, Seongnam 461-701,  republic of Korea Tel +82 31 750 8826 Fax +82 31 750 8984 email sckang73@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Kim et al Running head recto: Anticancer potency of self-assembled metalla-bowls DOI: http://dx.doi.org/10.2147/IJN.S88287",Non-OADS,/arxiv_data1/oa_pdf/3d/24/ijn-10-143.PMC4554412.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3d/24/ijn-10-143.PMC4554412.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/24/ijn-10-143.PMC4554412.pdf
"It has been shown that Chlamydia pneu - moniae  promotes experimental choroidal neovascularization Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > Received 10 March 2015 | Accepted 29 August 2015 | Published 31 August 2015© 2015 Molecular Vision 1000Gene expression regulation in retinal pigment epithelial cells  induced by viral RNA and viral/bacterial DNA Anton Brosig,1 Heidrun Kuhrt,2 Peter Wiedemann,1 Leon Kohen,1,3 Andreas Bringmann,1 Margrit Hollborn1 1Department of Ophthalmology and Eye Hospital, University of Leipzig, Leipzig, Germany; 2Paul Flechsig Institute of Brain  Research, University of Leipzig, Leipzig, Germany; 3Helios Klinikum Aue, Aue, Germany Purpose:  The pathogenesis of age-related macular degeneration (AMD) is associated with systemic and local inflam - mation.",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1001via the activation of TLR2 in the RPE [ 26].,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1002Table  1.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1003amplification in a final volume of 20 µl.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1004transcription factor genes (Figure 3A).,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
"Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1005factor genes in RPE cells, including HIF-1α (viral RNA), p65/ NF-κB (RNA and DNA), and NFAT5 (RNA and DNA).",OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
"Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1006of interleukin (IL)-1β, IL-6, TNFα, monocyte chemoattrac - tant protein (MCP)-1, and macrophage inflammatory protein  (MIP)-2.",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
"Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1007to the CFB gene than to the other complement factor genes  investigated (Figure 6B,C).",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  100820 min of stimulation (Figure 7).,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
"Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1009the following genes: TLR3 (Figure 8A), bFGF (Figure 8B),  TNFα (Figure 8C), and CFB (Figure 8E).",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1010and CFB (Figure 9F) genes.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1011 Figure 8.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
"Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1012DISCUSSION AMD is associated with systemic and local inflammation,  macrophage activation, and other immunological abnormali - ties, such as subretinal deposition of activated complement  proteins [ 1,4-7].",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
"Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1013production of inflammatory factors in RPE cells, while the  activation of TLR9 (which recognizes unmethylated CpG  dinucleotides in viral and bacterial DNA) has limited effects  [25].",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
"Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  1014gene expression of RPE cells, which may aggravate retinal  inflammation (Figure 10).",Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  101510.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
Molecular Vision  2015; 21:1000-1016 <http://www.molvis.org/molvis/v 21/1000 > © 2015 Molecular Vision  101632.,Non-OADS,/arxiv_data1/oa_pdf/c2/9c/mv-v21-1000.PMC4554413.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/d6/ijn-10-5383.PMC4554414.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5383–5396International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5383OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8797 8spray-dried powders enhance vaginal sirNa  delivery by potentially modulating the mucus  molecular sieve structure Na Wu1,2,* Xinxin Zhang2,* Feifei li2 Tao Zhang2 Y ong gan2 Juan li1 1school of Pharmacy, china  Pharmaceutical University, Nanjing,   People’s republic of china; 2shanghai  Institute of Materia Medica, chinese  academy of sciences, shanghai,   People’s republic of china *These authors contributed equally  to this workAbstract:  Vaginal small interfering RNA (siRNA) delivery provides a promising strategy for  the prevention and treatment of vaginal diseases.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/ijn-10-5383.PMC4554414.pdf
"The interactions correspondence: Yong gan shanghai Institute of Materia Medica,  chinese academy of sciences, 501 haike  road, shanghai 201203, People’s republic  of china Tel +86 21 2023 1000 ext 1424 Fax +86 21 2023 1000 ext 1425 email simm2122@vip.sina.co m  Juan li school of Pharmacy, china  Pharmaceutical University,  24 Tongjiaxiang, Nanjing 210009,  People’s republic of china Tel +86 25 8327 1287 Fax +86 25 8327 1766 email lijuancpu@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wu et al Running head recto: Enhanced vaginal siRNA delivery by spray-dried powders DOI: http://dx.doi.org/10.2147/IJN.S87978",Non-OADS,/arxiv_data1/oa_pdf/16/d6/ijn-10-5383.PMC4554414.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/ijn-10-5383.PMC4554414.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/d6/ijn-10-5383.PMC4554414.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/c7/amep-6-525.PMC4554415.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 525–532Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  525OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S8858 0stress and burnout in residents: impact of  mindfulness-based resilience training Brian E goldhagen1  Karen Kingsolver2 sandra s stinnett1 Jullia A rosdahl1 1Department of Ophthalmology,   2Department of Family and  community Medicine, Duke  University Medical center, Durham,   nc, UsA correspondence: Jullia A rosdahl   Duke Eye center, Duke University  Medical center 2351 Erwin road, DUMc  3802, Durham, nc 27710, UsA   T el +1 919 684 8850   Fax +1 919 681 8267   Email jullia.rosdahl@duke.ed uBackground and objective:  Stress and burnout impact resident physicians.",Non-OADS,/arxiv_data1/oa_pdf/b4/c7/amep-6-525.PMC4554415.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/b4/c7/amep-6-525.PMC4554415.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/c7/amep-6-525.PMC4554415.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/95/ijn-10-093.PMC4554416.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 93–99International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  93OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8837 8Measurement of creatinine in human plasma  using a functional porous polymer structure  sensing motif Sitansu Sekhar Nanda1 Seong Soo a an1 Dong Kee Yi2,3 1Department of Bionanotechnology,   gachon Medical research Institute,   gachon University, Seongnam,   2Department of chemistry,   3Department of environmental  engineering, Myongji University,   Y ongin, South KoreaAbstract:  In this study, a new method for detecting creatinine was developed.",Non-OADS,/arxiv_data1/oa_pdf/29/95/ijn-10-093.PMC4554416.pdf
"These methods are based on using either Jaffe’s  reaction5 or the enzymatic colorimetric method.6 However, numerous metabolites  and drugs in the sample can also interfere with these methods.7 Also, a long waiting  period for the results can be a problem for the efficient treatments.8 Moreover, meth - ods, such as Jaffe’s reaction, are not selective for creatinine and can detect a wide  range of biomolecules, such as sugar, urea, uric acid, pyruvate, and dopamine.6 Other  available methods, such as ion-sensitive field effect transistor creatinine sensors9–13 correspondence: Seong Soo a an Department of Bionanotechnology,  gachon Medical research Institute,  gachon University, Seongnam 461-701,  South Korea Tel +82 31 750 8755 email seongaan@gachon.ac.k r  Dong Kee Yi Department of chemistry, Myongji  University, Yongin 449-728, South Korea Tel +82 31 330 6178 email vitalis@mju.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Nanda et al Running head recto: Measurement of creatinine in human plasma DOI: http://dx.doi.org/10.2147/IJN.S88378",Non-OADS,/arxiv_data1/oa_pdf/29/95/ijn-10-093.PMC4554416.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/29/95/ijn-10-093.PMC4554416.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/95/ijn-10-093.PMC4554416.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/ijn-10-5293.PMC4554417.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5293–5299International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5293OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8300 7Increased NIH 3T3 fibroblast functions on cell  culture dishes which mimic the nanometer  fibers of natural tissues garima Bhardwaj1 Thomas J Webster1,2 1Department of chemical engineering,   Northeastern University, Boston,   Ma, Usa; 2center of excellence  for advanced Materials research,   King Abdulaziz University, Jeddah,   Saudi ArabiaAbstract:  Traditional flat tissue cell culture dishes have consisted of polystyrene treated  with plasma gases for growing, subculturing, and studying cell behavior in vitro.",Non-OADS,/arxiv_data1/oa_pdf/9e/36/ijn-10-5293.PMC4554417.pdf
"Conventional  tissue culture is carried out on 2D surfaces without scope for cells to adopt natural  morphologies or to communicate efficiently with their neighbors.1 It has been shown  using alternative cell culture applications that the growth and function of cells as  multicellular 3D structures is significantly different to their growth as conventional  2D monolayer cultures.2 This 2D confinement is far removed from the aforemen - tioned 3D complexities of living tissue.3 Although there are a variety of technologies Correspondence: Thomas J Webster Department of chemical engineering,  Northeastern University, 360 huntington  ave, Boston, Ma 02115 Usa email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Bhardwaj and Webster Running head recto: Increased NIH 3T3 fibroblast functions on XanoMatrix surfaces DOI: http://dx.doi.org/10.2147/IJN.S83007",Non-OADS,/arxiv_data1/oa_pdf/9e/36/ijn-10-5293.PMC4554417.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9e/36/ijn-10-5293.PMC4554417.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/36/ijn-10-5293.PMC4554417.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/9e/ijn-10-5273.PMC4554418.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5273–5292International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5273OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8805 2Small molecule PZL318: forming fluorescent  nanoparticles capable of tracing their interactions  with cancer cells and activated platelets, slowing  tumor growth and inhibiting thrombosis shan li,1 Yuji Wang,1  Feng Wang,1 Yaonan Wang,1  Xiaoyi Zhang,1 Ming Zhao,1,2  Qiqi Feng,1 Jianhui Wu,1  shurui Zhao,1 Wei Wu,3  shiqi Peng1 1Beijing area Major laboratory of  Peptide and small Molecular Drugs,   Beijing laboratory of Biomedical  Materials, engineering research  center of endogenous Prophylactic  of Ministry of education of china,   college of Pharmaceutical sciences  of capital Medical University,   Beijing, People’s republic of china;   2Department of Biomedical science  and environmental Biology, Kaohsiung  Medical University, Kaohsiung, Taiwan;   3college of Basic Medicine of capital  Medical University, Beijing, People’s  republic of chinaAbstract:  Low selectivity of chemotherapy correlates with poor outcomes of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4c/9e/ijn-10-5273.PMC4554418.pdf
"β-carbolines are indole alkaloids that interact with DNA,8–12 and induce crossing- over and conversion of mitotic genes.13 Other effects on cells and organs include  modulating the extrinsic or death receptor pathway and the intrinsic or mitochondrial  pathway,14 interfering with Ras-related signaling pathways,15 inhibiting tumor-related  enzymes,16–19 and limiting thrombosis and inflammation.20–22 Inflammation is a well- recognized and critical component of the tumor progression,23,24 and thromboembolism  is a leading cause of cancer patient death.25,26 In contrast to other indole alkaloids  targeting DNA, β-carboline-3-carboxilic acid exhibits lower toxicity.27correspondence: shiqi Peng  college of Pharmaceutical sciences  of capital Medical University, No 10  Xitoutiao, Youanmenwai, Beijing 100069,  the People’s republic of china Tel +86 10 8391 1528 Fax +86 10 8391 1528 email sqpeng@bjmu.edu.c n  Ming Zhao Tel +86 10 8391 1535 Fax +86 10 8391 1535 email mingzhao@bjmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Li et al Running head recto: Small molecule PZL318 DOI: http://dx.doi.org/10.2147/IJN.S88052",Non-OADS,/arxiv_data1/oa_pdf/4c/9e/ijn-10-5273.PMC4554418.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4c/9e/ijn-10-5273.PMC4554418.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/9e/ijn-10-5273.PMC4554418.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/61/ijn-10-033.PMC4554419.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 33–45International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  33OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8830 7lipid-coated gold nanocomposites for enhanced  cancer therapy Ji hee Kang Y oung Tag Ko college of Pharmacy, gachon  University, Incheon, republic of KoreaAbstract:  The aim of the work reported here was to develop lipid-coated multifunctional nano - composites composed of drugs and nanoparticles for use in cancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/56/61/ijn-10-033.PMC4554419.pdf
"Active and passive targeting of liposomes are  extensively utilized for the enhanced permeability and retention (EPR) effect and  ligand conjugation.3–5 Thermosensitive liposomes are commonly used as drug carriers, correspondence: Young Tag Ko college of Pharmacy, gachon University,  191 hambakmoero, Yeonsu-gu, Incheon  406-799, republic of Korea Tel +82 32 899 6417 Fax +82 32 820 4829 email youngtakko@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Kang and Ko Running head recto: Lipid-coated gold nanocomposites for enhanced cancer therapy DOI: http://dx.doi.org/10.2147/IJN.S88307",Non-OADS,/arxiv_data1/oa_pdf/56/61/ijn-10-033.PMC4554419.pdf
Available  from: http://ofmpub.epa.gov/eims/eimscomm.getfile?p_download_ id=490825.,OADS,/arxiv_data1/oa_pdf/56/61/ijn-10-033.PMC4554419.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/56/61/ijn-10-033.PMC4554419.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/61/ijn-10-033.PMC4554419.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/b1/ijn-10-047.PMC4554420.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 47–54International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  47OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8830 8The characteristic agcoreaushell nanoparticles as  SerS substrates in detecting dopamine molecules  at various ph ranges Yanru Bu1 Sang-Wha lee2 1Department of chemical engineering,   Faculty of engineering, Monash  University, Melbourne, VIc , australia;   2Department of chemical and  Biochemical engineering, gachon  University, Seongnam-si, gyeonggi-do,   republic of KoreaAbstract:  AgcoreAushell nanoparticles (NPs) are a promising surface-enhanced Raman scattering  (SERS) substrate, which can offer a high enhancement factor through the combined effect of  the high SERS activity of the Ag core and the biocompatibility of the Au shell.",Non-OADS,/arxiv_data1/oa_pdf/71/b1/ijn-10-047.PMC4554420.pdf
"Thus, AgcoreAushell NPs could offer a high enhance - ment factor in SERS measurements through the combined effect of the high SERS  activity of the Ag core and the biocompatibility of the Au shell.4,18–20 There are many correspondence: Sang-Wha lee Department of chemical and Biochemical  engineering, gachon University,  Seongnam-daero 1342, Sujeong-gu,  Seongnam si, gyeonggi-do, republic of  Korea 461-701 Tel +82 31 750 5360 Fax +82 31 750 5363 email lswha@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Bu and Lee Running head recto: The characteristic AgcoreAushell nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S88308",Non-OADS,/arxiv_data1/oa_pdf/71/b1/ijn-10-047.PMC4554420.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/71/b1/ijn-10-047.PMC4554420.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/b1/ijn-10-047.PMC4554420.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ijn-10-067.PMC4554421.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 67–78International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  67OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8831 8Ultraviolet light and laser irradiation enhances the  antibacterial activity of glucosamine-functionalized  gold nanoparticles Saravanan govindaraju1,3 Mohankandhasamy  ramasamy1 rengarajan Baskaran2 Sang Jung ahn3,4 Kyusik Yun1 1Department of Bionanotechnology,   gachon University, gyeonggi-do,  2college of Pharmacy, gachon  University, Incheon, 3centre for  advanced Instrumentation, Korea  research Institute of Standard and  Science, University of Science and  Technology, Daejeon, republic  of Korea; 4Major of Nano Science,   University of Science and T echnology,   Daejeon, republic of KoreaAbstract:  Here we report a novel method for the synthesis of glucosamine-functionalized gold  nanoparticles (GlcN-AuNPs) using biocompatible and biodegradable glucosamine for antibacte - rial activity.",Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ijn-10-067.PMC4554421.pdf
"In particular, AuNPs have been extensively correspondence: Sang Jung ahn centre for advanced Instrumentation,  Korea research Institute of Standard  and Science, University of Science and  Technology, Daejeon 34113, republic  of Korea Tel +82 42 868 5609 email sjahn@kriss.re.k r  Kyusik Yun Department of Bionanotechnology,  gachon University, gyeonggi-do 13120,  republic of Korea Tel +82 31 750 8753 email ykyusik@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Govindaraju et al Running head recto: UV and laser enhances antibacterial activity of GlcN-AuNPs  DOI: http://dx.doi.org/10.2147/IJN.S88318",Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ijn-10-067.PMC4554421.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ijn-10-067.PMC4554421.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/6d/ijn-10-067.PMC4554421.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/a2/dddt-9-4883.PMC4554422.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4883–4896Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4883Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8763 4high-throughput sequencing of 16S rDNA   amplicons characterizes bacterial composition  in bronchoalveolar lavage fluid in patients with  ventilator-associated pneumonia Xiao-Jun Yang1,* Yan-Bo Wang2,3,* Zhi-Wei Zhou4,* guo-Wei Wang2 Xiao-hong Wang1 Qing-Fu liu1 shu-Feng Zhou4 Zhen-hai Wang2,3 1Department of intensive care Unit,   2neurology center, general hospital  of ningxia Medical University,   Yinchuan, ningxia, People’s republic  of china; 3Key laboratory of Brain  Diseases of ningxia, Yinchuan,   ningxia, People’s republic of china;   4Department of Pharmaceutical  sciences, college of Pharmacy,   University of south Florida, Tampa,   Fl, Usa *These authors contributed equally  to this workAbstract:  Ventilator-associated pneumonia (VAP) is a life-threatening disease that is  associated with high rates of morbidity and likely mortality, placing a heavy burden on an  individual and society.",Non-OADS,/arxiv_data1/oa_pdf/c0/a2/dddt-9-4883.PMC4554422.pdf
"The VAP mortality ranges from 24%–76%, correspondence: Zhen-hai Wang neurology center, general hospital  of ningxia Medical University, Key  laboratory of Brain Diseases of ningxia,  804 shengli street, Yinchuan, ningxia  750004, People’s republic of china Tel +86 951 6744 205 Fax +86 951 4082 981 email 13995089189@163.co m shu-Feng Zhou Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, 12901 Bruce B Downs Boulevard,  Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y ang et al Running head recto: 16S rDNA  amplicons characterizes bacterial composition DOI: http://dx.doi.org/10.2147/DDDT.S87634",Non-OADS,/arxiv_data1/oa_pdf/c0/a2/dddt-9-4883.PMC4554422.pdf
"The  OTUs that reached 97% similarity level were used for alpha  diversity analysis that analyzed the species diversity in the  single sample by the evaluation of Chao, abundance-based  coverage estimators (ACE), Shannon, and Simpson param - eters; and the rarefaction curve was also analyzed using the  Mothur software v1.27.0 program.18–21 Following the alpha  diversity analysis, taxonomy-based analyses were performed  through the classification of each sequence using the Naïve  Bayesian classifier program in Ribosomal Database Project  (RDP) at the Center for Microbial Ecology in Michigan State  University ( http://rdp.cme.msu.edu /; MI, USA).20,21 The  confidence level was of 95%.",OADS,/arxiv_data1/oa_pdf/c0/a2/dddt-9-4883.PMC4554422.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c0/a2/dddt-9-4883.PMC4554422.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/a2/dddt-9-4883.PMC4554422.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/b2/ijn-10-009.PMC4554423.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 9–24International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  9RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8828 5Current applications of graphene oxide in  nanomedicine Si-Ying wu Seong Soo A An John Hulme Department of Bionanotechnology,   Gachon Medical Research Institute,   Gachon University, Sungnamsi,   Republic of KoreaAbstract:  Graphene has attracted the attention of the entire scientific community due to its  unique mechanical and electrochemical, electronic, biomaterial, and chemical properties.",Non-OADS,/arxiv_data1/oa_pdf/6f/b2/ijn-10-009.PMC4554423.pdf
"Studies Correspondence: Seong Soo A An;   John Hulme Department of Bionanotechnology,  Gachon Medical Research Institute,  Gachon University, San 65, Sungnam  461-701, Republic of Korea Tel +82 31 750 8755 Fax +82 31 750 8755 email seongaan@gachon.ac.k r;   flp15@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Wu et al Running head recto: Current applications of graphene oxide DOI: http://dx.doi.org/10.2147/IJN.S88285",Non-OADS,/arxiv_data1/oa_pdf/6f/b2/ijn-10-009.PMC4554423.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6f/b2/ijn-10-009.PMC4554423.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/b2/ijn-10-009.PMC4554423.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/bf/dddt-9-4873.PMC4554424.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4873–4882Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4873Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9111 6Hydrogen sulfide-releasing naproxen suppresses  colon cancer cell growth and inhibits NF- κB  signaling ravinder Kodela1 niharika nath2 Mitali chattopadhyay1 Diandra e nesbitt1  Carlos A Velázquez- Martínez3 Khosrow Kashfi1 1Department of Physiology,   Pharmacology and neuroscience,   sophie Davis school of Biomedical  education, city University of new  Y ork Medical school, 2Department  of life sciences, n ew Y ork institute  of T echnology, new Y ork, nY,   Usa; 3Faculty of Pharmacy and  Pharmaceutical sciences, University  of alberta, edmonton, aB, canadaAbstract:  Colorectal cancer (CRC) is the second leading cause of death due to cancer and the  third most common cancer in men and women in the USA.",Non-OADS,/arxiv_data1/oa_pdf/de/bf/dddt-9-4873.PMC4554424.pdf
"These reports suggest that traditional  NSAIDs can reduce the incidence of colon cancer (regress precancerous lesions),  and may be promising chemopreventive drugs for CRC.1–5 Nevertheless, long-term  administration of NSAIDs is associated with the development of side effects, including Correspondence: Khosrow Kashfi Department of Physiology and  Pharmacology, city University of  new York Medical school, 138th  street and convent avenue,  new York, nY 10031, Usa Tel +1 212 650 6641 Fax +1 212 650 7692 email kashfi@med.cuny.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Kodela et al Running head recto: HS-NAP inhibits colorectal cancer DOI: http://dx.doi.org/10.2147/DDDT.S91116",Non-OADS,/arxiv_data1/oa_pdf/de/bf/dddt-9-4873.PMC4554424.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/de/bf/dddt-9-4873.PMC4554424.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/bf/dddt-9-4873.PMC4554424.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/f9/ijn-10-055.PMC4554425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 55–66International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  55OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S8831 5amperometric urea biosensors based on  sulfonated graphene/polyaniline nanocomposite gautam Das hyon hee Y oon Department of chemical and  Biological engineering, gachon  University, Seongnam, gyeonggi-do,   South KoreaAbstract:  An electrochemical biosensor based on sulfonated graphene/polyaniline  nanocomposite was developed for urea analysis.",Non-OADS,/arxiv_data1/oa_pdf/3f/f9/ijn-10-055.PMC4554425.pdf
"For  this reason, considerable efforts have recently been devoted toward the adaptation correspondence: hyon hee Yoon Department of chemical and Biological  engineering, gachon Univeristy, 1342  Seongnam Daero, Sujeong gu, gyeonggi  Do, republic of Korea, 461-701 Tel +82 31 750 8518 Fax +82 31 750 5363 email hhyoon@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Das and Y oon Running head recto: Biosensors based on sulfonated graphene/polyaniline nanocomposite DOI: http://dx.doi.org/10.2147/IJN.S88315",Non-OADS,/arxiv_data1/oa_pdf/3f/f9/ijn-10-055.PMC4554425.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3f/f9/ijn-10-055.PMC4554425.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/f9/ijn-10-055.PMC4554425.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/b1/ijnrd-8-111.PMC4554426.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 111–118International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  111ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S9079 1effects of lanthanum carbonate versus calcium  carbonate on vascular stiffness and bone mineral  metabolism in hemodialysis patients with type 2  diabetes mellitus: a randomized controlled trial Kentaro Wada1 Yuko Wada2 haruhito adam Uchida3 shuichi Tsuruoka4 1Division of Nephrology and Dialysis,   Department of Internal Medicine,   Nippon Kokan Fukuyama hospital,   hiroshima, 2Department of Internal  Medicine, central hospital, hiroshima,   3Department of chronic Kidney  Disease and cardiovascular Disease,   Okayama University graduate  school of Medicine, Dentistry and  Pharmaceutical sciences, Okayama,   4Division of Nephrology, Department  of Internal Medicine, graduate school  of Medicine, Nippon Medical school,   T okyo, Japan correspondence: Kentaro Wada   Division of Nephrology and Dialysis,  Department of Internal Medicine,   Nippon Kokan Fukuyama hospital,   1844 Tsunoshita, Daimon-cho, Fukuyama  city, hiroshima, 721-0927, Japan   Tel +81 84 945 3105   Fax +81 84 945 3564   email kyw620@hotmail.co.j pBackground:  Vascular calcification contributes to cardiovascular disease in hemodialysis (HD)  patients with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/20/b1/ijnrd-8-111.PMC4554426.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/20/b1/ijnrd-8-111.PMC4554426.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/b1/ijnrd-8-111.PMC4554426.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/d1/clep-7-381.PMC4554427.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 381–389Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  381Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S8542 7The impact of preadmission oral bisphosphonate  use on  30-day mortality following stroke: a  population-based cohort study of  100,043 patients Diana hedevang  Christensen1,2 Erzsébet horváth-Puhó1 Morten schmidt1 Christian Fynbo  Christiansen1 lars Pedersen1 Bente lomholt langdahl2 reimar Wernich Thomsen1 1Department of Clinical Epidemiology,   2Department of Endocrinology and  internal Medicine, aarhus University  hospital, aarhus, Denmark Correspondence: Diana hedevang  Christensen   Department of Clinical Epidemiology,  aarhus University hospital, Olof   Palmes allé  43-45, DK-8200,   aarhus n, Denmark   Tel +45 2530 6121  Fax +45 8716 7215  Email dhcr@clin.au.d kPurpose:  Bisphosphonate use has been associated with increased risk of fatal stroke.",Non-OADS,/arxiv_data1/oa_pdf/e6/d1/clep-7-381.PMC4554427.pdf
Relevant ICD-codes and Anatomical  Therapeutic Chemi cal codes are provided in Table S1.http://www.dovepress.com/get_supplementary_file.,Non-OADS,/arxiv_data1/oa_pdf/e6/d1/clep-7-381.PMC4554427.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/e6/d1/clep-7-381.PMC4554427.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/1b/tcrm-11-1259.PMC4554428.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1259–1264Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1259ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9036 5CD226  gene polymorphisms are associated with  non-small-cell lung cancer in the Chinese han  population Zhi-Xin Qiu1,* Ying Peng2,* Wei-Min li1 1Department of Respiratory Medicine,   2Department of Cardiology, West  China hospital, sichuan University,   Chengdu, People’s Republic of China *These authors contributed equally  to this workBackground:  The immunoglobulin-like glycoprotein CD226  (DNAX accessory molecule-1)  represents receptor-activating cytotoxic T lymphocyte and natural killer cells taking part in  tumor surveillance, the pathogenesis of inflammation, and autoimmune disorders.",Non-OADS,/arxiv_data1/oa_pdf/6f/1b/tcrm-11-1259.PMC4554428.pdf
"It is highly  conserved among humans, gibbons, monkeys, and mice, and its gene has been mapped  to human chromosome 18.3–6 In humans, CD226 is expressed on the majority of natural  killer (NK) cells, T cells, and monocytes, and on a small subset of B cells.5 Recently, rs763361 (C/T polymorphism), the non-synonymous (Gly307Ser) cod - ing variant that is located at 18q22.3 in the CD226  gene, was first correlated to type 1 Correspondence: Wei-Min li  Department of Respiratory Medicine,  West China hospital, sichuan University,  no 37, guoxuexiang street, Chengdu,  610041, People’s Republic of China Tel +86 28 8542 3998 email weimi003@yahoo.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Qiu et al Running head recto: Polymorphisms of the CD226 gene DOI: http://dx.doi.org/10.2147/TCRM.S90365",Non-OADS,/arxiv_data1/oa_pdf/6f/1b/tcrm-11-1259.PMC4554428.pdf
The primers were established with the primer-introduced  restriction analysis (PIRA) polymerase chain reaction (PCR)   designer ( http://primer1.soton.ac.uk/primer2.html ).,Non-OADS,/arxiv_data1/oa_pdf/6f/1b/tcrm-11-1259.PMC4554428.pdf
The study power was calculated by  using the Quanto 1.1.1 program ( http://hydra.usc.edu/gx e).,OADS,/arxiv_data1/oa_pdf/6f/1b/tcrm-11-1259.PMC4554428.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/6f/1b/tcrm-11-1259.PMC4554428.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/1b/tcrm-11-1259.PMC4554428.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/6e/opth-9-1537.PMC4554429.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1537–1541Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1537Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8791 9submacular predominantly hemorrhagic choroidal  neovascularization: resolution of bleedings under  anti-VegF therapy spyridon Dimopoulos Martin alexander leitritz Focke Ziemssen Bogomil Voykov Karl Ulrich Bartz-schmidt Faik gelisken Centre for Ophthalmology,   eberhard-Karls University,   T uebingen,  germanyPurpose:  To report the visual and morphological outcomes following intravitreal bevacizumab  in neovascular age-related macular degeneration (nAMD) with submacular, predominantly  hemorrhagic, lesions.",Non-OADS,/arxiv_data1/oa_pdf/70/6e/opth-9-1537.PMC4554429.pdf
"Although, the outcomes of anti-VEGF Correspondence: spyridon Dimopoulos Centre for Ophthalmology,  eberhard-Karls University, schleichstr 12,  72076 Tuebingen, germany Tel +49 7071 298 3721 Fax +49 7071 29 4675 email spyridon.dimopoulos@med.uni- tuebingen.d e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Dimopoulos et al Running head recto: Anti-VEGF in hemorrhagic AMD DOI: http://dx.doi.org/10.2147/OPTH.S87919",Non-OADS,/arxiv_data1/oa_pdf/70/6e/opth-9-1537.PMC4554429.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/70/6e/opth-9-1537.PMC4554429.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/6e/opth-9-1537.PMC4554429.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/54/dddt-9-4861.PMC4554430.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 4861–4868Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  4861Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8785 8Blood pyrrole-protein adducts as a diagnostic and  prognostic index in pyrrolizidine alkaloid-hepatic  sinusoidal obstruction syndrome hong gao1,* Jianqing Q ruan2,* Jie chen1 na li2 changqiang Q Ke3 Yang Ye3–5 ge lin2,4,5 Jiyao Y Wang1,6 1Department of gastroenterology,   Zhongshan hospital, Fudan University,   shanghai, People’s republic of china;   2school of Biomedical sciences,   chinese University of hong Kong,   hong Kong; 3shanghai institute  of Materia Medica, shanghai,   People’s republic of china; 4Joint  research laboratory for Promoting  globalization of Traditional chinese  Medicines, shanghai institute of  Materia Medica, 5chinese University  of hong Kong, hong Kong; 6center  of evidence-Based Medicine Fudan  University, shanghai, People’s republic  of china *These authors contributed equally to  this work and share first authorshipBackground:  The diagnosis of hepatic sinusoidal obstruction syndrome (HSOS) induced  by pyrrolizidine alkaloids is mainly based on clinical investigation.",Non-OADS,/arxiv_data1/oa_pdf/a5/54/dddt-9-4861.PMC4554430.pdf
"correspondence: Jiyao Wang Department of gastroenterology,  Zhongshan hospital, Fudan University,  Fenglin road 180, shanghai 200032,  People’s republic of china  Tel +86 21 6404 1990 Fax +86 21 6443 2583 email wang.jiyao@zs-hospital.sh.c n  ge lin school of Biomedical sciences, lo Kwee  seong integrated Biomedical sciences  Building, chinese University of hong  Kong, shatin, nT hong Kong Tel +852 3943 6824 Fax +852 2603 5139 email linge@cuhk.edu.h k Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Gao et al Running head recto: Pyrrole-protein adducts for diagnosis and prognosis  DOI: http://dx.doi.org/10.2147/DDDT.S87858",Non-OADS,/arxiv_data1/oa_pdf/a5/54/dddt-9-4861.PMC4554430.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a5/54/dddt-9-4861.PMC4554430.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/54/dddt-9-4861.PMC4554430.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/82/ijn-10-5435.PMC4554431.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5435–5445International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5435OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8649 5Photothermal treatment of liver cancer with  albumin-conjugated gold nanoparticles initiates  golgi apparatus–er dysfunction and caspase-3  apoptotic pathway activation by selective targeting  of gp60 receptor lucian Mocan1,2 cristian Matea1 Flaviu a Tabaran3 Ofelia Mosteanu1,4 T eodora Pop1,4 T eodora Mocan1,5 cornel Iancu1,2 1Nanomedicine Department, regional  Institute of gastroenterology  and hepatology “Octavian Fodor”,   2Department of surgery, University  of Medicine and Pharmacy, “Iuliu  hatieganu”, 3Department of Pathology,   Faculty of Veterinary Medicine,   University of agricultural sciences  and Veterinary Medicine, 4Department  of gastroenterology, 5Department  of Physiology, University of Medicine  and Pharmacy, “Iuliu hatieganu”,   croitorilor, cluj-Napoca, romaniaAbstract:  We present a method of enhanced laser thermal ablation of HepG2 cells based on a  simple gold nanoparticle (GNP) carrier system such as serum albumin (Alb), and demonstrate  its selective therapeutic efficacy compared with normal hepatocyte cells.",Non-OADS,/arxiv_data1/oa_pdf/cf/82/ijn-10-5435.PMC4554431.pdf
"Since chemotherapy and radiotherapy have produced modest results in HC treatment,  new methods of therapy would bring about a better outcome.2 Most data suggest that nanotechnologies hold great hopes for the development of  new cancer treatments.3 The ability of light-heat conversion in gold nanoparticles (GNPs) following near- infrared (NIR) laser radiation provides an opportunity to create novel nanoparticle- based therapies with high performance and efficacy in selective thermal ablation of  cancer at a molecular level.4–8 Cancer nanotechnology, an interdisciplinary research domain, has already brought  to light promising results in cancer diagnosis and treatment.9 The first GNP therapy to correspondence: Teodora Mocan;   cornel Iancu  Nanomedicine Department, regional   Institute of gastroenterology and   hepatology ‘Octavian Fodor’,  croitorilor street 19-21, cluj Napoca,   400162, romania Tel +40 264 439 696 Fax +40 264 439 696 email teodora.mocan@umfcluj.r o;  cornel.iancu@umfcluj.r o Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mocan et al Running head recto: Photothermal treatment of liver cancer with Alb-GNPs DOI: http://dx.doi.org/10.2147/IJN.S86495",Non-OADS,/arxiv_data1/oa_pdf/cf/82/ijn-10-5435.PMC4554431.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/cf/82/ijn-10-5435.PMC4554431.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/82/ijn-10-5435.PMC4554431.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/62/ahmt-6-149.PMC4554432.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdolescent Health, Medicine and Therapeutics 2015:6 149–158Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  149Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S6834 4weight status and body image perceptions in  adolescents: current perspectives Dana K voelker1 Justine J Reel2 Christy Greenleaf3 1west virginia University, College of  Physical Activity and Sport Sciences,   Morgantown, wv, 2University of  North Carolina wilmington, College  of Health and Human Services,   wilmington, NC, 3University of  wisconsin–Milwaukee, College of  Health Sciences, Milwaukee, wi, USA Correspondence: Dana K voelker   Department of Sport Sciences,  west virginia University, Health  and education Building, CPASS 207,  PO Box 6116, 375 Birch Street,  Morgantown, wv 26506-6116, USA   Tel +1 304 293 0871   email dkvoelker@mail.wvu.ed uAbstract:  Adolescence represents a pivotal stage in the development of positive or negative  body image.",Non-OADS,/arxiv_data1/oa_pdf/cc/62/ahmt-6-149.PMC4554432.pdf
Or use: http://youtu.be/IR6dnYCa8_ c,Non-OADS,/arxiv_data1/oa_pdf/cc/62/ahmt-6-149.PMC4554432.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/cc/62/ahmt-6-149.PMC4554432.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/62/ahmt-6-149.PMC4554432.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/c3/ijn-10-079.PMC4554433.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 79–92International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  79OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8831 9Graphene oxide-modified ZnO particles:  synthesis, characterization, and antibacterial  properties Linlin Zhong Kyusik Yun Department of Bionanotechnology,   Gachon University, Gyeonggi-do,   republic of KoreaAbstract:  Nanosized ZnO particles with diameters of 15 nm were prepared with a solution  precipitation method at low cost and high yield.",Non-OADS,/arxiv_data1/oa_pdf/7f/c3/ijn-10-079.PMC4554433.pdf
"Synthesis of ZnO particles  with a precipitation method in alcohol solution is the most commonly used and promis - ing low-cost route.9–11 However, ZnO particles aggregate easily in solution due to van  der Waals forces and surface effects.12 Therefore, the surface of ZnO particles must  be modified with an organic reagent or stable polymers to decrease aggregation.13–15   In this study, we separated ZnO particles by anchoring them on the surface of graphene  oxide sheets, thus achieving more stable and dispersed composites.correspondence: Kyusik Yun Department of Bionanotechnology,  Gachon University, Gyeonggi-do 13120,  republic of Korea Tel +82 31 750 8753 Fax +82 31 750 8819 email ykyusik@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Zhong and Yun Running head recto: Antibacterial properties of ZnO/graphene oxide composites DOI: http://dx.doi.org/10.2147/IJN.S88319",Non-OADS,/arxiv_data1/oa_pdf/7f/c3/ijn-10-079.PMC4554433.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/7f/c3/ijn-10-079.PMC4554433.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/c3/ijn-10-079.PMC4554433.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/11/ijn-10-113.PMC4554434.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics)  113–119International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  113OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8838 8Selective detection of dopamine in the presence  of ascorbic acid via fluorescence quenching  of InP/ZnS quantum dots Seshadri reddy ankireddy Jongsung Kim Department of chemical and  Biological Engineering, Gachon  University, Seongnam, South KoreaAbstract:  Dopamine is a neurotransmitter of the catecholamine family and has many important  roles, especially in human brain.",Non-OADS,/arxiv_data1/oa_pdf/4a/11/ijn-10-113.PMC4554434.pdf
"In the extracellular fluid of the central nervous system and cerebrospinal Correspondence: Jongsung Kim Department of Chemical and Biological  Engineering, Gachon University,  Seongnam, Gyeonggi-Do, 461-701,  South Korea Tel +82 10 2212 5361 Fax +82 31 750 5363 email jongkim@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Ankireddy and Kim Running head recto: Selective detection of dopamine in the presence of ascorbic acid DOI: http://dx.doi.org/10.2147/IJN.S88388",Non-OADS,/arxiv_data1/oa_pdf/4a/11/ijn-10-113.PMC4554434.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4a/11/ijn-10-113.PMC4554434.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/11/ijn-10-113.PMC4554434.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/03/ijn-10-121.PMC4554435.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 121–128International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  121OrIg INal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8846 5Dopamine-functionalized InP/ZnS quantum dots  as fluorescence probes for the detection of  adenosine in microfluidic chip Seshadri reddy ankireddy Jongsung Kim Department of chemical and  Biological engineering, gachon  University, Seongnam, gyeonggi-Do,   South KoreaAbstract:  Microbeads are frequently used as solid supports for biomolecules such as proteins  and nucleic acids in heterogeneous microfluidic assays.",Non-OADS,/arxiv_data1/oa_pdf/09/03/ijn-10-121.PMC4554435.pdf
"Several studies have been performed on surface modifications of correspondence: Jongsung Kim Department of chemical and Biological  engineering, gachon University,  Seongnam, gyeonggi-Do 461-701,  South Korea email jongkim@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Ankireddy and Kim Running head recto: Detection of adenosine using microfluidic chip DOI: http://dx.doi.org/10.2147/IJN.S88465",Non-OADS,/arxiv_data1/oa_pdf/09/03/ijn-10-121.PMC4554435.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/09/03/ijn-10-121.PMC4554435.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/03/ijn-10-121.PMC4554435.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/cia-10-1393.PMC4554436.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1393–1399Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1393OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8940 1One-site versus two-site phacotrabeculectomy:  a prospective randomized study Marilita M Moschos1 Irini P Chatziralli2 Michael Tsatsos3 1First Department of Ophthalmology,   University of Athens, 2second  Department of Ophthalmology,   Ophthalmiatrion Athinon,   Athens, greece; 3Department of  Ophthalmology, Cambridge University  hospital nhs, Cambridge, UKPurpose:  The purpose of this study is to compare the efficacy and safety of one-site and  two-site combined phacotrabeculectomy with foldable posterior chamber intraocular lens  implantation.",Non-OADS,/arxiv_data1/oa_pdf/34/a2/cia-10-1393.PMC4554436.pdf
"Therefore, in patients with visually significant  cataract and glaucoma that is not adequately controlled with topical medication, the  risk of failure of the glaucoma-filtering surgery is lower when phacoemulsification is  preferred to extracapsular cataract extraction for the treatment of cataract.4 However, phacoemulsification may cause a significant short-term intraocular  pressure (IOP) rise in the early postoperative period, and trabeculectomy is associated Correspondence: Marilita M Moschos First Department of Ophthalmology,  University of Athens, 6, Ikarias street,  ekali, 14578 Athens, greece Tel +30 69 4488 7319 Fax +30 21 0412 2139 email moschosmarilita@yahoo.f r Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Moschos et al Running head recto: One-site versus two-site phacotrabeculectomy DOI: http://dx.doi.org/10.2147/CIA.S89401",Non-OADS,/arxiv_data1/oa_pdf/34/a2/cia-10-1393.PMC4554436.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/34/a2/cia-10-1393.PMC4554436.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/cia-10-1393.PMC4554436.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/d6/ijn-10-5407.PMC4554438.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5407–5420International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5407RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8915 6Molecular targets in arthritis and recent trends  in nanotherapy Kislay Roy Rupinder Kaur Kanwar Jagat Rakesh Kanwar Nanomedicine-Laboratory of  Immunology and Molecular Biomedical  Research (NLIMBR), Centre for  Molecular and Medical Research  (C-MMR), Strategic Research Centre,   School of Medicine (SoM), Faculty  of Health, Deakin University, waurn  Ponds, vIC, AustraliaAbstract:  Due to its severity and increasing epidemiology, arthritis needs no description.",Non-OADS,/arxiv_data1/oa_pdf/f4/d6/ijn-10-5407.PMC4554438.pdf
"With the  increase in the aging population, the number of people with arthritis is also growing;  hence, the current trends suggest that, by 2050, seven million Australians will suffer  from some form of arthritis ( http://www.arthritisaustralia.com.a u).",Non-OADS,/arxiv_data1/oa_pdf/f4/d6/ijn-10-5407.PMC4554438.pdf
Worldwide statistics shows that symptomatic OA will  develop in 9.6% of men and 18% of women aged over 60 years ( http://www.who.int /).,Non-OADS,/arxiv_data1/oa_pdf/f4/d6/ijn-10-5407.PMC4554438.pdf
"Globally, of the 291 conditions Correspondence: Jagat Rakesh Kanwar Nanomedicine-Laboratory of Immunology  and Molecular Biomedical Research  (NLIMBR), Centre for Molecular and  Medical Research (C-MMR), School  of Medicine (SoM), Faculty of Health,  Deakin University, 75 Pigdons Road,  waurn Ponds, vIC 3217, Australia Tel +61 3 5227 1148 Fax +61 3 5227 3402 email jagat.kanwar@deakin.edu.a u Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Roy et al Running head recto: Molecular targets in arthritis and recent trends in nanotherapy DOI: http://dx.doi.org/10.2147/IJN.S89156",Non-OADS,/arxiv_data1/oa_pdf/f4/d6/ijn-10-5407.PMC4554438.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f4/d6/ijn-10-5407.PMC4554438.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/d6/ijn-10-5407.PMC4554438.pdf
"18–20Curcumin is an ingredient of turmeric –a natural component of normal human diet commonlyconsidered safe –and has been tested worldwide inmore than 100 registered clinical trials, mainly investigat- ing its effects on neurodegenerative, inﬂammatory and cancer diseases (http://clinicaltrials.gov, search for “curc-umin,” April 2015).",Non-OADS,/arxiv_data1/oa_pdf/41/d0/acn30002-0787.PMC4554440.pdf
"Imputation Imputation of allele dosages used the March 2012 referencepanel from 1000 Genomes (1000G) –build hg37 and the IMPUTE2 software (http://mathgen.stats.ox.ac.uk/impute/ impute_v2.html 15), applying strict variant position and strand alignment controls, prephasing and preimputationﬁltering.",OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
Relatedness and unrelated case –control sample selection Identity by descent (IBD) was computed using PLINK (http://pngu.mgh.harvard.edu/~purcell/plink/) in order to(1) identify (latent) relatedness among subjects (2) iden-tify duplicates and (3) select a subsample of unrelatedindividuals.,OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
"Population stratiﬁcation Population stratiﬁcation was investigated using EIGEN- STRAT (EIGENSOFT 3.0, http://genepath.med.har- vard.edu/~reich/EIGENSTRAT.htm).18Tracy –Widom statistics in the software allows for determination of thenumber of signiﬁcant principal components (PC) neces-sary to control for population stratiﬁcation in the associa-tion analysis.",OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
21and implemented in the KING software.22 Association analysis Associations between LOAD and SNPs passing quality con-trol were reassessed using multivariate logistic regression inPLINK version 1.07 (http://pngu.mgh.harvard.edu/~pur- cell/plink/) for the case –control data set.,OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
Both tests were per- formed with R (http://www.r-project.org).,Non-OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
Expanded cohort and general estimating equation In order to verify ﬁndings obtained in the case –control GWAS in the whole sample (related and unrelated indi- viduals) we ﬁtted a logistic regression model via General- ized Estimation Equation (GEE) implemented in theGWAF package in R (http://cran.r-project.org/) to testassociation between the affection status and imputedSNPs under additive genetic model.,OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
Signiﬁcance was assessed with Student’s t-test in R (http://cran.r-project.org).,Non-OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
"On the con-trary, all NOMAS individuals were genotyped at one time.Each batch was imputed singularly although we used the same algorithm that is, the March 2012 reference panel from 1000 Genomes (1000G) –build 37 and the IMPUTE2 software (http://mathgen.stats.ox.ac.uk/impute/impute_v2.html [Marchini et al.",OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
"The resultingimputed datasets were then merged using the GTOOLsoftware (http://www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html); ﬁnally, imputed SNPs were included inthe combined dataset only if present in all four cohorts.",OADS,/arxiv_data1/oa_pdf/8f/a7/acn30002-0810.PMC4554442.pdf
The exome design covers 50megabases of human genome that includes all exons anno-tated in the GENCODE project (reference annotation forthe ENCODE project; Wellcome Trust Sanger Institute)and consensus CDS database (CCDS –March 2009) as well as 10 bp of ﬂanking sequence for each targeted region andsmall noncoding RNAs from miRBase (http://www.mirba- se.org/) (v.13) and Rfam (http://rfam.xfam.org/).,OADS,/arxiv_data1/oa_pdf/bd/fd/acn30002-0821.PMC4554443.pdf
"Whole exome analysis and linkage mapping Exome sequencing reads were aligned with Novoalign ver- sion 3.02.00 (http://www.novocraft.com/) to the humangenome assembly with ambiguous SNPs (hg19 dbSNP132-masked, UCSC Genome Browser).",OADS,/arxiv_data1/oa_pdf/bd/fd/acn30002-0821.PMC4554443.pdf
"23 Exome variants were ﬁltered and selected according to thefollowing criteria for the homozygous and compound het- erozygous recessive models: location within a linkage region, genotypes ﬁtting the disease model, a minor allelefrequency ≤0.01 (0.05) in the exome variant server dataset (http://evs.gs.washington.edu/EVS/) and 1000 Genomes, 24 a minor allele frequency of ≤0.05 in the Exome Aggregation Consortium database, appearance in <10 alleles of our in-house exome dataset, and mutation type (missense,nonsense, coding indel or splice site variant).",OADS,/arxiv_data1/oa_pdf/bd/fd/acn30002-0821.PMC4554443.pdf
PCR and sanger sequencing The PRIMA1 gene and exome variants were ampliﬁed using gene-speciﬁc primers (Table 1) designed to the ref-erence human gene transcripts (NCBI Gene; http://www.ncbi.nlm.nih.gov/).,OADS,/arxiv_data1/oa_pdf/bd/fd/acn30002-0821.PMC4554443.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/d7/ijgm-8-267.PMC4554448.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 267–273International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  267OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S8374 9changes in retinal microvascular diameter   in patients with diabetes andréa Vasconcellos Batista  da silva1 sonia alves Gouvea2 aurélio Paulo Batista da  silva1 saulo Bortolon3 anabel nunes rodrigues2 Glaucia rodrigues abreu2 Fernando luiz herkenhoff2 1Department of Morphology,   2Department of Physiological sciences,   health sciences center, 3Department  of T echnology, Informatic center,   Federal University of espírito santo,   Vitoria, espirito santo, Brazil correspondence: sonia alves Gouvea   Departamento de ciências Fisiológicas –   centro de ciências da saúde da  Universidade, Federal do espírito   santo, avenida Marechal campos,   1456 – Maruípe, Vitória, espírito   santo, ceP 29040-577, Brazil   Fax +55 27 3335 7330   email gouveasa@yahoo.com.b rBackground and objectives:  Diabetic retinopathy is the main microvascular complica - tion in diabetes mellitus and needs to be diagnosed early to prevent severe sight-threatening  retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/22/d7/ijgm-8-267.PMC4554448.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/22/d7/ijgm-8-267.PMC4554448.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/d7/ijgm-8-267.PMC4554448.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/1a/vhrm-11-493.PMC4554462.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 493–501Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  493ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S7469 2New developments in atherosclerosis: clinical  potential of PCSK9 inhibition ilaria Giunzioni Hagai Tavori Knight Cardiovascular institute,   Center for Preventive Cardiology,   Oregon Health and Science University,   Portland, OR, USA Correspondence: Hagai Tavori   Oregon Health and Science University,  Knight Cardiovascular institute Center  for Preventive Cardiology, 3181 Sw Sam  Jackson Park Road, Mail Code HRC5N,  Portland, OR 97239, USA   Tel +1 503 418 2685   email tavori@ohsu.ed uAbstract:  Pro-protein convertase subtilisin/kexin type 9 (PCSK9) is a secreted 692-amino acid  protein that binds surface low-density lipoprotein (LDL) receptor (LDLR) and targets it toward  lysosomal degradation.",Non-OADS,/arxiv_data1/oa_pdf/f3/1a/vhrm-11-493.PMC4554462.pdf
Available from: http://www.cvshealth.,Non-OADS,/arxiv_data1/oa_pdf/f3/1a/vhrm-11-493.PMC4554462.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/f3/1a/vhrm-11-493.PMC4554462.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/1a/vhrm-11-493.PMC4554462.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/8c/amep-6-533.PMC4554479.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 533–537Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  533OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S8658 3Anatomy by whole body dissection: a focus   group study of students’ learning experience Annette Burgess1 george ramsey-stewart2 1central clinical school, sydney  Medical school, The University of  sydney, 2sydney Medical school, The  University of sydney, sydney, nsW,   Australia correspondence: Annette Burgess   central clinical school, sydney Medical  school, The University of sydney, Building  63, level 4, royal Prince Alfred hospital,  Missenden road, camperdown, nsW  2050, Australia   Tel +61 2 9515 8172   Email annette.burgess@sydney.edu.a uBackground:  The social construction of knowledge within medical education is essential for  learning.",Non-OADS,/arxiv_data1/oa_pdf/d5/8c/amep-6-533.PMC4554479.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d5/8c/amep-6-533.PMC4554479.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/8c/amep-6-533.PMC4554479.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/43/ijgm-8-275.PMC4554480.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 275–281International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  275OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S8647 9sleep apnea clinical score, Berlin Questionnaire,  or epworth sleepiness scale: which is the best  obstructive sleep apnea predictor in patients   with cOPD?",Non-OADS,/arxiv_data1/oa_pdf/c6/43/ijgm-8-275.PMC4554480.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/c6/43/ijgm-8-275.PMC4554480.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/43/ijgm-8-275.PMC4554480.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/93/idr-8-297.PMC4554481.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 297–309Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  297RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S3918 6Impact of the New Delhi metallo-beta-lactamase  on beta-lactam antibiotics Monika T Zmarlicka1 Michael D Nailor2 David P Nicolau3 1Department of Pharmacy, Hartford  Hospital, Hartford,  2School of  Pharmacy, Department of Pharmacy  Practice, University of Connecticut,   Storrs,  3Center for Anti-Infective  Research and Development, Hartford  Hospital, Hartford, CT, USA Correspondence: David P Nicolau  Center for Anti-Infective Research  and Development, Hartford Hospital,  80 Seymour Street, Hartford,   CT 06102, USA   Tel +1 860 545 3941  Fax +1 860 972 3992  email david.nicolau@hhchealth.or gAbstract:  Since the first New Delhi metallo-beta-lactamase (NDM) report in  2009, NDM has  spread globally causing various types of infections.",Non-OADS,/arxiv_data1/oa_pdf/60/93/idr-8-297.PMC4554481.pdf
Available from: http://clsi.org/blog/2015/01/08/clsi-publishes-new-an - timicrobial-susceptibility-testing-standards /.,Non-OADS,/arxiv_data1/oa_pdf/60/93/idr-8-297.PMC4554481.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/60/93/idr-8-297.PMC4554481.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/93/idr-8-297.PMC4554481.pdf
"Accessed from: http://tphase.com/pipeline/ eravacyclin e. Accessed May  7, 2015.",OADS,/arxiv_data1/oa_pdf/60/93/idr-8-297.PMC4554481.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijn-10-003.PMC4554482.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 (Special Issue on diverse applications in Nano-Theranostics) 3–8International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3EdIT orIalopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9138 9Spotlight on nano-theranostics in South Korea:  applications in diagnostics and treatment  of diseases Sangwha lee1,* Jongsung Kim1,* Chung Wung Bark2 Bonghee lee3 Heongkyu Ju4 Se Chan Kang5 TaeY oung Kim6 Moon Il Kim6 Y oung Tag Ko3 Jeong-Seok Nam3 Hyon Hee Y oon1 Kyu-Sik Yun1,6 Y oung Soo Y oon1 Seong Soo a an1,6 John Hulme6 1BioNano Sensor research Center,   2department of Electrical Engineering,   Gachon University, Seongnam-si,   3lee Gil Ya Cancer and diabetes  Institute, Gachon University, Incheon,   4department of Nano-Physics,   5department of life Science, Gachon  University, 6department of BioNano  Technology, Gachon BioNano  research Institute, Seongnam-si,   South Korea *These authors contributed equally  to this workAbstract:  From the synergistic integration and the multidisciplinary strengths of the BioNano  Sensor Research Center, Gachon Bionano Research Institute, and Lee Gil Y a Cancer and Diabetes   Institute, researchers, students, and faculties at Gachon University in collaboration with other  institutions in Korea, Australia, France, America, and Japan have come together to produce a  special issue on the diverse applications of nano-theranostics in nanomedicine.",Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijn-10-003.PMC4554482.pdf
"BSRC/GBRI’s research activities consist of developing and transferring various  nanobiotechnologies for detecting and controlling DNA, RNA, proteins, cells, and Correspondence: John Hulme;   Seong Soo a an department of BioNano Technology,  Gachon BioNano research Institute,  Gachon University, 1342 Sungnam-daero,  Sujung-gu, Seongnam-si,  Gyeonggi-do 461-701, South Korea Tel +82 31 750 8550 Fax +82 31 750 8755 Email johnhulme21@gmail.co m;   seongaan@gachon.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Editorial Y ear: 2015 Volume: 10 (Special Issue on diverse applications in Nano-Theranostics) Running head verso: Lee et al Running head recto: Spotlight on nano-theranostics in South Korea DOI: http://dx.doi.org/10.2147/IJN.S91389",Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijn-10-003.PMC4554482.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijn-10-003.PMC4554482.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/2a/ijn-10-003.PMC4554482.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribu tion Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e0/f7/hum.2015.070.PMC4554547.pdf
https://clinicaltrials.gov/ct2/show/NCT00259753?term =bevasiranib&rank =5.,Non-OADS,/arxiv_data1/oa_pdf/e0/f7/hum.2015.070.PMC4554547.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attri bution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproductio n in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/82/54/hgtb.2015.051.PMC4554548.pdf
S1; supplementary data are available online at http://online.liebertpub.com/hgtb).,OADS,/arxiv_data1/oa_pdf/82/54/hgtb.2015.051.PMC4554548.pdf
"@ERSpublications This paper summarises key changes in the GINA global strategy report, a practical new resource for asthma care http://ow.ly/ObvYi Copyright ©ERS 2015.",Non-OADS,/arxiv_data1/oa_pdf/49/18/ERJ-00853-2015.PMC4554554.pdf
Graphical abstract This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/59/nihms710522.PMC4554733.pdf
"Supplemental Information: Supplemental Information includes Supplemental Experimental Procedures, three figures, and three tables  and can be found with this article online at http://dx.doi.org/10.1016/j.celrep.2015.07.036 .",OADS,/arxiv_data1/oa_pdf/5b/59/nihms710522.PMC4554733.pdf
"Cell Rep. 2015;  12 Published online August 27, 2015. http://dx.doi.org/10.1016/j.celrep.2015.07.060 .",OADS,/arxiv_data1/oa_pdf/5b/59/nihms710522.PMC4554733.pdf
"The tight control of cytosolicCa 2Cis critical not only for signaling spec- iﬁcity but also for cell survival, since a pro-longed and uncontrolled global increase incytosolic Ca 2Cis toxic to the cell and eventually leads to cell death.7By organiz- ing SOCE signals in the form of Ca2C oscillation, melanoma cells are able to © Jianwei Sun, Shengchen Lin, Tyler Keeley, and Shengyu Yang *Correspondence to: Shengyu Yang; Email: shengyu.yang@mof ﬁtt.org Submitted: 12/17/2014; Revised: 12/19/2014; Accepted: 12/20/2014 http://dx.doi.org/10.1080/23723556.2014.1002714 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/44/kmco-02-04-1002714.PMC4554758.pdf
Nat Eev Cancer 2011; 11(3):177–87; PMID:21326322; http://dx.doi.org/10.1038/nrc3003 2.,Non-OADS,/arxiv_data1/oa_pdf/fa/44/kmco-02-04-1002714.PMC4554758.pdf
2003; 114(1):33-45; PMID:12859896; http://dx.doi.org/10.1016/S0092-8674(03)00513-0 3.,Non-OADS,/arxiv_data1/oa_pdf/fa/44/kmco-02-04-1002714.PMC4554758.pdf
2014;PMID:25381814; http://dx.doi.org/10.1038/onc.,OADS,/arxiv_data1/oa_pdf/fa/44/kmco-02-04-1002714.PMC4554758.pdf
2007; 131 (6):1047-58; PMID:18083096; http://dx.doi.org/ 10.1016/j.cell.2007.11.028 7.,OADS,/arxiv_data1/oa_pdf/fa/44/kmco-02-04-1002714.PMC4554758.pdf
2003; 4(7):552-65; PMID:12838338; http://dx.doi.org/10.1038/ nrm1150 8.,Non-OADS,/arxiv_data1/oa_pdf/fa/44/kmco-02-04-1002714.PMC4554758.pdf
Nat Cell Biol 2012; 14(12):1261-9; PMID:23143397; http://dx.doi.org/10.1038/ncb2614 9.,OADS,/arxiv_data1/oa_pdf/fa/44/kmco-02-04-1002714.PMC4554758.pdf
Cancer Cell 2013; 23(4):541-56; PMID:23597567; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/fa/44/kmco-02-04-1002714.PMC4554758.pdf
"http://timesofindia.indiati- mes.com/india/India-needs-a-complete-law-on-end-of-life-car e/articleshow/47336216.cms  (accessed Jun 20, 2015).",Non-OADS,/arxiv_data1/oa_pdf/eb/98/jgc-12-04-329.PMC4554781.pdf
"http://lawcommissionofindia.nic.in/reports/rep196.pdf (ac-cessed on Jun 17, 2015).",Non-OADS,/arxiv_data1/oa_pdf/eb/98/jgc-12-04-329.PMC4554781.pdf
"http://www.polst.org  (accessed on Jun 18, 2015).",Non-OADS,/arxiv_data1/oa_pdf/eb/98/jgc-12-04-329.PMC4554781.pdf
http://www.fda.gov/Drugs/Re- sourcesForYou/SpecialFeatures/ucm290856.htm.,Non-OADS,/arxiv_data1/oa_pdf/24/62/jgc-12-04-431.PMC4554788.pdf
http://www.ema.europa.eu/do cs/en_GB/document_library/Re port/2012/01/WC500120115.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/62/jgc-12-04-431.PMC4554788.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/ea/bmjopen-2015-008617.PMC4554895.pdf
MMWR Morb Mortal Wkly Rep 2012;61. http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm6104a9.htm 8.,OADS,/arxiv_data1/oa_pdf/e7/ea/bmjopen-2015-008617.PMC4554895.pdf
http://content.healthaffairs.org/content/early/2004/10/07/ hlthaff.var.33.long 48.,Non-OADS,/arxiv_data1/oa_pdf/e7/ea/bmjopen-2015-008617.PMC4554895.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008439).,Non-OADS,/arxiv_data1/oa_pdf/5b/65/bmjopen-2015-008439.PMC4554896.pdf
"These samples are also genotyped using the RHA Kit Skin ( β) HPV (Diassay B.V ., Rijswijk, The Netherlands) which is able to identify HPV5, 8(I), 8(II), 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25 36, 37, 38, 47, 49, 75, 80, 92, 93and 96, or by Sanger sequencing of the CP65/CP70 amplicon and comparison with the (National Center for Biotechnology Information) NCBI Blast nucleotide data-base (http://www.ncbi.nlm.nih.gov/Blast.cgi) and/or HPV-QUEST database (http://www.ijbcb.org/HPV/) 51 to identify the closest matching known sequence.",Non-OADS,/arxiv_data1/oa_pdf/5b/65/bmjopen-2015-008439.PMC4554896.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5b/65/bmjopen-2015-008439.PMC4554896.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/5b/65/bmjopen-2015-008439.PMC4554896.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008424).,Non-OADS,/arxiv_data1/oa_pdf/6e/6b/bmjopen-2015-008424.PMC4554897.pdf
"All analyses wereperformed using R V .3.0.1 (http://www.r-project.org) and SPSS Statistics 20 (IBM, Armonk, New York, USA).",OADS,/arxiv_data1/oa_pdf/6e/6b/bmjopen-2015-008424.PMC4554897.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/6b/bmjopen-2015-008424.PMC4554897.pdf
http://wwwqualityindicatorsahrqgov/modules/ psi_resourcesaspx 2014 (cited 18 Mar 2014); http://www.qualityindicators.ahrq.gov/modules/psi_resources.aspx 7.,OADS,/arxiv_data1/oa_pdf/6e/6b/bmjopen-2015-008424.PMC4554897.pdf
▪http://www.clinicaltrials.gov was the only source for selection of clinical trials this study.,Non-OADS,/arxiv_data1/oa_pdf/d0/0d/bmjopen-2014-007304.PMC4554898.pdf
METHODS Eligibility criteriaWe screened all multinational randomised controlled trials from http://www.clinicaltrials.gov conducted in the period from 1 January 2005 to 31 December 2010.,Non-OADS,/arxiv_data1/oa_pdf/d0/0d/bmjopen-2014-007304.PMC4554898.pdf
"Therefore, we excluded the clinical trials having update information later than 14 month after completion date.We searched http://www.fda.gov US Food and Drug Administration, http://www.ema.europa.eu European Medicines Agency, http://www.cdsco.nic.in CentralDrug Standard Control Organization, India (CDSCO) and http://www.mccza.com Medicines Control Council (MCC), South Africa along with South African MedicinePrice Registry http://www.mpr.gov.za for new drug approval in the USA, the EU, India and South Africa, respectively, for the time period from 2006 until 2013.",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/bmjopen-2014-007304.PMC4554898.pdf
We screened 1175 trials from http://www.clinicaltrials.gov registered in theperiod from 1 January 2005 to 31 December 2010.,Non-OADS,/arxiv_data1/oa_pdf/d0/0d/bmjopen-2014-007304.PMC4554898.pdf
"These clinical trials were screened at the Indian regulatory site (http://www.cdsco.nic.in), South Africanregulatory sites (http://www.mccza.com and http:// www.mpr.gov.za), European Medicines Agency site (http://www.ema.europa.eu) and USFDA site (http://www.fda.gov) to determine the new drug approval status in respective countries.",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/bmjopen-2014-007304.PMC4554898.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.013hq.,OADS,/arxiv_data1/oa_pdf/d0/0d/bmjopen-2014-007304.PMC4554898.pdf
2010. http://www.who.int/gho/countries/en/ 9.,Non-OADS,/arxiv_data1/oa_pdf/d0/0d/bmjopen-2014-007304.PMC4554898.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006581).,Non-OADS,/arxiv_data1/oa_pdf/d9/2c/bmjopen-2014-006581.PMC4554899.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-008646).,Non-OADS,/arxiv_data1/oa_pdf/0b/70/bmjopen-2015-008646.PMC4554900.pdf
(http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014012900).,Non-OADS,/arxiv_data1/oa_pdf/0b/70/bmjopen-2015-008646.PMC4554900.pdf
"METHODS This review protocol has been published in thePROSPERO International Prospective Register of system- atic reviews (http://www.crd.york.ac.uk/PROSPERO), registration number CRD42014012900, and is preparedaccording to the Preferred Reporting Items for Systematic reviews and Meta-Analysis Protocols (PRISMA-P) 2015 Statement.",OADS,/arxiv_data1/oa_pdf/0b/70/bmjopen-2015-008646.PMC4554900.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 008709).,Non-OADS,/arxiv_data1/oa_pdf/b6/f5/bmjopen-2015-008709.PMC4554901.pdf
2014. http://www.pasientsikkerhetsprogrammet.no/no/I+trygge+hender/In +English (accessed 5 Jun 2014).,OADS,/arxiv_data1/oa_pdf/6b/3b/bmjopen-2015-007584.PMC4554903.pdf
2012. http://www.epuap.org/guidelines/QRG_ Prevention_in_Norwegian.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/6b/3b/bmjopen-2015-007584.PMC4554903.pdf
"After adapter trim- ming, the reads were mapped to human genome build 37 using STAR (https://code.google.com/p/rna-star/).Of these, 96% of reads were successfully mapped to the genome.",OADS,/arxiv_data1/oa_pdf/e8/64/bmjopen-2014-006772.PMC4554905.pdf
"Transcription was quanti ﬁed on the gene and meta-exon level using BEDTools (https://code.google.com/p/bedtools/) and custom scripts, and on the tran- script level using FluxCapacitor (http://sammeth.net/ conﬂuence/display/FLUX/Home).",OADS,/arxiv_data1/oa_pdf/e8/64/bmjopen-2014-006772.PMC4554905.pdf
Detailed infor- mation on the measured variables can be found in theonline LifeLines data catalogue (http://www.lifelines.,OADS,/arxiv_data1/oa_pdf/e8/64/bmjopen-2014-006772.PMC4554905.pdf
"Furthermore, the authors would like to thank The Target project (http://www.rug.nl/target) for providing the computer infrastructure and the BigGrid/eBioGrid project (http://www.ebiogrid.nl) forsponsoring the imputation pipeline implementation.",Non-OADS,/arxiv_data1/oa_pdf/e8/64/bmjopen-2014-006772.PMC4554905.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-007836).,Non-OADS,/arxiv_data1/oa_pdf/f5/49/bmjopen-2015-007836.PMC4554906.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ 10 Busse JW, et al.BMJ Open 2015; 5:e007836.",Non-OADS,/arxiv_data1/oa_pdf/f5/49/bmjopen-2015-007836.PMC4554906.pdf
2014. http://www.wsibstatistics.ca/WSIB-StatisticalReport_S1.pdf(accessed 3 Aug 2014).,OADS,/arxiv_data1/oa_pdf/f5/49/bmjopen-2015-007836.PMC4554906.pdf
2013. http://www.wsib.on.ca/files/Content/SufficiencySufficiencyReport2013/2013Q1WSIBSufficiencyReport.pdf (accessed 3 Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/f5/49/bmjopen-2015-007836.PMC4554906.pdf
2008. http://www.nationalpost.com/opinion/story.html?id=eb83e348-1660-4771-9804-e47a502aa756 (accessed 3 Aug2014).,Non-OADS,/arxiv_data1/oa_pdf/f5/49/bmjopen-2015-007836.PMC4554906.pdf
2012. http://www.ufcw.ca/index.php?option=com_content&view=article&id=2760:wsib-president-gets-80k-bonus-on-the-backs-of-injured-workers&Itemid=6&lang=en (accessed 3 Aug2014).,Non-OADS,/arxiv_data1/oa_pdf/f5/49/bmjopen-2015-007836.PMC4554906.pdf
2010. http://www.mromagazine.com/news/wsib-raises-its-rates-to-tackle-12-billion-in-unfunded-liabilities/1000391835/?&er=NA (accessed 3 Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/f5/49/bmjopen-2015-007836.PMC4554906.pdf
"Madison, WI: University of Wisconsin Paul P Carbone Comprehensive Cancer Center, 2011 https://ppsg.medicine.wisc.",Non-OADS,/arxiv_data1/oa_pdf/f5/49/bmjopen-2015-007836.PMC4554906.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-008800).,Non-OADS,/arxiv_data1/oa_pdf/b2/ed/bmjopen-2015-008800.PMC4554907.pdf
http://www.health.wa.gov.au/advancecareplanning/docs/AdvanceCareDirectives2011.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/ed/bmjopen-2015-008800.PMC4554907.pdf
http://docs.health.vic.gov.au/docs/doc/C1BEDB926ED9A6E7CA257C9A0005231A/$FILE/Advancecareplanning —strategy2014 –18.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/b2/ed/bmjopen-2015-008800.PMC4554907.pdf
http://www.multicultural.vic.gov.au/images/stories/documents/2014/RAC_documents/a2-section1-australianoverview-pp1to55.pdf (cited25 April 2015).,Non-OADS,/arxiv_data1/oa_pdf/b2/ed/bmjopen-2015-008800.PMC4554907.pdf
http://www.bccancer.bc.ca/research-programs-site/Documents/COLOUR030408_Con.pdfCanada.,OADS,/arxiv_data1/oa_pdf/b2/ed/bmjopen-2015-008800.PMC4554907.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007938).,Non-OADS,/arxiv_data1/oa_pdf/b6/02/bmjopen-2015-007938.PMC4554908.pdf
2008. http://www.gpsa.org.,Non-OADS,/arxiv_data1/oa_pdf/b6/02/bmjopen-2015-007938.PMC4554908.pdf
2002. http://www.ahrq.gov/clinic/uspstf/uspsdepr.htm#summary 17.,OADS,/arxiv_data1/oa_pdf/b6/02/bmjopen-2015-007938.PMC4554908.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-007971).,Non-OADS,/arxiv_data1/oa_pdf/8c/3a/bmjopen-2015-007971.PMC4554909.pdf
Additional information regard-ing GMI is available online (http://www.gmi-mr.com/ global-panel/panel-quality.php).,Non-OADS,/arxiv_data1/oa_pdf/8c/3a/bmjopen-2015-007971.PMC4554909.pdf
2012. http://www.smokinginengland.info/latest-statistics/ (accessed21 Aug 2014).,OADS,/arxiv_data1/oa_pdf/8c/3a/bmjopen-2015-007971.PMC4554909.pdf
http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/pol/notice_avis_e-cig-eng.php (accessed Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/8c/3a/bmjopen-2015-007971.PMC4554909.pdf
http://www.healthycanadians.gc.ca/recall-alert- rappel-avis/hc-sc/2009/13373a-eng.php (accessed Apr 2014).,OADS,/arxiv_data1/oa_pdf/8c/3a/bmjopen-2015-007971.PMC4554909.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-006509).,Non-OADS,/arxiv_data1/oa_pdf/4b/92/bmjopen-2014-006509.PMC4554911.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.4tj59.,OADS,/arxiv_data1/oa_pdf/4b/92/bmjopen-2014-006509.PMC4554911.pdf
http://www.ghanahealthservice.org/region.php?dd=6&region=Brong&nbsp;Ahafo&nbsp;Region 15.,Non-OADS,/arxiv_data1/oa_pdf/4b/92/bmjopen-2014-006509.PMC4554911.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007293).,Non-OADS,/arxiv_data1/oa_pdf/dc/7d/bmjopen-2014-007293.PMC4554912.pdf
"Information and Statistics Division, Common Services Agency, NHS.http://www.isdscotland.org/Health-Topics/General-Practice/Publications/2013-10-29/2013-10-29-PTI-Report.pdf (accessed20 Mar 2014).",Non-OADS,/arxiv_data1/oa_pdf/dc/7d/bmjopen-2014-007293.PMC4554912.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 007957).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
http://www.icmje.org/recommendations/ (accessed 6 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
http://www.wame.org/about/wame-editorial-on-coi (accessed 6 Aug2015).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
http://jams.med.or.jp/coi/coi_seminar_07.html(accessed 6 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
http://jams.med.or.jp/guideline/coi-management_201402.pdf (accessed 6 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
http://jams.med.or.,Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
Uniform Requirements for Manuscripts Submitted to Biomedical Journals.http://www.icmje.org/ (accessed 6 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
http://www.icmje.org/ (accessed 6 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
"In processing, to be added to the existing http://www.ronbun.jp (accessed 21 Aug 2015).",Non-OADS,/arxiv_data1/oa_pdf/a5/18/bmjopen-2015-007957.PMC4554913.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part A Volume 21, Numbers 17 and 18, 2015 DOI: 10.1089/ten.tea.2015.0139 2448",Non-OADS,/arxiv_data1/oa_pdf/c4/71/ten.tea.2015.0139.PMC4554934.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/94/ehv254.PMC4554960.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/93/rjv112.PMC4555002.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/67/rjv115.PMC4555003.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/06/rjv107.PMC4555009.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/openhrt-2015- 000284).,Non-OADS,/arxiv_data1/oa_pdf/79/80/openhrt-2015-000284.PMC4555068.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/openhrt-2015- 000278) Received 8 April 2015 Revised 16 June 2015 Accepted 31 July 2015 For numbered affiliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/76/50/openhrt-2015-000278.PMC4555070.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/05/08/openhrt-2015-000273.PMC4555071.pdf
"The NNT , 17 Sept 2010. http://www.thennt.com/nnt/ mediterranean-diet-for-post-heart-attack-care/ 10.",Non-OADS,/arxiv_data1/oa_pdf/05/08/openhrt-2015-000273.PMC4555071.pdf
"Web MD, 8 March 2013. http://diabetes.webmd.com/news/20130308/ diabetes-costs-rising 26.",Non-OADS,/arxiv_data1/oa_pdf/05/08/openhrt-2015-000273.PMC4555071.pdf
"The Lancet , 22 Jul 2014. http://thelancet.com/global-burden-of- disease 27.",Non-OADS,/arxiv_data1/oa_pdf/05/08/openhrt-2015-000273.PMC4555071.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/openhrt-2015- 000265).,Non-OADS,/arxiv_data1/oa_pdf/b1/29/openhrt-2015-000265.PMC4555072.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/openhrt-2014- 000231).,Non-OADS,/arxiv_data1/oa_pdf/e9/81/openhrt-2014-000231.PMC4555073.pdf
https://www.umcg.nl/ SiteCollectionDocuments/research/institutes/SHARE/assessmenttools/syntax_file_rand-36_v1_withoutaggregatescores.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/e9/81/openhrt-2014-000231.PMC4555073.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/e9/81/openhrt-2014-000231.PMC4555073.pdf
"2.4 Statistical Analysis Statistical analysis was performed with the Statistica soft- ware version 10 (Statsoft, Inc., 2011; http://www.statsoft.",OADS,/arxiv_data1/oa_pdf/7d/81/40291_2015_Article_132.PMC4555232.pdf
2014. http://www.azilect.com/ Resources/pdf/PrescribingInformation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d9/5c/40263_2015_Article_242.PMC4555339.pdf
"Hand Clin 1987; 3(3): 325–336, http://www.ncbi.nlm.nih.gov/pubmed/3308909  (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Expert Opin Biol Ther 2010; 10(1): 43–55, http://www.ncbi.nlm.nih.gov/ pubmed/20420516  3.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Tissue Eng Part B Rev 2010; 16(3): 305–329, http://www.ncbi.nlm.nih.gov/pubmed/20025455  4.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"N Engl J Med 1994; 331(14): 889–895,  http://www.ncbi.nlm.nih.gov/pubmed/8078550 (accessed 25 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"1): S40–S49, http://www.ncbi.nlm.nih.gov/pubmed/18313471 (accessed 28 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Sports Med Arthrosc Rehabil Ther Technol 2011;  3(1): 10, http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Methods 2008; 45(1): 2–9, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"J Cell Biochem  2001; 81(2): 368–377, http://www.ncbi.nlm.nih.gov/ pubmed/11241676  10.",OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Exp Cell Res 1997; 237(2): 318–325, http://www.ncbi.nlm.nih.gov/ pubmed/9434627  11.",OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Tissue Eng Part A 2008; 15(7), http://online.liebert- pub.com/doi/abs/10.1089/ten.tea.2008.0368 (accessed 30  July 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Arch Oral Biol 1999; 44(11): 935–946, http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"): 137–141, http://www.ncbi.nlm.nih.gov/ pubmed/12721357 (accessed 30 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Histol Histopathol 2014, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"1): S11–S15, http://www.ncbi.nlm.nih.gov/pubmed/23351863  (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Osteoarthritis Cartilage 2013; 21(11): 1627–1637, http://www.ncbi.nlm.nih.gov/pub- med/23933379 (accessed 2 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Biomed Mater 2009; 4(4): 045012, http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Science 1999; 284(5411): 143–147,  http://www.sciencemag.org/cgi/doi/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"J Cell Physiol 2007; 213: 341–347, http://onlinelibrary.wiley.com/doi/10.1002/ jcp.21200/full (accessed 9 July 2014).",OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Arthritis  Rheum 2005; 52(8): 2521–2529, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Stem Cell Res 2012; 8(2): 292–299, http://www.ncbi.nlm.nih.gov/pubmed/22099383 (accessed 9 June 2014).",OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Tissue Eng 2000; 6(4): 321–330, http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Stem Cells Dev 2011; 20(12): 2077–2091, http://www.ncbi.nlm.nih.gov/pubmed/ 21401444 (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Mater Sci Eng C Mater Biol Appl 2014; 40: 445–454, http://www.ncbi.nlm.nih.gov/pubmed/24857513 (accessed 9 July 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Stem Cell Res Ther 2013; 4(3): 67, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3706762&tool=pmcentrez &rendertype=abstract  31.",OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"J Mech Behav Biomed  Mater 2012; 11: 41–52, http://www.ncbi.nlm.nih.gov/  pubmed/22658153 (accessed 10 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Nat Protoc 2008; 3(7): 1125–1131, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Stem Cells Dev 2012; 21(12): 2160–2169,  http://www.pubmedcentral.nih.gov/articlerender.fcgi?",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Tissue Eng Part A 2014; 20(5–6): 930–939, http://www.ncbi.nlm.nih.gov/pubmed/24090441 (accessed 26 December 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Biotechnol Prog 2009; 4–10, http://onlinelibrary.wiley.com/doi/10.1002/btpr.186/full (accessed 26 December 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Biomaterials 2009; 30(27): 4657– 4664, http://www.ncbi.nlm.nih.gov/pubmed/19520426 (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Biomaterials 2012; 33(31): 7699– 7711, http://www.ncbi.nlm.nih.gov/pubmed/22841919 (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Nat Methods 2012; 9(7), http://www.nature.com/nmeth/journal/v9/n7/ full/nmeth.2019.html%3FWT.ec_id%3DNMETH-201207  (accessed 10 June 2014).",OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Methods 2001; 25(4): 402– 408, http://www.ncbi.nlm.nih.gov/pubmed/11846609  43.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Bone 2004; 34(4): 665–671, http://www.ncbi.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Biomaterials 2005;  26(14): 1953–1960, http://www.ncbi.nlm.nih.gov/pubmed/ 15576169 (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"J Cell Biochem 2009;  108(5): 1153–1165, http://www.ncbi.nlm.nih.gov/pub- med/19731249 (accessed 9 June 2014).",OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Tissue Eng Part C Methods 2013; 19(11):  892–899, http://www.ncbi.nlm.nih.gov/pubmed/23621108  (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Biotechnol Lett  2010; 32(9): 1339–1346, http://www.ncbi.nlm.nih.gov/  pubmed/20464452 (accessed 24 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"PLoS One 2014; 9(2): e88053, http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3917883&tool=pmcentrez&rendertype=abstract (accessed 9 June 2014).",OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Med Biol Eng Comput 2002; 40(4): 485–490, http://www.ncbi.nlm.nih.gov/pubmed/12227637  54.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Osteoarthritis Cartilage 2006; 14(12): 1272–1280, http://www.ncbi.nlm.nih.gov/pub-med/16820306 (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Cells Tissues Organs 2009; 189(5): 317–326, http://www.ncbi.nlm.nih.gov/pubmed/18689989 (accessed 9 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Muscles Ligaments Tendons J 2014; 4(1): 52–62,  http://www.mltj.org/index.php?PAGE=articolo_dett&ID_ ISSUE=744&id_article=6420 (accessed 13 August 2014).",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
"Proc Natl Acad Sci U S A 2002; 99(7):  4397–402, http://www.pubmedcentral.nih.gov/articlerender.",Non-OADS,/arxiv_data1/oa_pdf/af/28/10.1177_2041731415594127.PMC4555349.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
The online supple - mental material is available at http://www.jgp.org/cgi/content/full/jgp.201511431/DC1.,Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1093/emboj/18.1.131 Eismann, E., F. Müller, S.H.",Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1073/ pnas.91.3.1109 Fesenko, E.E., S.S. Kolesnikov, and A.L.",Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi .org/10.1038/313310a0 Frings, S., R. Seifert, M. Godde, and U.B.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1016/0896-6273(95)90074-8 Gavazzo, P., C. Picco, E. Eismann, U.B.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1085/jgp.116.3.311 Haynes, L., and K.W.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1038/317061a0 Kaupp, U.B., and R. Seifert.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
http://dx.doi.org/10.1152/physrev.,Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi .org/10.1038/nature06265 Ma, W. 2011.",Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1016/S0076-6879(97)76066-X Patton, C., S. Thompson, and D. Epel.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1016/j.ceca.2003.10.006 Picco, C., P. Gavazzo, and A. Menini.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1097/00001756- 200108080-00016 Root, M.J., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1016/0896-6273(93)90150-P Shi, N., S. Ye, A. Alam, L. Chen, and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1038/nature04508 Yau, K.W., and D.A.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"12:289– 327. http://dx.doi.org/10.1146/annurev.ne.12.030189.001445 Yau, K.W., and K. Nakatani.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1038/ 317252a0 Zhou, Y., J.H.",Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
http://dx.doi.org/10.1038/35102009undergoing structural rearrangement upon mutation.,Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10 .1038/nsmb.1531 Alam, A., and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi .org/10.1038/nsmb.1537 Alam, A., N. Shi, and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1016/B978-0-12-374841-6.00001-3 Derebe, M.G., W. Zeng, Y. Li, A. Alam, and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
"http://dx.doi.org/10.1126/science.280.5360.69 Dryer, S.E., and D. Henderson.",OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
353:756– 758. http://dx.doi.org/10.1038/353756a0,Non-OADS,/arxiv_data1/oa_pdf/cc/27/JGP_201511431.PMC4555469.pdf
© 2015 Lu and Kassab  This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1161/01.RES.79.5 .1039 Hamza, L.H., Q. Dang, X. Lu, A. Mian, S. Molloi, and G.S.",Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1152/ajpheart.00090.2003 Haul, S., A. Gödecke, J. Schrader, H.L.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/ 10.1161/01.HYP.25.3.449 Hoffman, J.I.",Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1016/0033-0620 (87)90016-8 Kuebler, W.M., U. Uhlig, T. Goldmann, G. Schael, A. Kerem, K.  Exner, C. Martin, E. Vollmer, and S. Uhlig.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/ 10.1164/rccm.200304-562OC Kuo, L., M.J. Davis, and W.M.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi .org/10.1113/jphysiol.2004.075218 Lu, X., and G.S.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1152/ajpheart.00708.2010 Lu, X., X. Guo, C. Linares, and G.S.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1152/ ajpheart.00863.2003 Lu, X., V.H.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1152/ajpheart.00550.2012 Martinez-Lemus, L.A., X. Wu, E. Wilson, M.A.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi .org/10.1159/000071886 Mogford, J.E., G.E.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/ 10.1172/JCI119689 Morello, F., A. Perino, and E. Hirsch.",Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1093/cvr/cvn325 Muller, J.M., W.M.",Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1161/01.RES.80.3.320 Naik, J.S., Z. Valic, J.B. Buckwalter, and P.S.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1172/ JCI118181 Buckwalter, J.B., S.B.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1152/physrev.00047 .2009 Clifford, P.S., H.A.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"70:1143– 1149. http://dx.doi.org/10.1124/mol.106.025809 Platts, S.H., J.E.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1111/j.1476-5381.1990.tb14151.x Schlaepfer, D.D., and T. Hunter.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi .org/10.1074/jbc.272.20.13189 Sejersted, O.M., A.R.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi .org/10.1161/01.RES.0000038487.19924.18 Sorop, O., J.A.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1161/01.RES.0000078604.47063.2B Spaan, J.A.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1161/01.RES.56.3.293Sun, D., A. Huang, F.A.",Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1152/ ajpheart.00364.2004 Takeda, H., K. Komori, N. Nishikimi, Y. Nimura, M. Sokabe, and  K. Naruse.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1016/j.lfs .2005.12.051 Tucker, G.C.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1016/S1471-4892(02)00175-3 VanTeeffelen, J.W., and S.S. Segal.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/10.1152/ ajpheart.00197.2005 Wang, H., C. Wu, S. Wan, H. Zhang, S. Zhou, and G. Liu.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi .org/10.1016/j.tox.2013.03.015 Williams, B.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"http://dx.doi.org/ 10.1097/00004872-199816121-00011 Yano, Y., J. Geibel, and B.E.",OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
"64:505– 513. http://dx.doi.org/10.1002/(SICI)1097-4644(19970301)64: 3<505::AID-JCB17>3.0.CO;2-E Yip, K.P., and D.J.",Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
http://dx.doi.org/10.1161/01 .HYP.32.2.351,Non-OADS,/arxiv_data1/oa_pdf/8b/93/JGP_201411350.PMC4555471.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
The online supplemental material is available at  http://www.jgp.org/cgi/content/full/jgp.201511458/DC1.,Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1152/physrev.00044.2006 Assad, J.A., N. Hacohen, and D.P.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/ 10.1073/pnas.86.8.2918 Beurg, M., M.G.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2188-06.2006 Beurg, M., R. Fettiplace, J.H.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10 .1038/nn.2295 Beurg, M., J.H.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1152/jn.00019 .2010 Beurg, M., K.X.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1085/jgp.201411173 Beurg, M., W. Xiong, B. Zhao, U. Müller, and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1074/jbc .M110.170092 Bosher, S.K., and R.L.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1038/273377a0 Chen, Q., S. Mahendrasingam, J.A.",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1111/j.1460-9568.2012.08159.x Corey, D.P., and A.J.",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1073/ pnas.1409920111 Coste, B., S.E.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"6:7223.  http://dx.doi.org/10.1038/ncomms8223 Crawford, A.C., and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"364:359– 379. http://dx.doi.org/10.1113/jphysiol.1985.sp015750 Crawford, A.C., M.G.",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1113/ jphysiol.1991.sp018475 Dumont, R.A., U. Lins, A.G. Filoteo, J.T.",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1146/annurev.neuro.23.1.285 Fettiplace, R., and K.X.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1152/physrev.00038.2013 Hackney, C.M., and D.N.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/ 10.1242/jcs.106120 Hackney, C.M., S. Mahendrasingam, A. Penn, and R. Fettiplace.",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1016/ 0378-5955(87)90040-2 Johnson, S.L., M. Beurg, W. Marcotti, and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1172/JCI60405 Kazmierczak, P., H. Sakaguchi, J. Tokita, E.M. Wilson-Kubalek,  R.A. Milligan, U. Müller, and B. Kachar.",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1038/ nature06091 Kim, K.X., and R. Fettiplace.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1085/jgp.201210913 Kim, K.X., M. Beurg, C.M.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1085/ jgp.201311068 Kros, C.J., A. Rüsch, and G.P.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1098/ rspb.1992.0102 Marcotti, W., A. Erven, S.L.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1113/jphysiol.2005.095661 Pan, B., G.S.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1021/ je900320r Peng, A.W., T. Effertz, and A.J.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1016/j .neuron.2013.08.025 Pickles, J.O., S.D.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1016/0378-5955(84)90041-8 Rard, J.A., and S.L.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/ 10.1083/jcb.201001138 Street, V.A., J.W.",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1038/1284 Vreugde, S., A. Erven, C.J.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1038/ ng848 Xiong, W., N. Grillet, H.M. Elledge, T.F.",Non-OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
"http://dx.doi.org/10.1016/ j.cell.2012.10.041 Zhao, B., Z. Wu, N. Grillet, L. Yan, W. Xiong, S. Harkins-Perry, and  U. Müller.",OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
84:954– 967. http://dx.doi.org/10.1016/j.neuron.2014.10.041,OADS,/arxiv_data1/oa_pdf/70/f1/JGP_201511458.PMC4555472.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1124/ mol.109.056101 Cabral, A., O. Suescun, J.M.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1371/journal.pone .0031462 Cabral, A., G. Fernandez, and M. Perello.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.neuroscience .2013.09.008 Cabral, A., S. Valdivia, G. Fernandez, M. Reynaldo, and M. Perello.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/ 10.1111/jne.12168 Cao, Y.Q., E.S.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi .org/10.1016/j.neuron.2004.07.014 Catterall, W.A., and A.P.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/ 10.1016/j.neuron.2008.09.005 Chuang, J.C., M. Perello, I. Sakata, S. Osborne-Lawrence, J.M.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"121:2684– 2692. http://dx.doi.org/10.1172/JCI57660 Chuang, J.C., I. Sakata, D. Kohno, M. Perello, S. Osborne-Lawrence,  J.J. Repa, and J.M.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1210/me.2011-1001 Cogger, V.C., G.P.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.jsb.2010.06.001 Cowley, M.A., R.G.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi .org/10.1016/S0896-6273(03)00063-1 Cui, R.J., X. Li, and S.M.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.3187-10.2011 Diano, S., S.A. Farr, S.C. Benoit, E.C.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/ 10.1038/nn1656 Evron, T., S.M.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1074/jbc.M114.581397 Furness, J.B., B. Hunne, N. Matsuda, L. Yin, D. Russo, I. Kato, M.  Fujimiya, M. Patterson, J. McLeod, Z.B.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.3869-04.20042006) that are not accessed by plasma ghrelin (Cabral  et al., 2013, 2014).",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1038/ nn1605 Andrews, Z.B., Z.W.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"29:14057– 14065. http://dx.doi.org/10.1523/JNEUROSCI.3890-09.2009 Beedle, A.M., J.E.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi .org/10.1038/nn1180 Bennett, K.A., C.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"278:25101– 25108. http://dx.doi.org/10.1074/jbc.M303266200 Kurrasch, D.M., J. Huang, T.M.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/S0076- 6879(04)89001-3 Lauckner, J.E., B. Hille, and K. Mackie.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.tins .2013.06.008 Liu, G., J.P. Fortin, M. Beinborn, and A.S. Kopin.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1124/jpet.107.123141 Liu, L., and A.R.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.neulet .2012.06.074 Mani, B.K., A.K.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"522:3644– 3666. http://dx.doi.org/10.1002/cne.23627 McGirr, R., M.S.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.regpep.2011 .08.011 Nakazato, M., N. Murakami, Y.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/ 10.1038/35051587 Pantel, J., M. Legendre, S. Cabrol, L. Hilal, Y. Hajaji, S. Morisset, S.  Nivot, M.P.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1172/JCI25303 Paxinos, G., and K. Franklin.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10 .1210/en.2008-1638 Raingo, J., A.J.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1007/s00424-014-1476-4 Heneghan, J.F., T. Mitra-Ganguli, L.F. Stanish, L. Liu, R. Zhao, and  A.R.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10 .1085/jgp.200910203 Holst, B., A. Cygankiewicz, T.H.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1210/me.2003-0069 Howard, A.D., S.D.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1126/science.273.5277.974 Ikeda, S.R.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1038/380255a0 Jiang, H., L. Betancourt, and R.G.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/ 10.1210/me.2005-0084 Jiang, M., and G. Chen.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1038/nprot.2006.86 Kammermeier, P.J., and S.R.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/ 10.1016/S0896-6273(00)80740-0 Kammermeier, P.J., V. Ruiz-Velasco, and S.R.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.neuron .2011.10.038 Keum, D., C. Baek, D.I.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1085/jgp.201411245 Kim, M.S., C.Y.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1210/en.2007-0441 Kisilevsky, A.E., and G.W.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10 .1074/jbc.M111.287607 Ribeiro, L.F., T. Catarino, S.D.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1073/ pnas.1313798111 Sakata, I., Y. Nakano, S. Osborne-Lawrence, S.A. Rovinsky, C.E.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.regpep.2009.04.001 Schaeffer, M., F. Langlet, C. Lafont, F. Molino, D.J.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1074/jbc.M112.382473 Shi, L., X. Bian, Z. Qu, Z. Ma, Y. Zhou, K. Wang, H. Jiang, and J. Xie.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"4:1435.  http://dx.doi.org/10.1038/ncomms2439 Suh, B.C., K. Leal, and B. Hille.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j .neuron.2010.07.001Suh, B.C., D.I.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1038/nn.2167 Uchida, A., J.M.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"7:121. http://dx.doi.org/10.3389/ fnins.2013.00121 Wu, L., C.S.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1038/nature01118 Wu, Q., M.P.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.cell .2009.04.022 Yang, Y., D. Atasoy, H.H.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10 .1016/j.cell.2011.07.039 Yu, B., and M.I.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1074/jbc .273.46.30183 Zamponi, G.W., and K.P.",Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"http://dx.doi.org/10.1016/j.bbamem.2012.10 .004 Zigman, J.M., J.E.",OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
http://dx.doi.org/10 .1002/cne.20823,Non-OADS,/arxiv_data1/oa_pdf/5a/52/JGP_201511383.PMC4555474.pdf
"However, GHSR1a exhibits among  the highest constitutive activities of members of the  GPCR family, and agonist-independent constitutive activ - ity of GHSR1a has been proposed to modulate neuronal All roads lead to presynaptic calcium channel inhibition by the ghrelin  receptor: Separate agonist-dependent and -independent   signaling pathways Norbert Weiss1 and Gerald W. Zamponi2 1Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., 199 00 Prague 9,  Czech Republic 2Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary,  Alberta T2N 4N1, Canada © 2015 Weiss and Zamponi  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1038/nn1605 Aridor, M., G. Rajmilevich, M.A.",OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1126/science.7504324 Cabral, A., O. Suescun, J.M.",OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1371/journal.pone.0031462 Dunlap, K., and G.D. Fischbach.",OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1038/276837a0 Dunlap, K., and G.D. Fischbach.",OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1016/j.neuron .2011.10.038 Kohno, D., H.Z.",OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.2337/ diabetes.52.4.948 Lampe, P.D., Q. Qiu, R.A. Meyer, E.M. TenBroek, T.F.",Non-OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1038/tp.2013.130 Pantel, J., M. Legendre, S. Cabrol, L. Hilal, Y. Hajaji, S. Morisset, S.  Nivot, M.P.",Non-OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1172/JCI25303 Patterson, M., S.R.",Non-OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1016/ j.peptides.2011.07.021 Proft, J., and N. Weiss.",OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1124/mol.114.096008 Stow, J.L., J.B. de Almeida, N. Narula, E.J.",Non-OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"114:1113– 1124. http://dx.doi.org/10.1083/jcb.114.6.1113 Valenti, G., G. Procino, U. Liebenhoff, A. Frigeri, P.A.",Non-OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1074/jbc.273.35.22627 Wren, A.M., C.J.",Non-OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1210/endo.141 .11.7873 Wu, Q., M.P.",OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"http://dx.doi.org/10.1016/ j.cell.2009.04.022 Zamponi, G.W.",OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
http://dx.doi.org/10.1016/j.bbamem .2012.10.004,OADS,/arxiv_data1/oa_pdf/42/d4/JGP_201511462.PMC4555476.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.8Anderson et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/26/24/10.1177_2325967113496546.PMC4555482.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.APPENDIX (continued) Case Group (Year 4 After ACLR) Control Group PValue Games played per season 19.2 +5.73 14.3 +7.58 .088 Minutes per game 73.8 +16.6 71.6 +34.6 .609 Goals per season 5.00 +11.4 1.26 +1.54 .087 Total shots per season 14.7 +12.9 10.7 +9.42 .139 Shots on goal per season 6.22 +5.74 4.27 +4.15 .173 Assists per season 1.78 +1.39 1.27 +2.12 .259 Yellow cards per season 2.56 +1.67 1.82 +1.47 .131 Red cards per season 0.33 +0.50 0.23 +0.53 .390 Fouls committed per season 23.2 +14.7 13.0 +7.72 .012 Case Group (Year 5 After ACLR) Control Group PValue (Paired Samples Student tTest) Games played per season 16.3 +10.2 15.2 +10.1 .704 Minutes per game 75.7 +15.9 64.3 +27.3 .164 Goals per season 7.17 +15.6 1.00 +1.35 .098 Total shots per season 10.8 +10.0 9.50 +10.1 .406 Shots on goal per season 2.20 +2.68 3.50 +3.55 .622 Assists per season 1.80 +1.64 0.75 +0.75 .089 Yellow cards per season 2.00 +2.35 1.83 +2.98 .990 Red cards per season 0.20 +0.45 0.25 +0.62 .938 Fouls committed per season 15.0 +13.1 12.9 +11.0 .518 aValues are expressed as mean +standard deviation.",Non-OADS,/arxiv_data1/oa_pdf/63/8c/10.1177_2325967113497189.PMC4555483.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Clinical Application of the ‘‘Glenoid Track’’ Concept 7",Non-OADS,/arxiv_data1/oa_pdf/b7/1b/10.1177_2325967113496213.PMC4555484.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Brunkhorst et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/7b/5e/10.1177_2325967113496059.PMC4555485.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine 25 Years of ACLR 7",Non-OADS,/arxiv_data1/oa_pdf/8e/67/10.1177_2325967113501789.PMC4555486.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Koyama et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/8e/99/10.1177_2325967113500222.PMC4555487.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Epidemiology of Hip Injuries in the NBA 7",Non-OADS,/arxiv_data1/oa_pdf/d1/5b/10.1177_2325967113499130.PMC4555488.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.8Sonnery-Cottet et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/f8/1c/10.1177_2325967113501624.PMC4555489.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Laible et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/5c/ae/10.1177_2325967113500638.PMC4555490.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine 3D Gait Analysis and Achilles Tendon Rupture 9",Non-OADS,/arxiv_data1/oa_pdf/60/81/10.1177_2325967113504734.PMC4555491.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Medium-Term Results After Treatment of Lateral Epicondylitis 7",Non-OADS,/arxiv_data1/oa_pdf/d2/d6/10.1177_2325967113505433.PMC4555492.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.4Greenrod,* et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/6d/37/10.1177_2325967113502638.PMC4555493.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Preservable ACL Remnants in ACLR 7",Non-OADS,/arxiv_data1/oa_pdf/4f/cc/10.1177_2325967113505076.PMC4555494.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.4Matsuura et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/ad/dd/10.1177_2325967113509948.PMC4555495.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Anesthesia Charges and Use for ACL Reconstruction 5",Non-OADS,/arxiv_data1/oa_pdf/0e/f5/10.1177_2325967113505270.PMC4555496.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.8Solomito et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/a6/ae/10.1177_2325967113508255.PMC4555497.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Outcomes After Arthroscopic Scapulothoracic Bursectomy 5",Non-OADS,/arxiv_data1/oa_pdf/60/84/10.1177_2325967113505739.PMC4555498.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Joint Space Width After Medial Meniscectomy 5",Non-OADS,/arxiv_data1/oa_pdf/b9/fd/10.1177_2325967113507539.PMC4555499.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Functional Outcome of Percutaneous Achilles Repair 7",Non-OADS,/arxiv_data1/oa_pdf/6c/5d/10.1177_2325967113494584.PMC4555500.pdf
"Nicho- lasville, KY; April 4, 2012. http://www.jockeysguild.com/news/2012/ 04/jockeysguildannounceslaunchofjockeyinjurydatabaseaimistotrack- trendsprotectriders.html.",Non-OADS,/arxiv_data1/oa_pdf/30/86/10.1177_2325967113492625.PMC4555501.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Jockey Falls and Injuries 7",Non-OADS,/arxiv_data1/oa_pdf/30/86/10.1177_2325967113492625.PMC4555501.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Tunnel Enlargement After Double-Bundle ACLR 9",Non-OADS,/arxiv_data1/oa_pdf/bb/d0/10.1177_2325967113486441.PMC4555502.pdf
"In the worst-case scenario, the 95 %limits of agreement between the 2 GPS watches are /C042 to 31 mover a 1000-m distance.15Finally, the participants were instructed to upload their training data to their personal training diary (available at http://www.vilober.dk/).",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/10.1177_2325967113487316.PMC4555503.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Predictors of Running-Related Injuries Among Novice Runners 7",Non-OADS,/arxiv_data1/oa_pdf/a4/1a/10.1177_2325967113487316.PMC4555503.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.8Owens et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/f1/fd/10.1177_2325967113492707.PMC4555504.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Roach et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/e0/ec/10.1177_2325967113489097.PMC4555505.pdf
Appropriate articles may now be submitted for peer review online (http://submit.ojsm.org).,Non-OADS,/arxiv_data1/oa_pdf/06/01/10.1177_2325967113477627.PMC4555506.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.2Editorial The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/06/01/10.1177_2325967113477627.PMC4555506.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine PRP and Rehabilitation for Hamstring Injuries in NFL Players 5",Non-OADS,/arxiv_data1/oa_pdf/0e/22/10.1177_2325967113494354.PMC4555507.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Matsushita et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/6e/74/10.1177_2325967113487855.PMC4555508.pdf
"METHODS Data were obtained from the National High School Sports- Related Injury Surveillance System, High School Reporting Information Online (High School RIO; http://www.ucdenver.",OADS,/arxiv_data1/oa_pdf/b8/47/10.1177_2325967113511588.PMC4555510.pdf
http://www.higherpeak.com/altitudechart.html.,Non-OADS,/arxiv_data1/oa_pdf/b8/47/10.1177_2325967113511588.PMC4555510.pdf
http://www.ucdenver.edu/academics/colleges/PublicHealth/ research/ResearchProjects/piper/projects/RIO/Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b8/47/10.1177_2325967113511588.PMC4555510.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Association Between Altitude and Concussion Rates 7",Non-OADS,/arxiv_data1/oa_pdf/b8/47/10.1177_2325967113511588.PMC4555510.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine MRI Findings After Patellar Dislocation 5",Non-OADS,/arxiv_data1/oa_pdf/43/c4/10.1177_2325967113512460.PMC4555511.pdf
"May 20, 2013. http://www.sportsbusinessdaily.com/ Daily/Morning-Buzz/2013/01/28/X-GAmes.aspx.",Non-OADS,/arxiv_data1/oa_pdf/ab/db/10.1177_2325967113511196.PMC4555512.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine ACL Reconstruction in X-Games Athletes 5",Non-OADS,/arxiv_data1/oa_pdf/ab/db/10.1177_2325967113511196.PMC4555512.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.APPENDIX Years 1 to 5 Following Microfracture (Cases) Versus Index Year (Controls)a Case Group (Microfracture) Control GroupPValue (Paired Samples Student tTest) 95 %CI Year 1 No.",Non-OADS,/arxiv_data1/oa_pdf/72/32/10.1177_2325967113512759.PMC4555513.pdf
Available at: http://www.medscape.com/ viewarticle/408520.,Non-OADS,/arxiv_data1/oa_pdf/c5/34/10.1177_2325967113513423.PMC4555514.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Low-Field MRI for Evaluating Knee Pathology 7",Non-OADS,/arxiv_data1/oa_pdf/c5/34/10.1177_2325967113513423.PMC4555514.pdf
2013. http://www.nbcnews.com/health/head-injuries-clearly-linked-brain-da mage-8C11034117.,Non-OADS,/arxiv_data1/oa_pdf/7d/78/10.1177_2325967113517860.PMC4555515.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Jacobson et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/7d/78/10.1177_2325967113517860.PMC4555515.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6ElMaraghy et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/51/04/10.1177_2325967113516729.PMC4555516.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Anatomy of the Anterolateral Ligament 5",Non-OADS,/arxiv_data1/oa_pdf/74/0a/10.1177_2325967113513546.PMC4555517.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.8Kobayashi et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/0a/85/10.1177_2325967113518163.PMC4555518.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Anatomic Pattern of Injuries in Acute Ankle Sprains 5",Non-OADS,/arxiv_data1/oa_pdf/4f/25/10.1177_2325967113517078.PMC4555519.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Monazzam et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/f1/f0/10.1177_2325967113512467.PMC4555520.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Humeral Head SRA in Young, Active Patients 7",Non-OADS,/arxiv_data1/oa_pdf/dd/83/10.1177_2325967113519407.PMC4555521.pdf
http://www.amawa.com.au/mixed-martial-arts- must-be-banned-ama-wa/.,Non-OADS,/arxiv_data1/oa_pdf/18/37/10.1177_2325967113518492.PMC4555522.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.10 Lystad et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/18/37/10.1177_2325967113518492.PMC4555522.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Medial Epicondyle Morphology in Overhead Athletes 7",Non-OADS,/arxiv_data1/oa_pdf/fe/43/10.1177_2325967113517211.PMC4555523.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Differences in Ice Hockey Injuries Between the Sexes 7",Non-OADS,/arxiv_data1/oa_pdf/3d/9d/10.1177_2325967113518181.PMC4555524.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.10 Abrams et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/a8/76/10.1177_2325967113518305.PMC4555525.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Shea et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/23/e5/10.1177_2325967113519741.PMC4555526.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/11/0a/10.1177_2325967114562371.PMC4555527.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c2/ac/10.1177_2325967114562191.PMC4555528.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/68/2f/10.1177_2325967114560130.PMC4555529.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/81/34/10.1177_2325967114562205.PMC4555530.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ce/cf/10.1177_2325967114561962.PMC4555531.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fb/ea/10.1177_2325967114561585.PMC4555532.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/96/bd/10.1177_2325967114561737.PMC4555533.pdf
http://www.agingstats.gov/ Main_Site/Data/2012_Documents/docs/EntireChartbook.pdf.,OADS,/arxiv_data1/oa_pdf/96/bd/10.1177_2325967114561737.PMC4555533.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/0f/a6/10.1177_2325967114562781.PMC4555534.pdf
2011. http://www.rfu.com/news/2012/january/newsarticles/ */ media/files/2012/rfu_injury%20and%20training%20audit%202010-11_ v5.ashx.,Non-OADS,/arxiv_data1/oa_pdf/0f/a6/10.1177_2325967114562781.PMC4555534.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/12/99/10.1177_2325967114533646.PMC4555535.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/1f/17/10.1177_2325967114531213.PMC4555536.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/51/6b/10.1177_2325967114532424.PMC4555537.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/58/6b/10.1177_2325967114534824.PMC4555538.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8d/f1/10.1177_2325967114534387.PMC4555540.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8e/83/10.1177_2325967114532762.PMC4555541.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/bd/d0/10.1177_2325967114533482.PMC4555542.pdf
http://www.fifa.com/mm/ document/afdeveloping/pitchequip/fqc_football_turf_folder_342.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/10.1177_2325967114533482.PMC4555542.pdf
http://www.fieldturf.com/media/W1siZiIsIjIwM TIvMDgvMDEvMjIvMjUvNTQvNzEyL3Blbm5fc3RhdGVfdW5pdmVyc 2l0eV9zdGFwaF9zdHVkeS5wZGYiXV0/penn-state-university-staph- study.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/d0/10.1177_2325967114533482.PMC4555542.pdf
http://plantscience.psu.edu/re search/centers/ssrc/documents/temperature-irrigation.pdf.,OADS,/arxiv_data1/oa_pdf/bd/d0/10.1177_2325967114533482.PMC4555542.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c4/41/10.1177_2325967114532780.PMC4555543.pdf
"March 27, 2001. http://www.defense.gov/news/newsarticle.",OADS,/arxiv_data1/oa_pdf/c4/41/10.1177_2325967114532780.PMC4555543.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f6/cb/10.1177_2325967114553164.PMC4555544.pdf
http://www.cms.gov/Newsroom/MediaReleaseDatabase/Press- Releases/2013-Press-Releases-Items/2013-08-02.html.,Non-OADS,/arxiv_data1/oa_pdf/f6/cb/10.1177_2325967114553164.PMC4555544.pdf
http://www.nber.org/papers/w19503.,Non-OADS,/arxiv_data1/oa_pdf/f6/cb/10.1177_2325967114553164.PMC4555544.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/9e/e3/10.1177_2325967114553916.PMC4555545.pdf
http://www.baseball-almanac.com/players/birthplace.php.,Non-OADS,/arxiv_data1/oa_pdf/9e/e3/10.1177_2325967114553916.PMC4555545.pdf
http://mste.illinois.edu/ malcz/DATA/WEATHER/Temperatures.html.,Non-OADS,/arxiv_data1/oa_pdf/9e/e3/10.1177_2325967114553916.PMC4555545.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/78/39/10.1177_2325967114553552.PMC4555546.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a3/eb/10.1177_2325967114551528.PMC4555547.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f9/c3/10.1177_2325967114551328.PMC4555548.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7c/19/10.1177_2325967114552405.PMC4555549.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/6d/63/10.1177_2325967114552800.PMC4555550.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a7/58/10.1177_2325967114553558.PMC4555551.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/1b/b0/10.1177_2325967114554195.PMC4555552.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/06/1f/10.1177_2325967114555678.PMC4555553.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f4/52/10.1177_2325967114556257.PMC4555554.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/47/6a/10.1177_2325967114554550.PMC4555555.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f9/99/10.1177_2325967114554549.PMC4555556.pdf
http://0-go.galegroup.com.skyline.,Non-OADS,/arxiv_data1/oa_pdf/f9/99/10.1177_2325967114554549.PMC4555556.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8c/94/10.1177_2325967114555478.PMC4555557.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/74/6c/10.1177_2325967114559892.PMC4555558.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c4/61/10.1177_2325967114559506.PMC4555560.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine, 2(3), 2325967114527235 DOI: 10.1177/2325967114527235 ªThe Author(s) 2014 1",Non-OADS,/arxiv_data1/oa_pdf/5a/7f/10.1177_2325967114527235.PMC4555561.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Effects of an 8-Week Barefoot Running Program 5",Non-OADS,/arxiv_data1/oa_pdf/c0/21/10.1177_2325967114525582.PMC4555562.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine, 2(3), 2325967114527234 DOI: 10.1177/2325967114527234 ªThe Author(s) 2014 1",Non-OADS,/arxiv_data1/oa_pdf/13/13/10.1177_2325967114527234.PMC4555563.pdf
"December 9, 2013. http://www.denverpost.",Non-OADS,/arxiv_data1/oa_pdf/13/13/10.1177_2325967114527234.PMC4555563.pdf
"December 6, 2013. http://foxnewsinsider.com/2013/12/ 06/higher-altitudes-result-redu ced-concussion-rates.",Non-OADS,/arxiv_data1/oa_pdf/13/13/10.1177_2325967114527234.PMC4555563.pdf
"Pub- lished December 10, 2013. http://www.nlm.nih.gov/medlineplus/ news/fullstory_143291.html.",Non-OADS,/arxiv_data1/oa_pdf/13/13/10.1177_2325967114527234.PMC4555563.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.§Address correspondence to Kai-Ming Chan, Department of Ortho- paedics and Traumatology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong (e-mail: kaimingchan@cuhk.edu.hk).",Non-OADS,/arxiv_data1/oa_pdf/d1/5f/10.1177_2325967114526687.PMC4555564.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine TMT Injuries in Football Players: Video Analysis 7",Non-OADS,/arxiv_data1/oa_pdf/52/64/10.1177_2325967114525347.PMC4555565.pdf
"All costs associated with diagnostic workup and medical management prior to diagnosis were calculated using the 2012B version (March 2012 release) of the Physician Fee Schedule Search, available through the Centers for Medi- care & Medicaid Services Web site (https://www.cms.gov/ apps/physician-fee-schedule/search/search-criteria.aspx).",OADS,/arxiv_data1/oa_pdf/7c/22/10.1177_2325967114523916.PMC4555566.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Time and Cost of Diagnosis for FAI 7",Non-OADS,/arxiv_data1/oa_pdf/7c/22/10.1177_2325967114523916.PMC4555566.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Effect of Notchplasty on Transtibial/Medial Portal Drilling 7",Non-OADS,/arxiv_data1/oa_pdf/1e/4d/10.1177_2325967114525572.PMC4555567.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine The KneeM to Evaluate Rotational Knee Laxity 7",Non-OADS,/arxiv_data1/oa_pdf/0f/a8/10.1177_2325967114525583.PMC4555568.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/01/7b/10.1177_2325967114527901.PMC4555569.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/41/e9/10.1177_2325967114526135.PMC4555570.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/4b/8b/10.1177_2325967114544021.PMC4555571.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/5b/19/10.1177_2325967114544107.PMC4555572.pdf
2008. http://www.hosonline.org/survey s/hos/download/Veterans_RAND_ 12_Item_Health_Survey_White_Paper_Summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5b/19/10.1177_2325967114544107.PMC4555572.pdf
2012. http://www.ncaa.org/wps/wcm/connect/public/ncaa/pdfs/2012/ estimated þprobability þofþcompeting þinþathletics þbeyond þtheþ highþschool þinterscholastic þlevel.,Non-OADS,/arxiv_data1/oa_pdf/5b/19/10.1177_2325967114544107.PMC4555572.pdf
2013. http://www.ncaa.org/wps/wcm/connect/ public/NCAA/Resources/Latest þNews/2012/September/NCAA þ student-athlete þparticipation þhitsþ450000.,Non-OADS,/arxiv_data1/oa_pdf/5b/19/10.1177_2325967114544107.PMC4555572.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/89/9b/10.1177_2325967114544104.PMC4555573.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/df/03/10.1177_2325967114543901.PMC4555574.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/47/eb/10.1177_2325967114541237.PMC4555575.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/2b/05/10.1177_2325967114544457.PMC4555576.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d9/33/10.1177_2325967114547346.PMC4555577.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/02/1b/10.1177_2325967114548176.PMC4555578.pdf
Available at: http://www.cdc.gov/nccdphp/dnpao/ growthcharts/resources/sas.htm.,OADS,/arxiv_data1/oa_pdf/02/1b/10.1177_2325967114548176.PMC4555578.pdf
Available at: http://stats.oecd.org/.,Non-OADS,/arxiv_data1/oa_pdf/02/1b/10.1177_2325967114548176.PMC4555578.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/20/5b/10.1177_2325967114545298.PMC4555579.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d3/be/10.1177_2325967115569198.PMC4555580.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/00/0e/10.1177_2325967114566599.PMC4555582.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/42/8a/10.1177_2325967114564358.PMC4555583.pdf
http://www.cpsc.gov/en/Resear ch–Statistics/NEISS-Injury-Data/.,OADS,/arxiv_data1/oa_pdf/42/8a/10.1177_2325967114564358.PMC4555583.pdf
http://www.outdoorfoundati on.org/research.participation.,Non-OADS,/arxiv_data1/oa_pdf/42/8a/10.1177_2325967114564358.PMC4555583.pdf
http://www.cpsc.gov//PageFiles/106617/2001d011-6b6.pdf.,Non-OADS,/arxiv_data1/oa_pdf/42/8a/10.1177_2325967114564358.PMC4555583.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7a/82/10.1177_2325967115571084.PMC4555584.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7d/ac/10.1177_2325967114566796.PMC4555585.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/75/dd/10.1177_2325967114566788.PMC4555587.pdf
http://jsbb.or.jp/outline/ teams.,Non-OADS,/arxiv_data1/oa_pdf/75/dd/10.1177_2325967114566788.PMC4555587.pdf
http://web.usa baseball.com/news /article.jsp?ymd ¼20090813&content_id ¼640 9508.,Non-OADS,/arxiv_data1/oa_pdf/75/dd/10.1177_2325967114566788.PMC4555587.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8c/6d/10.1177_2325967114563664.PMC4555588.pdf
http://www.cdc.gov/nchs/icd/ icd9cm.htm.,Non-OADS,/arxiv_data1/oa_pdf/8c/6d/10.1177_2325967114563664.PMC4555588.pdf
http://www.cdc.gov/nchs/nsas.htm.,OADS,/arxiv_data1/oa_pdf/8c/6d/10.1177_2325967114563664.PMC4555588.pdf
http://www.cdc.gov/nchs/nhds.htm.,Non-OADS,/arxiv_data1/oa_pdf/8c/6d/10.1177_2325967114563664.PMC4555588.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/6e/26/10.1177_2325967114528862.PMC4555589.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a2/af/10.1177_2325967114530988.PMC4555590.pdf
http://www.nfhs.org/ content.aspx?id ¼3282.,Non-OADS,/arxiv_data1/oa_pdf/a2/af/10.1177_2325967114530988.PMC4555590.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/90/69/10.1177_2325967114531177.PMC4555591.pdf
"Study data were collected from October 2012 to February 2013 via an electronic survey (see th e Appendix, available at http://ojsm.sagepub.com/supplemental).",OADS,/arxiv_data1/oa_pdf/90/69/10.1177_2325967114531177.PMC4555591.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/b9/04/10.1177_2325967114530969.PMC4555592.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/2a/3a/10.1177_2325967114528460.PMC4555593.pdf
"Washington, DC: Division of Hazard and Injury Data Systems, US Consumer Product Safety Commission; 2001. http://www.cpsc.gov/PageFiles/106617/2001d011-6b6.pdf.",Non-OADS,/arxiv_data1/oa_pdf/2a/3a/10.1177_2325967114528460.PMC4555593.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e7/a4/10.1177_2325967114530840.PMC4555594.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/7d/9b/10.1177_2325967114530090.PMC4555595.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/da/2b/10.1177_2325967114529920.PMC4555596.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ea/67/10.1177_2325967114529703.PMC4555597.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/33/81/10.1177_2325967114530075.PMC4555598.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/b3/54/10.1177_2325967114529257.PMC4555599.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e8/92/10.1177_2325967114537588.PMC4555600.pdf
http://www.afl.com.au/staticfile/AFL%20Tenant/ AFL/Files/AFLInjuryReportFor2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e8/92/10.1177_2325967114537588.PMC4555600.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/43/68/10.1177_2325967114535351.PMC4555601.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ca/be/10.1177_2325967114535188.PMC4555602.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/9e/e8/10.1177_2325967114539122.PMC4555603.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/14/1d/10.1177_2325967114534591.PMC4555604.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/14/29/10.1177_2325967114537032.PMC4555605.pdf
http://web.usabaseball.,Non-OADS,/arxiv_data1/oa_pdf/14/29/10.1177_2325967114537032.PMC4555605.pdf
http://www.littleleague.org/assets/forms_pubs/media/ pitchingregulationchanges_bb_11-13-09.pdf.,Non-OADS,/arxiv_data1/oa_pdf/14/29/10.1177_2325967114537032.PMC4555605.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/82/b3/10.1177_2325967114535553.PMC4555606.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/07/1e/10.1177_2325967115570848.PMC4555607.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c2/a0/10.1177_2325967115569691.PMC4555608.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/07/59/10.1177_2325967115572573.PMC4555609.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/e5/03/10.1177_2325967115570560.PMC4555610.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/73/4b/10.1177_2325967115572135.PMC4555611.pdf
R package version 1.1-2. http://CRAN.R-project.org/package ¼OptimalCutpoints.,Non-OADS,/arxiv_data1/oa_pdf/73/4b/10.1177_2325967115572135.PMC4555611.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8f/8b/10.1177_2325967115570019.PMC4555612.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d6/ca/10.1177_2325967115571300.PMC4555613.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8c/4b/10.1177_2325967115571079.PMC4555614.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Adductor-Related Groin Pain in Soccer Players 7",Non-OADS,/arxiv_data1/oa_pdf/0a/a2/10.1177_2325967114521778.PMC4555615.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6McCulloch et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/a1/ca/10.1177_2325967114521575.PMC4555616.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.8Chalmers et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/52/bf/10.1177_2325967114523902.PMC4555617.pdf
http://espn.go.com/espn/story/_/ id/7058209/peyton-manning-last-star-linked-stem-cell-therapy- espn-magazine.,Non-OADS,/arxiv_data1/oa_pdf/7d/bc/10.1177_2325967113519935.PMC4555618.pdf
http://www.cnn.com/2011/09/22/health/peyton-manning-stem- cells/index.html.,Non-OADS,/arxiv_data1/oa_pdf/7d/bc/10.1177_2325967113519935.PMC4555618.pdf
http://clinicaltrials.gov/.,Non-OADS,/arxiv_data1/oa_pdf/7d/bc/10.1177_2325967113519935.PMC4555618.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Stem Cell and Regenerative Medicine in Sports Injuries 7",Non-OADS,/arxiv_data1/oa_pdf/7d/bc/10.1177_2325967113519935.PMC4555618.pdf
2012. http://www.hcahpsonline.org.,Non-OADS,/arxiv_data1/oa_pdf/29/e3/10.1177_2325967113512606.PMC4555619.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Cartilage-Specific Study Quality Score 9",Non-OADS,/arxiv_data1/oa_pdf/29/e3/10.1177_2325967113512606.PMC4555619.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Injuries During Brazilian Jiu-Jitsu Competition 7",Non-OADS,/arxiv_data1/oa_pdf/9e/85/10.1177_2325967114522184.PMC4555620.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.6Tompkins et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/ee/7d/10.1177_2325967114523384.PMC4555621.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.8Kovack et al The Orthopaedic Journal of Sports Medicine",Non-OADS,/arxiv_data1/oa_pdf/b4/4e/10.1177_2325967114522198.PMC4555622.pdf
"July 28, 2003. http://usatoday30.usatoday.com/sports/baseball/2003-07- 28-cover-tommy-john_x.htm.",Non-OADS,/arxiv_data1/oa_pdf/c9/44/10.1177_2325967114522592.PMC4555623.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Pitch Velocity After UCL Reconstruction 5",Non-OADS,/arxiv_data1/oa_pdf/c9/44/10.1177_2325967114522592.PMC4555623.pdf
"For reprints and permission queries, please visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.The Orthopaedic Journal of Sports Medicine Return to Play After Open Bankart Repair 5",Non-OADS,/arxiv_data1/oa_pdf/85/27/10.1177_2325967114522960.PMC4555624.pdf
2013;1(7):1-6. http://ojs.sagepub.com/content/1/7/2325967113512467.,Non-OADS,/arxiv_data1/oa_pdf/fa/31/10.1177_2325967114525574.PMC4555625.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d0/86/10.1177_2325967114550276.PMC4555626.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/9a/80/10.1177_2325967114550781.PMC4555627.pdf
"For details, see http://www.broadinstitute.org/gsea/index.jsp.",Non-OADS,/arxiv_data1/oa_pdf/9a/80/10.1177_2325967114550781.PMC4555627.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/dd/13/10.1177_2325967114549948.PMC4555628.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/38/1e/10.1177_2325967114549541.PMC4555629.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c2/c4/10.1177_2325967114550638.PMC4555630.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a3/e0/10.1177_2325967114550987.PMC4555631.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/64/ac/10.1177_2325967114550274.PMC4555632.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a8/77/10.1177_2325967114550623.PMC4555633.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/db/52/10.1177_2325967114548831.PMC4555634.pdf
http://www.nhl.com/ice/news.htm?id ¼559630.,Non-OADS,/arxiv_data1/oa_pdf/db/52/10.1177_2325967114548831.PMC4555634.pdf
"Published by Oxford University Press.JNCI J Natl Cancer Inst  (2015) 107(5): djv034 doi:10.1093/jnci/djv034 First published online February 24, 2015 Article 1 of 9 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/a0/djv034.PMC4555639.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.MEDICAL ACUPUNCTURE Volume 27, Number 4, 2015 DOI: 10.1089/acu.2015.1106 253",Non-OADS,/arxiv_data1/oa_pdf/2a/f8/acu.2015.1106.PMC4555646.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).*A.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
Cellular metabolic measurements ECAR and OCR were measured in real time using the Seahorse XFp analyzer instrument according to the Seahorse standard protocols: XFp Glycolysis Stress Test kit (http://www.seahorsebio.com/resources/ pdfs/manual-xf96-glycolysis-stress-test-kit.pdf) and XFp Cell Mito  Stress Test kit (http://www.seahorsebio.com/resources/pdfs/manual-xf24-cell-mito-stress-test-kit.pdf).,OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"The peptides/proteins were iden-tified by the Integrated Proteomics Pipeline-IP2 software (Integrated  Proteomics Applications, http://www.integratedproteomics.com/) using  ProLuCID and DTASelect2 (Tabb et al., 2002) with a decoy database strategy.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"The  stringent ([Q/N][K/R][F/I/V/L][E/D][K/R], [K/R][F/I/V/L][E/D][K/R][Q/N]) and relaxed ([Q/N/V][D/E/K/R/F][E/K/V/L][D/E/K/R/V/F/L][D/E/Q]) CMA motifs were designed based on Kaushik and Cuervo (2012) using MotifGen software (http://www.proteinguru.com/toolbox/ motifgen/).",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"Protein sequences were batch retrieved from Uniprot (ver - sion 07-05-2014, http://www.uniprot.org/) and CMA motif searches  were performed using the regular expression search engine BASALT (http://www.proteinguru.com/toolbox/basalt/).",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
Online supplemental material is avail-able at http://www.jcb.org/cgi/content/full/jcb.201503044/DC1.,Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1093/carcin/bgr241 Cuervo, A.M.  2010.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1016/j.tem.2009.10.003 Cuervo, A.M., W. Hu, B. Lim, and J.F. Dice.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1091/mbc.9.8.1995 Degterev, A., Z. Huang, M. Boyce, Y .",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1038/nchembio711 Dey, P., S. Rachagani, S. Chakraborty, P.K.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1158/1078-0432.CCR-12-1789 Elstrom, R.L., D.E.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-03-2904Kaushik, S., and A.M. Cuervo.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.3109/10428194.2013.800198 Kroemer, G., and J. Pouyssegur.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1016/j.ccr.2008.05.005 Liu, J., H. Xia, M. Kim, L. Xu, Y .",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1016/j.cell.2011.08.037 Lu, W., Y .",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1016/j.cell.2014.12.001 Mason, E.F., Y .",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1016/j.cell.2011.10.026 Mulichak, A.M., J.E.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1038/811 Nederlof, R., O. Eerbeek, M.W.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1111/bph.12363 Parcells, B.W., A.K.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1634/ stemcells.2005-0519 Patra, K.C., Q. Wang, P.T.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1016/j.ccr.2013.06.014 Rauniyar, N., K.  Subramanian, M.  Lavallee-Adam, S.  Martinez-Bartolome,  W.E.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1074/mcp.M114.045609 Schröter, C.J., M.  Braun, J.  Englert, H.  Beck, H.  Schmid, and H.  Kalbacher.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1016/ S0022-1759(99)00079-4 Shaw, R.J., and L.C. Cantley.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1038/nature04869 Tabb, D.L., W.H.",OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1021/pr015504q Vakifahmetoglu-Norberg, H., M. Kim, H.G.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1101/gad.220897.113 Vaux, D.L. 2012.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1038/85686 White, E. 2012.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1038/nrc3262 Wolf, A., S. Agnihotri, J. Micallef, J. Mukherjee, N. Sabha, R. Cairns, C. Hawkins,  and A. Guha.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
"http://dx.doi.org/10.1084/jem.20101470 Zarrinkar, P.P., R.N.",Non-OADS,/arxiv_data1/oa_pdf/70/c6/JCB_201503044.PMC4555813.pdf
http://dx.doi.org/10.1083/jcb.201506107)  find that the spindle area is demarcated by a semiperme - able organelle barrier.,Non-OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"Their re - sults add an important new feature to the models of how  this structure assembles and is regulated.Concentrating on the mitotic spindle Paul S. Maddox and Anne -Marie Ladouceur Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 © 2015 Maddox and Ladouceur This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1083/ jcb.201308087 Brown, K.S., M.D.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1038/nature03061 Cleveland, D.W., Y .",Non-OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00115-6 Gerhold, A.R., J.  Ryan, J.N.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1016/j.cub.2015.02.054 Good, M.C., M.D.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1126/science.1243147 Hazel, J., K.  Krutkramelis, P.  Mooney, M.  Tomschik, K.  Gerow, J.  Oakey,  and J.C. Gatlin.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1126/ science.1243110 Lee, C., H. Zhang, A.E.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1016/j.devcel.2013.05.007 Levy, D.L., and R.  Heald.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-092910-154158 Pickett-Heaps, J., T. Spurck, and D. Tippit.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1083/jcb.99.1.137s Qi, H., U.  Rath, D.  Wang, Y .Z.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
http://dx.doi.org/10.1002/jcb.20243Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1016/j.ceb.2014.01.002 Schweizer, N., N.  Pawar, M.  Weiss, and H.  Maiato.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1083/ jcb.201506107http://dx.doi.org/10.1016/j.ceb.2014.01.002 Slep, K.C.",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1042/ BST0371002Walker, D.L., D. Wang, Y .",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1083/jcb.151.7.1401 Weber, S.C., and C.P. Brangwynne.",Non-OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
"http://dx.doi.org/10.1016/j.cell.2012.05.022 Wühr, M., Y .",OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
http://dx.doi.org/10.1016/j.cub.2008.07.092,OADS,/arxiv_data1/oa_pdf/77/28/JCB_201508007.PMC4555814.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e2/b9/JCB_201501114.PMC4555815.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Katalin Schlett: schlettk@ludens.elte.hu Abbreviations used in this paper: cLTP, chemical LTP; DI, discrimination index;  DOX, doxycycline; EPSP, excitatory postsynaptic potential; HFS, high-frequency  stimulation; LTP, long-term potentiation; MF, mossy fiber; POPS, population spike;  PSD, postsynaptic density; ROI, region of interest; SC, Schaffer collateral.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e2/b9/JCB_201501114.PMC4555815.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201501114/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e2/b9/JCB_201501114.PMC4555815.pdf
"http://dx.doi.org/10.1007/s10339-011-0430-z Arévalo, J.C., D.B.",Non-OADS,/arxiv_data1/oa_pdf/e2/b9/JCB_201501114.PMC4555815.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/b9/JCB_201501114.PMC4555815.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.1879-08.2008 Borbély, S., E.  Dobó, D.  Czégé, E.  Molnár, M.  Bakos, B.  Szucs, A.  Vincze,  I. Világi, and A. Mihály.",Non-OADS,/arxiv_data1/oa_pdf/e2/b9/JCB_201501114.PMC4555815.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/b9/JCB_201501114.PMC4555815.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/b9/JCB_201501114.PMC4555815.pdf
